{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 141062, "items": [{"indexed": {"date-parts": [[2019, 12, 20]], "date-time": "2019-12-20T09:05:09Z", "timestamp": 1576832709827}, "reference-count": 163, "publisher": "Elsevier BV", "issue": "22", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2003, 4, 1]], "date-time": "2003-04-01T00:00:00Z", "timestamp": 1049155200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Life Sciences"], "published-print": {"date-parts": [[2003, 4]]}, "DOI": "10.1016/s0024-3205(03)00141-3", "type": "journal-article", "created": {"date-parts": [[2003, 3, 25]], "date-time": "2003-03-25T23:24:25Z", "timestamp": 1048634665000}, "page": "2429-2449", "source": "Crossref", "is-referenced-by-count": 132, "title": ["5-HT2A and 5-HT2C receptors and their atypical regulation properties"], "prefix": "10.1016", "volume": "72", "author": [{"given": "Dirk", "family": "Van Oekelen", "sequence": "first", "affiliation": []}, {"given": "Walter H.M.L", "family": "Luyten", "sequence": "additional", "affiliation": []}, {"given": "Jos\u00e9e E", "family": "Leysen", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Life Sciences"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0024320503001413?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0024320503001413?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 2, 23]], "date-time": "2019-02-23T00:15:43Z", "timestamp": 1550880943000}, "score": 60.759098, "issued": {"date-parts": [[2003, 4]]}, "references-count": 163, "journal-issue": {"published-print": {"date-parts": [[2003, 4]]}, "issue": "22"}, "alternative-id": ["S0024320503001413"], "URL": "http://dx.doi.org/10.1016/s0024-3205(03)00141-3", "ISSN": ["0024-3205"], "issn-type": [{"value": "0024-3205", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T17:46:45Z", "timestamp": 1574099205184}, "reference-count": 41, "publisher": "Elsevier BV", "issue": "1", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2001, 8, 1]], "date-time": "2001-08-01T00:00:00Z", "timestamp": 996624000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["European Journal of Pharmacology"], "published-print": {"date-parts": [[2001, 8]]}, "DOI": "10.1016/s0014-2999(01)01170-0", "type": "journal-article", "created": {"date-parts": [[2002, 10, 31]], "date-time": "2002-10-31T19:09:39Z", "timestamp": 1036091379000}, "page": "21-32", "source": "Crossref", "is-referenced-by-count": 7, "title": ["Different regulation of rat 5-HT2A and rat 5-HT2C receptors in NIH 3T3 cells upon exposure to 5-HT and pipamperone"], "prefix": "10.1016", "volume": "425", "author": [{"given": "Dirk Van", "family": "Oekelen", "sequence": "first", "affiliation": []}, {"given": "Mirek", "family": "Jurzak", "sequence": "additional", "affiliation": []}, {"given": "Danielle", "family": "Van de Wiel", "sequence": "additional", "affiliation": []}, {"given": "Geert", "family": "Van Hecke", "sequence": "additional", "affiliation": []}, {"given": "Walter H.M.L.", "family": "Luyten", "sequence": "additional", "affiliation": []}, {"given": "Jos\u00e9e E.", "family": "Leysen", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["European Journal of Pharmacology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0014299901011700?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0014299901011700?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 4, 25]], "date-time": "2019-04-25T20:23:32Z", "timestamp": 1556223812000}, "score": 39.554276, "issued": {"date-parts": [[2001, 8]]}, "references-count": 41, "journal-issue": {"published-print": {"date-parts": [[2001, 8]]}, "issue": "1"}, "alternative-id": ["S0014299901011700"], "URL": "http://dx.doi.org/10.1016/s0014-2999(01)01170-0", "ISSN": ["0014-2999"], "issn-type": [{"value": "0014-2999", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T07:06:34Z", "timestamp": 1574319994510}, "reference-count": 75, "publisher": "Elsevier", "isbn-type": [{"value": "9780444820419", "type": "print"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[1997]]}, "DOI": "10.1016/s0165-7208(97)80013-x", "type": "book-chapter", "created": {"date-parts": [[2007, 9, 7]], "date-time": "2007-09-07T23:06:56Z", "timestamp": 1189206416000}, "page": "161-197", "source": "Crossref", "is-referenced-by-count": 3, "title": ["5-HT2A, 5-HT2B and 5-HT2C receptor ligands"], "prefix": "10.1016", "author": [{"given": "I.", "family": "van Wijngaarden", "sequence": "first", "affiliation": []}, {"given": "W.", "family": "Soudijn", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Serotonin Receptors And Their Ligands", "Pharmacochemistry Library"], "deposited": {"date-parts": [[2019, 5, 2]], "date-time": "2019-05-02T22:12:47Z", "timestamp": 1556835167000}, "score": 35.79355, "issued": {"date-parts": [[1997]]}, "ISBN": ["9780444820419"], "references-count": 75, "URL": "http://dx.doi.org/10.1016/s0165-7208(97)80013-x", "ISSN": ["0165-7208"], "issn-type": [{"value": "0165-7208", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T11:33:16Z", "timestamp": 1574163196948}, "reference-count": 39, "publisher": "Wiley", "issue": "5", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 4501, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.1046/j.1471-4159.2003.01738.x", "type": "journal-article", "created": {"date-parts": [[2003, 5, 14]], "date-time": "2003-05-14T09:03:10Z", "timestamp": 1052902990000}, "page": "1087-1100", "source": "Crossref", "is-referenced-by-count": 25, "title": ["Functional study of rat 5-HT2A receptors using antisense oligonucleotides"], "prefix": "10.1111", "volume": "85", "author": [{"given": "Dirk", "family": "Van Oekelen", "sequence": "first", "affiliation": []}, {"given": "Anton", "family": "Megens", "sequence": "additional", "affiliation": []}, {"given": "Theo", "family": "Meert", "sequence": "additional", "affiliation": []}, {"given": "Walter H. M. L.", "family": "Luyten", "sequence": "additional", "affiliation": []}, {"given": "Jos\u00e9e E.", "family": "Leysen", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2003, 5, 6]]}, "reference": [{"key": "10.1046/j.1471-4159.2003.01738.x-BIB21|cit2", "doi-asserted-by": "crossref", "first-page": "633", "DOI": "10.1016/0028-3908(77)90117-4", "article-title": "Wet-dog shake behavior in the rat: a possible quantitative model of central 5-hydroxytryptamine activity", "volume": "16", "author": "Bedard", "year": "1977", "journal-title": "Neuropharmacology"}, {"key": "10.1046/j.1471-4159.2003.01738.x-BIB26|cit3", "doi-asserted-by": "crossref", "first-page": "3494", "DOI": "10.1021/jm970424c", "article-title": "6-Chloro-5-methyl-1-[[2-[(2-methyl-3-pyridyl) oxy]-5-pyridyl]carbamoyl]- indoline (SB-242084): the first selective and brain penetrant 5-HT2C receptor antagonist", "volume": "40", "author": "Bromidge", "year": "1997", "journal-title": "J. Med. Chem."}, {"key": "10.1046/j.1471-4159.2003.01738.x-BIB34|cit4", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1016/0165-0173(93)90005-K", "article-title": "Psychopharmacological interactions between stress hormones and central serotonergic systems", "volume": "18", "author": "Chaouloff", "year": "1993", "journal-title": "Brain Res. Rev."}, {"key": "10.1046/j.1471-4159.2003.01738.x-BIB35|cit5", "doi-asserted-by": "crossref", "first-page": "449", "DOI": "10.1016/0028-3908(94)90075-2", "article-title": "Effects of chlorisondamine and restraint on cortical [3H]Ketanserin binding, 5-HT2A receptor-mediated head shakes, and behaviours in models of anxiety", "volume": "33", "author": "Chaouloff", "year": "1994", "journal-title": "Neuropharmacology"}, {"key": "10.1046/j.1471-4159.2003.01738.x-BIB27|cit6", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1016/S1054-3589(08)60136-2", "article-title": "Advances in understanding the pharmacological properties of antisense oligonucleotides", "volume": "40", "author": "Crooke", "year": "1997", "journal-title": "Adv. Pharmacol."}, {"key": "10.1046/j.1471-4159.2003.01738.x-BIB6|cit7", "doi-asserted-by": "crossref", "first-page": "601", "DOI": "10.1016/S0028-3908(97)00042-7", "article-title": "Activation of 5-HT2B receptors in the medial amygdala causes anxiolysis in the social interaction test in the rat", "volume": "36", "author": "Duxon", "year": "1997", "journal-title": "Neuropharmacology"}, {"key": "10.1046/j.1471-4159.2003.01738.x-BIB20|cit8", "author": "Finney", "first-page": "50", "year": "1980", "volume-title": "Probit Analysis"}, {"key": "10.1046/j.1471-4159.2003.01738.x-BIB4|cit9", "first-page": "323", "article-title": "Two kinds of tryptamine receptors", "volume": "12", "author": "Gaddum", "year": "1957", "journal-title": "Br. J. Pharmacol."}, {"key": "10.1046/j.1471-4159.2003.01738.x-BIB31|cit10", "doi-asserted-by": "crossref", "first-page": "457", "DOI": "10.1016/0028-3908(94)90076-0", "article-title": "Evidence that mCPP-induced anxiety in the plus-maze is mediated by postsynaptic 5-HT2C receptors but not by sympathomimetic effects", "volume": "33", "author": "Gibson", "year": "1994", "journal-title": "Neuropharmacology"}, {"key": "10.1046/j.1471-4159.2003.01738.x-BIB28|cit11", "doi-asserted-by": "crossref", "first-page": "223", "DOI": "10.1016/S0169-328X(97)00048-X", "article-title": "End-capped antisense oligonucleotides effectively inhibit gene expression in vivo and offer a non-toxic alternative to fully modified phosphorothioate oligodeoxynucleotide", "volume": "47", "author": "Hebb", "year": "1997", "journal-title": "Mol. Brain. Res."}, {"key": "10.1046/j.1471-4159.2003.01738.x-BIB1|cit12", "first-page": "157", "article-title": "International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin)", "volume": "46", "author": "Hoyer", "year": "1994", "journal-title": "Pharmaco1. Rev."}, {"key": "10.1046/j.1471-4159.2003.01738.x-BIB14|cit13", "first-page": "685", "article-title": "Pharmacology of risperidone (R 64 766), a new antipsychotic with serotonin-S2 and dopamine-D2 antagonistic properties", "volume": "244", "author": "Janssen", "year": "1988", "journal-title": "J. Pharmaco1. Exp. Ther."}, {"key": "10.1046/j.1471-4159.2003.01738.x-BIB7|cit14", "first-page": "968", "article-title": "Preclinical characterization of the potential of the putative atypical antipsychotic MDL 100,907 as a potent 5-HT2A antagonist with a favorable CNS safety profile", "volume": "277", "author": "Kehne", "year": "1996", "journal-title": "J. Pharmaco1. Exp. Ther."}, {"key": "10.1046/j.1471-4159.2003.01738.x-BIB8|cit15", "doi-asserted-by": "crossref", "first-page": "609", "DOI": "10.1016/S0028-3908(97)00038-5", "article-title": "SB 242084, a selective and brain penetrant 5-HT2C receptor antagonist", "volume": "36", "author": "Kennett", "year": "1997", "journal-title": "Neuropharmacology"}, {"key": "10.1046/j.1471-4159.2003.01738.x-BIB9|cit16", "doi-asserted-by": "crossref", "first-page": "1603", "DOI": "10.1016/S0028-3908(98)00115-4", "article-title": "Anxiolytic-like actions of BW 723C86 in the rat Vogel conflict test are 5-HT2B receptor mediated", "volume": "37", "author": "Kennett", "year": "1998", "journal-title": "Neuropharmacology"}, {"key": "10.1046/j.1471-4159.2003.01738.x-BIB2|cit17", "doi-asserted-by": "crossref", "first-page": "168", "DOI": "10.1038/272168a0", "article-title": "Serotonergic component of neuroleptic receptors", "volume": "272", "author": "Leysen", "year": "1978", "journal-title": "Nature"}, {"key": "10.1046/j.1471-4159.2003.01738.x-BIB23|cit18", "doi-asserted-by": "crossref", "first-page": "29", "DOI": "10.1080/00150198208210593", "article-title": "Ferroelectric polymers and their applications", "volume": "40", "author": "Marcus", "year": "1982", "journal-title": "Ferroelectrics"}, {"key": "10.1046/j.1471-4159.2003.01738.x-BIB24|cit19", "doi-asserted-by": "crossref", "first-page": "119", "DOI": "10.1002/ddr.430180204", "article-title": "The psychopharmacology of ritanserin: comparison with chlordiazepoxide", "volume": "18", "author": "Meert", "year": "1989", "journal-title": "Drug Dev. Res."}, {"key": "10.1046/j.1471-4159.2003.01738.x-BIB15|cit20", "doi-asserted-by": "crossref", "first-page": "185", "DOI": "10.1016/S0079-6468(08)70306-0", "article-title": "Risperidone and related 5HT2/D2 antagonists: a new type of antipsychotic agent?", "volume": "33", "author": "Megens", "year": "1996", "journal-title": "Prog. Med. Chem."}, {"key": "10.1046/j.1471-4159.2003.01738.x-BIB22|cit21", "doi-asserted-by": "crossref", "first-page": "382", "DOI": "10.1007/BF00187261", "article-title": "Behavioural activity of rats measured by a new method based on the piezo-electric principle", "volume": "93", "author": "Megens", "year": "1987", "journal-title": "Psychopharmacology"}, {"key": "10.1046/j.1471-4159.2003.01738.x-BIB16|cit22", "first-page": "146", "article-title": "Pharmacological profile of the new potent neuroleptic ocaperidone (R 79,598)", "volume": "260", "author": "Megens", "year": "1992", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "10.1046/j.1471-4159.2003.01738.x-BIB17|cit23", "doi-asserted-by": "crossref", "first-page": "9", "DOI": "10.1007/BF02245439", "article-title": "Survey on the pharmacodynamics of the new antipsychotic risperidone", "volume": "114", "author": "Megens", "year": "1994", "journal-title": "Psychopharmacology (Berl.)"}, {"key": "10.1046/j.1471-4159.2003.01738.x-BIB12|cit24", "doi-asserted-by": "crossref", "first-page": "123", "DOI": "10.1002/ddr.430030203", "article-title": "Mescaline-induced head-twitches in the rat: an in vivo method to evaluate serotonin S2 antagonists", "volume": "3", "author": "Niemegeers", "year": "1983", "journal-title": "Drug. Dev. Res."}, {"key": "10.1046/j.1471-4159.2003.01738.x-BIB29|cit25", "doi-asserted-by": "crossref", "first-page": "197", "DOI": "10.1016/0165-1781(96)02935-6", "article-title": "Modulation of learned helplessness by 5-hydroxytryptamine2A receptor antisense oligodeoxynucleotides", "volume": "63", "author": "Papolos", "year": "1996", "journal-title": "Psychiatry Res."}, {"key": "10.1046/j.1471-4159.2003.01738.x-BIB19|cit26", "author": "Paxinos", "year": "1988", "volume-title": "The Rat Brain in Stereotaxic Coordinates"}, {"key": "10.1046/j.1471-4159.2003.01738.x-BIB5|cit27", "doi-asserted-by": "crossref", "first-page": "539", "DOI": "10.1016/0014-2999(84)90057-8", "article-title": "The binding of serotonergic ligands to the porcine choroid plexus: characterisation of a new type of serotonin recognition site", "volume": "106", "author": "Pazos", "year": "1984", "journal-title": "Eur. J. Pharmacol."}, {"key": "10.1046/j.1471-4159.2003.01738.x-BIB3|cit28", "first-page": "687", "article-title": "Multiple serotonin receptors: differential binding of [3H]serotonin, [3H]lysergic acid diethylamide and [3H]spiroperidol", "volume": "16", "author": "Peroutka", "year": "1979", "journal-title": "Mol. Pharmacol."}, {"key": "10.1046/j.1471-4159.2003.01738.x-BIB11|cit29", "doi-asserted-by": "crossref", "first-page": "827", "DOI": "10.1126/science.7221567", "article-title": "Two distinct central serotonin receptors with different physiological functions", "volume": "212", "author": "Peroutka", "year": "1981", "journal-title": "Science (Wash. DC)"}, {"key": "10.1046/j.1471-4159.2003.01738.x-BIB18|cit30", "first-page": "4135", "article-title": "Structure and functional expression of cloned rat serotonin 5HT-2 receptor", "volume": "7", "author": "Pritchett", "year": "1988", "journal-title": "EMBO J."}, {"key": "10.1046/j.1471-4159.2003.01738.x-BIB10|cit31", "first-page": "924", "article-title": "Lysergic acid diethylamide and 2,5-dimethoxy-4-methylamphetamine are partial agonists at serotonin receptors linked to phosphoinositide hydrolysis", "volume": "246", "author": "Sanders-Bush", "year": "1988", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "10.1046/j.1471-4159.2003.01738.x-BIB33|cit32", "doi-asserted-by": "crossref", "first-page": "1457", "DOI": "10.1046/j.1471-4159.1998.71041457.x", "article-title": "Regulation of serotonin2A receptor expression by an antisense oligodeoxynucleotide", "volume": "71", "author": "Scalzitti", "year": "1998", "journal-title": "J. Neurochem."}, {"key": "10.1046/j.1471-4159.2003.01738.x-BIB13|cit33", "first-page": "101", "article-title": "(1-(2,5- Dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT)2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists", "volume": "273", "author": "Schreiber", "year": "1995", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "10.1046/j.1471-4159.2003.01738.x-BIB30|cit34", "first-page": "1056", "article-title": "Antisense inhibition of 5-hydroxytryptamine2a receptor induces an antidepressant-like effect in mice", "volume": "52", "author": "Sibille", "year": "1997", "journal-title": "Am. Soc. Pharmacol. Exp. Ther."}, {"key": "10.1046/j.1471-4159.2003.01738.x-BIB25|cit35", "author": "Siegel", "first-page": "116", "year": "1956", "volume-title": "Nonparametric Statistics for the Behavioural Sciences"}, {"key": "10.1046/j.1471-4159.2003.01738.x-BIB37|cit36", "doi-asserted-by": "crossref", "first-page": "198", "DOI": "10.1016/0006-8993(90)91138-7", "article-title": "Adrenergic regulation of [3H]ketanserin binding sites during immobilization stress in the rat frontal cortex", "volume": "527", "author": "Torda", "year": "1990", "journal-title": "Brain Res."}, {"key": "10.1046/j.1471-4159.2003.01738.x-BIB36|cit37", "doi-asserted-by": "crossref", "first-page": "291", "DOI": "10.1016/0006-8993(90)91718-V", "article-title": "Destruction of the nucleus raphe obscurus and potentiation of serotonin-mediated behaviours following administration of the neurotoxin 3-acetylpyridine", "volume": "520", "author": "Wieland", "year": "1990", "journal-title": "Brain Res."}, {"key": "10.1046/j.1471-4159.2003.01738.x-BIB32|cit38", "first-page": "699", "article-title": "Direct injection of 5-HT2A receptor agonists into the medial prefrontal cortex produces a head-twitch response in rats", "volume": "282", "author": "Willins", "year": "1997", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "10.1046/j.1471-4159.2003.01738.x-BIB38|cit39", "first-page": "1015", "article-title": "In vivo administration of an oligodeoxynucleotide antisense to the D2 dopamine receptor mRNA inhibits D2 dopamine receptor-mediated behavior and the expression of D2 dopamine receptors in mouse striatum", "volume": "268", "author": "Zhou", "year": "1993", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "10.1046/j.1471-4159.2003.01738.x-BIB39|cit40", "doi-asserted-by": "crossref", "first-page": "583", "DOI": "10.1016/S0197-0186(96)00064-2", "article-title": "Intrastriatal administration of an oligodeoxynucleotide antisense to the D2 dopamine receptor mRNA inhibits D2 dopamine receptors in normal mice and in mice lesioned with 6-hydroxytryptamine", "volume": "29", "author": "Zhou", "year": "1996", "journal-title": "Neurochem. Int."}], "container-title": ["Journal of Neurochemistry"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1471-4159.2003.01738.x", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 2, 16]], "date-time": "2018-02-16T11:40:10Z", "timestamp": 1518781210000}, "score": 33.37286, "subtitle": ["5-HT2A antisense inhibits 5-HT2A behaviours"], "issued": {"date-parts": [[2003, 5, 6]]}, "references-count": 39, "journal-issue": {"issue": "5"}, "URL": "http://dx.doi.org/10.1046/j.1471-4159.2003.01738.x", "relation": {"cites": []}, "ISSN": ["0022-3042", "1471-4159"], "issn-type": [{"value": "0022-3042", "type": "print"}, {"value": "1471-4159", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T04:40:18Z", "timestamp": 1574138418704}, "reference-count": 52, "publisher": "Elsevier BV", "issue": "4", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2004, 9, 1]], "date-time": "2004-09-01T00:00:00Z", "timestamp": 1093996800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Neuropharmacology"], "published-print": {"date-parts": [[2004, 9]]}, "DOI": "10.1016/j.neuropharm.2004.04.020", "type": "journal-article", "created": {"date-parts": [[2004, 9, 22]], "date-time": "2004-09-22T16:16:26Z", "timestamp": 1095869786000}, "page": "527-537", "source": "Crossref", "is-referenced-by-count": 28, "title": ["The atypical antipsychotic drug clozapine enhances chronic PCP-induced regulation of prefrontal cortex 5-HT2A receptors"], "prefix": "10.1016", "volume": "47", "author": [{"given": "Lucinda J.", "family": "Steward", "sequence": "first", "affiliation": []}, {"given": "Matthew D.", "family": "Kennedy", "sequence": "additional", "affiliation": []}, {"given": "Brian J.", "family": "Morris", "sequence": "additional", "affiliation": []}, {"given": "Judith A.", "family": "Pratt", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Neuropharmacology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0028390804001406?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0028390804001406?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 2, 3]], "date-time": "2019-02-03T18:57:42Z", "timestamp": 1549220262000}, "score": 29.977528, "issued": {"date-parts": [[2004, 9]]}, "references-count": 52, "journal-issue": {"published-print": {"date-parts": [[2004, 9]]}, "issue": "4"}, "alternative-id": ["S0028390804001406"], "URL": "http://dx.doi.org/10.1016/j.neuropharm.2004.04.020", "ISSN": ["0028-3908"], "issn-type": [{"value": "0028-3908", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T08:02:28Z", "timestamp": 1575187348481}, "reference-count": 49, "publisher": "Springer Science and Business Media LLC", "issue": "2", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[1995, 5, 1]], "date-time": "1995-05-01T00:00:00Z", "timestamp": 799286400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Psychopharmacology"], "published-print": {"date-parts": [[1995, 5]]}, "DOI": "10.1007/bf02246164", "type": "journal-article", "created": {"date-parts": [[2005, 11, 15]], "date-time": "2005-11-15T05:04:26Z", "timestamp": 1132031066000}, "page": "222-230", "source": "Crossref", "is-referenced-by-count": 56, "title": ["The role of the 5-HT2A and 5-HT2C receptors in the stimulus effects ofm-chlorophenylpiperazine"], "prefix": "10.1007", "volume": "119", "author": [{"given": "D.", "family": "Fiorella", "sequence": "first", "affiliation": []}, {"given": "R. A.", "family": "Rabin", "sequence": "additional", "affiliation": []}, {"given": "J. C.", "family": "Winter", "sequence": "additional", "affiliation": []}], "member": "297", "reference": [{"key": "BF02246164_CR1", "doi-asserted-by": "crossref", "first-page": "355", "DOI": "10.1002/ddr.430160229", "volume": "16", "author": "NA Ator", "year": "1989", "unstructured": "Ator NA, Griffiths RR (1989) Asymmetrical cross-generalization in drug discrimination with lorazepam and pentobarbital training conditions. Drug Dev Res 16:355\u2013364", "journal-title": "Drug Dev Res"}, {"key": "BF02246164_CR2", "first-page": "72", "volume": "250", "author": "G Bagdy", "year": "1989", "unstructured": "Bagdy G, Szemeredi K, Kenyicska B, Murphy DL (1989a) Different serotonin receptors mediate blood-pressure, heart rate, plasma catecholamine and prolactin responses tom-chlorophenylpiperazine in conscious rats. J Pharmacol Exp Ther 250:72\u201378", "journal-title": "J Pharmacol Exp Ther"}, {"key": "BF02246164_CR3", "doi-asserted-by": "crossref", "first-page": "2664", "DOI": "10.1210/endo-125-5-2664", "volume": "125", "author": "G Bagdy", "year": "1989", "unstructured": "Bagdy G, Calogero AE, Murphy DL, Szemeredi K (1989b) Serotonin agonists cause parallel activation of the sympathoadrenomedullary system and the hypothalamo-pituitary-adrenocortical axis in conscious rats. Endocrinology 125:2664\u20132669", "journal-title": "Endocrinology"}, {"key": "BF02246164_CR4", "author": "RL Balster", "first-page": "127", "year": "1990", "unstructured": "Balster RL (1990) Perception of drug effects. In: Berkeley MA, Stebbins WG (eds) Comparative perception, vol 1: basic mechanisms. Wiley, N.Y. pp 127\u2013154", "volume-title": "Comparative perception, vol 1: basic mechanisms"}, {"key": "BF02246164_CR5", "doi-asserted-by": "crossref", "first-page": "231", "DOI": "10.1002/ddr.430200209", "volume": "20", "author": "JV Brady", "year": "1990", "unstructured": "Brady JV, Hienz RD, Ator NA (1990) Stimulus functions of drugs and the assessmet of abuse liability. Drug Res Dev 20:231\u2013249", "journal-title": "Drug Res Dev"}, {"key": "BF02246164_CR6", "doi-asserted-by": "crossref", "first-page": "477", "DOI": "10.1111/j.2042-7158.1981.tb13841.x", "volume": "33", "author": "S Caccia", "year": "1981", "unstructured": "Caccia S, Ballabio M, Samanin R, Zanini MG, Gavattini S (1981) (-)mCPP, a central 5-hydroxytrypatamine agonist, is a metabolite of trazadone. J Pharm Pharmacol 33:477\u2013478", "journal-title": "J Pharm Pharmacol"}, {"key": "BF02246164_CR7", "doi-asserted-by": "crossref", "first-page": "605", "DOI": "10.1111/j.2042-7158.1982.tb04807.x", "volume": "34", "author": "S Caccia", "year": "1982", "unstructured": "Caccia S, Fung MH, Gavattini S, Zanini MG (1982) Plasma concentrations of trazadone and 1-(3-chlorophenyl)piperazine in man after a single oral dose of trazadone. J Pharm Pharmacol 34:605\u2013606", "journal-title": "J Pharm Pharmacol"}, {"key": "BF02246164_CR8", "doi-asserted-by": "crossref", "first-page": "27", "DOI": "10.1016/0014-2999(94)90690-4", "volume": "257", "author": "PM Callahan", "year": "1994", "unstructured": "Callahan PM, Cunningham KA (1994) Involvement of 5-HT2C receptors in mediating the discriminative stimulus properties ofm-chlorophenylpiperazine (mCPP) Eur J Pharmacol 257:27\u201338", "journal-title": "Eur J Pharmacol"}, {"key": "BF02246164_CR9", "doi-asserted-by": "crossref", "first-page": "93", "DOI": "10.1016/0014-2999(90)94100-C", "volume": "191", "author": "H Canton", "year": "1990", "unstructured": "Canton H, Laurence V, Colpaert FC (1990) Binding of typical and atypical antipsychotics to 5-HT1C and 5-HT2 sites: clozapine potently interacts with 5-HT1C sites. Eur J Pharm 191:93\u201396", "journal-title": "Eur J Pharm"}, {"key": "BF02246164_CR10", "doi-asserted-by": "crossref", "first-page": "473", "DOI": "10.1111/j.1365-2125.1993.tb04172.x", "volume": "35", "author": "JG Carver", "year": "1992", "unstructured": "Carver JG, Grahame-Smith DG, Johnson ES, Madgwick Z (1992) The effects of 5-HT andm-chlorophenylpiperazine (mCPP) on the efflux of [3H]5-HT from human perfused platelets. Br J Clin Pharmacol 35:473\u2013478", "journal-title": "Br J Clin Pharmacol"}, {"key": "BF02246164_CR11", "doi-asserted-by": "crossref", "first-page": "14", "DOI": "10.1007/BF00215473", "volume": "92", "author": "PS Charney", "year": "1987", "unstructured": "Charney PS, Woods SW, Goodman WK, Heninger GR (1987) Serotonin function in anxiety II: Effects of the serotonin agonist mCPP in panic disorder patients and healthy subjects. Psychopharmacology 92:14\u201324", "journal-title": "Psychopharmacology"}, {"key": "BF02246164_CR12", "doi-asserted-by": "crossref", "first-page": "711", "DOI": "10.1016/0024-3205(83)90303-X", "volume": "32", "author": "ML Cohen", "year": "1983", "unstructured": "Cohen ML, Fuller RW (1983) Antagonism of vascular serotonin receptors by m-chlorophenylpiperazine andm-trifluoromethylphenylpiperazine. Life Sci 32:711\u2013718", "journal-title": "Life Sci"}, {"key": "BF02246164_CR13", "author": "FC Colpaert", "first-page": "341", "year": "1990", "unstructured": "Colpaert FC (1990) Drug discrimination: methods of manipulation, measurement and analysis. In: Bozarth MA (ed) Methods of assessing the reinforcing properties of abused drugs. Springer, Berlin pp 341\u2013372", "volume-title": "Methods of assessing the reinforcing properties of abused drugs"}, {"key": "BF02246164_CR14", "first-page": "195", "volume": "234", "author": "PJ Conn", "year": "1985", "unstructured": "Conn PJ, Sanders-Bush E (1985) Serotonin stimulated phosphoinositide turnover: mediation by the S2 binding site in rat cerebral cortex, but not subcortical regions. J Pharmacol Exp Ther 234:195\u2013203", "journal-title": "J Pharmacol Exp Ther"}, {"key": "BF02246164_CR15", "doi-asserted-by": "crossref", "first-page": "1754", "DOI": "10.1111/j.1471-4159.1986.tb13085.x", "volume": "47", "author": "PJ Conn", "year": "1986", "unstructured": "Conn PJ, Sanders-Bush E (1986) Agonist-induced phosphoinositide hydrolysis in rat choroid plexus. J Neurochem 47:1754\u20131769", "journal-title": "J Neurochem"}, {"key": "BF02246164_CR16", "first-page": "552", "volume": "242", "author": "PJ Conn", "year": "1987", "unstructured": "Conn PJ, Sanders-Bush E (1987) Relative efficacies of piperazines at the phosphoinositide hydrolysis-linked serotonergic 5-HT1C and 5-HT2 receptors. J Pharmacol Exp Ther 242:552\u2013557", "journal-title": "J Pharmacol Exp Ther"}, {"key": "BF02246164_CR17", "first-page": "628", "volume": "228", "author": "RL Friedman", "year": "1984", "unstructured": "Friedman RL, Barrett RJ, Sanders-Bush E (1984) Discriminative stimulus properties of quipazine: mediation by serotonin2 binding sites. J Pharmacol Exp Ther 228:628\u2013634", "journal-title": "J Pharmacol Exp Ther"}, {"key": "BF02246164_CR18", "doi-asserted-by": "crossref", "first-page": "155", "DOI": "10.1016/0028-3908(81)90198-2", "volume": "20", "author": "RW Fuller", "year": "1981", "unstructured": "Fuller RW, Snoddy HD, Mason MR, Owens JE (1981) Disposition and pharmacological effects ofm-chlorophenylpiperazine in rats. Neuropharmacology 20:155\u2013162", "journal-title": "Neuropharmacology"}, {"key": "BF02246164_CR19", "author": "RA Glennon", "first-page": "69", "year": "1982", "unstructured": "Glennon RA, Rosecrans JA, Young R (1982) The use of the drug discrimination paradigm for studying hallucinogenic agents. In: Colpaert FC, Slangen JL (eds) Drug discrimination: applications in CNS pharmacology. Elsevier Biomedical Press, Amsterdam, pp 69\u201396", "volume-title": "Drug discrimination: applications in CNS pharmacology"}, {"key": "BF02246164_CR20", "doi-asserted-by": "crossref", "first-page": "289", "DOI": "10.1002/med.2610030305", "volume": "3", "author": "RA Glennon", "year": "1984", "unstructured": "Glennon RA, Rosecrans JA, Young R (1984) Drug-induced discrimination: a description of the paradigm and a review of its specific application to the study of hallucinogenic agents. Med Res Rev 3:289\u2013376", "journal-title": "Med Res Rev"}, {"key": "BF02246164_CR21", "doi-asserted-by": "crossref", "first-page": "569", "DOI": "10.1016/0006-3223(89)90217-5", "volume": "25", "author": "A Hamick", "year": "1989", "unstructured": "Hamick A, Peroutka SJ (1989) 1-(m-Chloro-phenyl)piperazine interactions with neurotransmitters in the human brain. Biol Psychiatry 25:569\u2013575", "journal-title": "Biol Psychiatry"}, {"key": "BF02246164_CR22", "first-page": "276", "volume": "263", "author": "EM Hoenicke", "year": "1992", "unstructured": "Hoenicke EM, Vanacek SA, Woods JH (1992) The discriminative stimulus effects of clozapine in pigeons: involvement of 5-HT1C and 5-HT2 receptors. J Pharmacol Exp Ther 263:276\u2013284", "journal-title": "J Pharmacol Exp Ther"}, {"key": "BF02246164_CR23", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1016/0165-1781(91)90113-4", "volume": "36", "author": "E Hollander", "year": "1991", "unstructured": "Hollander E, Decaria C, Gully R (1991) Effects of chronic fluoxetine treatment on behavioral and neuroendocrine responses tom-chlorophenylpiperazine in obsessive-compulsive disorder. Psychiatry Res 36:1\u201317", "journal-title": "Psychiatry Res"}, {"key": "BF02246164_CR24", "doi-asserted-by": "crossref", "first-page": "59", "DOI": "10.3109/10799898809048978", "volume": "8", "author": "D Hoyer", "year": "1988", "unstructured": "Hoyer D (1988) Functional correlates of serotonin 5-HT1recognition sites. J Recept Res 8:59\u201381", "journal-title": "J Recept Res"}, {"key": "BF02246164_CR25", "doi-asserted-by": "crossref", "first-page": "225", "DOI": "10.1007/BF00173573", "volume": "339", "author": "D Hoyer", "year": "1989", "unstructured": "Hoyer D, Waeber C, Schoeffter P, Palacios JM, Dravid A (1989) 5-HT1C receptor mediated stimulation of inositol phosphate production in pig choroid plexus. Naunyn-Schmiedeberg's Arch Pharmacol 339:225\u2013238", "journal-title": "Naunyn-Schmiedeberg's Arch Pharmacol"}, {"key": "BF02246164_CR26", "doi-asserted-by": "crossref", "first-page": "137", "DOI": "10.1007/BF00167210", "volume": "344", "author": "D Hoyer", "year": "1991", "unstructured": "Hoyer D, Schoeffter P, Sahin-Erdemli I (1991) Competitive antagonism by recognized 5-HT2 receptor antagonists at 5-HT1C receptors in pig choroid plexus. Naunyn-Schmiedeberg's Arch Pharmacol 344:137\u2013142", "journal-title": "Naunyn-Schmiedeberg's Arch Pharmacol"}, {"key": "BF02246164_CR27", "first-page": "157", "volume": "46", "author": "D Hoyer", "year": "1994", "unstructured": "Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, Saxena PR, Humphrey PA (1994) International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev 46:157\u2013203", "journal-title": "Pharmacol Rev"}, {"key": "BF02246164_CR28", "doi-asserted-by": "crossref", "first-page": "99", "DOI": "10.1016/0014-2999(93)90981-M", "volume": "239", "author": "BA Hulihan-Giblin", "year": "1993", "unstructured": "Hulihan-Giblin BA, Park YD, Goldman D, Aulakh CS (1993) Analysis of the 5-HT1C receptor and the serotonin uptake site in Fawn-Hooded rat brain. Eur J Pharmacol 239:99\u2013102", "journal-title": "Eur J Pharmacol"}, {"key": "BF02246164_CR29", "doi-asserted-by": "crossref", "first-page": "770", "DOI": "10.1016/0006-3223(91)90233-C", "volume": "30", "author": "N Iqbal", "year": "1991", "unstructured": "Iqbal N, Asnis GM, Wetzler S, Kahn RS, Van Praag HM (1991) The mCPP challenge test in schizophrenia: humoral and behavioral responses. Biol Psychiatry 30:770\u2013778", "journal-title": "Biol Psychiatry"}, {"key": "BF02246164_CR30", "doi-asserted-by": "crossref", "first-page": "289", "DOI": "10.1016/0091-3057(93)90355-W", "volume": "46", "author": "RG Johnson", "year": "1993", "unstructured": "Johnson RG, Fiorella D, Rabin RA (1993) Effects of chronic cocaine administration on the serotonergic system in rat brain. Pharmacol Biochem Behav 46:289\u2013293", "journal-title": "Pharmacol Biochem Behav"}, {"key": "BF02246164_CR31", "doi-asserted-by": "crossref", "first-page": "558", "DOI": "10.1126/science.3399891", "volume": "241", "author": "DJ Julius", "year": "1988", "unstructured": "Julius DJ, Macdermott AB, Axel R, Jessell JM (1988) Molecular characterization of a functional cDNA encoding the serotonin1C receptor. Science 241:558\u2013564", "journal-title": "Science"}, {"key": "BF02246164_CR32", "doi-asserted-by": "crossref", "first-page": "1139", "DOI": "10.1016/0006-3223(91)90184-N", "volume": "30", "author": "RS Kahn", "year": "1991", "unstructured": "Kahn RS, Wetzler S (1991)m-Chlorophenylpiperazine as a probe of serotonin function. Biol Psychiatry 30:1139\u20131166", "journal-title": "Biol Psychiatry"}, {"key": "BF02246164_CR33", "doi-asserted-by": "crossref", "first-page": "101", "DOI": "10.1016/0165-1781(88)90163-1", "volume": "25", "author": "RS Kahn", "year": "1988", "unstructured": "Kahn RS, Wetzler S, Van Praag, Asnis GM, Strauman T (1988) Behavioral indications for serotonin receptor hypersensitivity in panic disorder. Psychiatry Res 25:101\u2013104", "journal-title": "Psychiatry Res"}, {"key": "BF02246164_CR34", "doi-asserted-by": "crossref", "first-page": "189", "DOI": "10.1016/0165-1781(90)90073-E", "volume": "33", "author": "RS Kahn", "year": "1990", "unstructured": "Kahn RS, Kalus O, Cahn W, Wetzler S, Asnis GM, Van Praag HM (1990) The effect of 5-HT antagonists onm-chlorophenylpiperazine mediated responses. Psychiatry Res 33:189\u2013198", "journal-title": "Psychiatry Res"}, {"key": "BF02246164_CR35", "doi-asserted-by": "crossref", "first-page": "1053", "DOI": "10.1016/0006-3223(90)90606-3", "volume": "28", "author": "O Kalus", "year": "1991", "unstructured": "Kalus O, Kahn RS, Wetzler S, Asnis GM, Van Praag HM (1991) Behavioral hypersensitivity tom-chlorophenylpiperazine in a subject with subclinical panic attacks. Biol Psychiatry 28:1053\u20131057", "journal-title": "Biol Psychiatry"}, {"key": "BF02246164_CR36", "doi-asserted-by": "crossref", "first-page": "137", "DOI": "10.1111/j.1476-5381.1988.tb11508.x", "volume": "94", "author": "GA Kennett", "year": "1988", "unstructured": "Kennett GA, Curzon G (1988) Evidence that mCPP may have behavioral effects mediated by central 5-HT1C receptors. Br J Pharmacol 94:137\u2013147", "journal-title": "Br J Pharmacol"}, {"key": "BF02246164_CR37", "doi-asserted-by": "crossref", "first-page": "2016", "DOI": "10.1111/j.1476-5381.1991.tb12369.x", "volume": "103", "author": "GA Kennett", "year": "1991", "unstructured": "Kennett GA, Curzon G (1991) Potencies of antagonists indicate that 5-HT1C receptors mediate 1-3(chlorophenyl)piperazine induced hypophagia. Br J Pharmacol 103:2016\u20132020", "journal-title": "Br J Pharmacol"}, {"key": "BF02246164_CR38", "doi-asserted-by": "crossref", "first-page": "624", "DOI": "10.1001/archpsyc.1993.01820200034004", "volume": "50", "author": "JH Krystal", "year": "1993", "unstructured": "Krystal JH, Seibyl JP, Lawrence HP, Woods SW, Heninger GR, Aghajanian GK, Charney DS (1993)m-Chlorophenylpiperazine effects in neuroleptic free schizophrenic patients. Arch Gen Psychiatry 50:624\u2013635", "journal-title": "Arch Gen Psychiatry"}, {"key": "BF02246164_CR39", "first-page": "155", "volume": "249", "author": "I Lucki", "year": "1989", "unstructured": "Lucki I, Ward HR, Frazer A (1989) Effect of 1-(m-chlorophenyl) piperazine and 1-(m-trifluoromethylphenyl)piperazine on locomotor activity. JPharmacol Exp Ther 249:155\u2013164", "journal-title": "JPharmacol Exp Ther"}, {"key": "BF02246164_CR40", "first-page": "527", "volume": "43", "author": "DL Murphy", "year": "1991", "unstructured": "Murphy DL, Lesch KP, Aulakh CS, Pigott TA (1991) Serotoninselective arylpiperazines with neuroendocrine, temperature, and cardiovascular effects in humans. Pharmacol Rev 43:527\u2013552", "journal-title": "Pharmacol Rev"}, {"key": "BF02246164_CR41", "first-page": "983", "volume": "14", "author": "DL Nelson", "year": "1978", "unstructured": "Nelson DL, Herbert A, Bergoin G, Glowinski J, Haman M (1978) Characteristics of central 5-HT receptors and their adaptive changes following intracerebral 5,7-dihydroxytryptamine administration in the rat. Mol Pharmacol 14:983\u2013995", "journal-title": "Mol Pharmacol"}, {"key": "BF02246164_CR42", "doi-asserted-by": "crossref", "first-page": "4135", "DOI": "10.1002/j.1460-2075.1988.tb03308.x", "volume": "7", "author": "DB Prichett", "year": "1988", "unstructured": "Prichett DB, Bach AW, Wozny M, Talab O, Taso RD, Shih JC, Seeberg PH (1988) Structure and functional expression of the cloned rat serotonin 5-HT1C receptors in choroid plexus. EMBO J 7:4135\u20134140", "journal-title": "EMBO J"}, {"key": "BF02246164_CR43", "first-page": "169", "volume": "247", "author": "E Sanders-Bush", "year": "1988", "unstructured": "Sanders-Bush E, Breeding M (1988) Putative selective 5-HT2antagonists block serotonin 5-HT1C receptors in choroid plexus. J Pharmacol Exp Ther 247:169\u2013173", "journal-title": "J Pharmacol Exp Ther"}, {"key": "BF02246164_CR44", "first-page": "924", "volume": "246", "author": "E Sanders-Bush", "year": "1988", "unstructured": "Sanders-Bush E, Conn PJ (1988) LSD and 2,5-dimethoxy-4-methylamphetamine are partial agonists at serotonin receptors linked to PI hydrolysis. J Pharmacol Exp Ther 246:924\u2013928", "journal-title": "J Pharmacol Exp Ther"}, {"key": "BF02246164_CR45", "doi-asserted-by": "crossref", "first-page": "357", "DOI": "10.1016/0014-2999(90)90176-7", "volume": "179", "author": "I Wijngaarden Van", "year": "1990", "unstructured": "Van Wijngaarden I, Tulp M Th M, Soudijn W (1990) The concept of selectivity in 5-HT research. Eur J Pharmacol 179:357\u2013366", "journal-title": "Eur J Pharmacol"}, {"key": "BF02246164_CR46", "author": "JC Winter", "first-page": "341", "year": "1978", "unstructured": "Winter JC (1978) Drug-induced stimulus control. In: Blackman D, Sanger J (eds) Contemporary research in behavioral pharmacology. Plenum Press, N.Y., pp 341\u2013372", "volume-title": "Contemporary research in behavioral pharmacology"}, {"key": "BF02246164_CR47", "unstructured": "Winter JC (1994) The stimulus effects of serotonergic hallucinogens in animals. In: Lin GC (ed) Hallucinogens, an update. NIDA Monograph, US Government Printing Office 146:157\u2013182"}, {"key": "BF02246164_CR48", "doi-asserted-by": "crossref", "first-page": "221", "DOI": "10.1016/0091-3057(93)90108-6", "volume": "45", "author": "JC Winter", "year": "1993", "unstructured": "Winter JC, Rabin RA (1993) Discriminative stimulus properties ofm-chloropiperazine. Pharmacol Biochem Behav 45:221\u2013223", "journal-title": "Pharmacol Biochem Behav"}, {"key": "BF02246164_CR49", "doi-asserted-by": "crossref", "first-page": "946", "DOI": "10.1001/archpsyc.1987.01800230026006", "volume": "44", "author": "J Zohar", "year": "1987", "unstructured": "Zohar J, Meuller EA, Insel TR, Zohar-Kadouch RC, Murphy DL (1987) Serotonergic responsivity in obsessive-compulsive disorder: comparison of patients and healthy controls. Arch Gen Psychiatry 44:946\u2013951", "journal-title": "Arch Gen Psychiatry"}], "container-title": ["Psychopharmacology"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/BF02246164.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1007/BF02246164/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/BF02246164", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 16]], "date-time": "2019-05-16T14:30:15Z", "timestamp": 1558017015000}, "score": 28.8037, "issued": {"date-parts": [[1995, 5]]}, "references-count": 49, "journal-issue": {"published-print": {"date-parts": [[1995, 5]]}, "issue": "2"}, "alternative-id": ["BF02246164"], "URL": "http://dx.doi.org/10.1007/bf02246164", "relation": {"cites": []}, "ISSN": ["0033-3158", "1432-2072"], "issn-type": [{"value": "0033-3158", "type": "print"}, {"value": "1432-2072", "type": "electronic"}], "subject": ["Pharmacology"]}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T18:34:43Z", "timestamp": 1574102083211}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "3", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1995, 9, 1]], "date-time": "1995-09-01T00:00:00Z", "timestamp": 809913600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["European Neuropsychopharmacology"], "published-print": {"date-parts": [[1995, 9]]}, "DOI": "10.1016/0924-977x(95)90458-p", "type": "journal-article", "created": {"date-parts": [[2002, 7, 25]], "date-time": "2002-07-25T19:46:18Z", "timestamp": 1027626378000}, "page": "306", "source": "Crossref", "is-referenced-by-count": 4, "title": ["P-2-93 Down regulation of 5-HT2A receptors after chronic treatment with remeron"], "prefix": "10.1016", "volume": "5", "author": [{"given": "H.H.G.", "family": "Berendsen", "sequence": "first", "affiliation": []}, {"given": "C.L.E.", "family": "Broekkamp", "sequence": "additional", "affiliation": []}, {"given": "A.M.L.", "family": "van Delft", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["European Neuropsychopharmacology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:0924977X9590458P?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:0924977X9590458P?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 4, 22]], "date-time": "2019-04-22T07:30:04Z", "timestamp": 1555918204000}, "score": 25.434334, "issued": {"date-parts": [[1995, 9]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1995, 9]]}, "issue": "3"}, "alternative-id": ["0924977X9590458P"], "URL": "http://dx.doi.org/10.1016/0924-977x(95)90458-p", "ISSN": ["0924-977X"], "issn-type": [{"value": "0924-977X", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T00:24:58Z", "timestamp": 1575246298525}, "publisher-location": "Cham", "reference-count": 90, "publisher": "Springer International Publishing", "isbn-type": [{"value": "9783319704722", "type": "print"}, {"value": "9783319704746", "type": "electronic"}], "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2018, 1, 1]], "date-time": "2018-01-01T00:00:00Z", "timestamp": 1514764800000}, "delay-in-days": 0, "content-version": "unspecified"}], "content-domain": {"domain": ["link.springer.com"], "crossmark-restriction": false}, "published-print": {"date-parts": [[2018]]}, "DOI": "10.1007/978-3-319-70474-6_13", "type": "book-chapter", "created": {"date-parts": [[2018, 2, 14]], "date-time": "2018-02-14T08:33:45Z", "timestamp": 1518597225000}, "page": "311-337", "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy", "source": "Crossref", "is-referenced-by-count": 1, "title": ["The Involvement of 5-HT2A Receptor in the Regulation of Sleep and Wakefulness, and the Potential Therapeutic Use of Selective 5-HT2A Receptor Antagonists and Inverse Agonists for the Treatment of an Insomnia Disorder"], "prefix": "10.1007", "author": [{"given": "Jaime M.", "family": "Monti", "sequence": "first", "affiliation": []}, {"given": "Seithikurippu R.", "family": "Pandi Perumal", "sequence": "additional", "affiliation": []}, {"given": "D.", "family": "Warren Spence", "sequence": "additional", "affiliation": []}, {"given": "Pablo", "family": "Torterolo", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2018, 2, 15]]}, "reference": [{"key": "13_CR1", "doi-asserted-by": "crossref", "first-page": "673", "DOI": "10.1016/0013-4694(57)90088-3", "volume": "9", "author": "W Dement", "year": "1957", "unstructured": "Dement W, Kleitman N (1957) Cyclic variations in EEG during sleep and their relation to eye movements, body motility and dreaming. Electroencephalogr Clin Neurophysiol 9:673\u2013690", "journal-title": "Electroencephalogr Clin Neurophysiol"}, {"key": "13_CR2", "unstructured": "Rechtschaffen A, Kales A (1968) A manual of standardized terminology, techniques and scoring system for sleep stages in human subjects. National Institute of Health Publ, Washington, DC. Government Printing Office 204"}, {"key": "13_CR3", "doi-asserted-by": "crossref", "first-page": "561", "DOI": "10.1042/cs0650561", "volume": "65", "author": "K Adam", "year": "1983", "unstructured": "Adam K, Oswald I (1983) Protein synthesis, bodily renewal and the sleep-wake cycle. Clin Sci (Lond) 65:561\u2013567", "journal-title": "Clin Sci (Lond)"}, {"key": "13_CR4", "doi-asserted-by": "crossref", "first-page": "1133", "DOI": "10.1097/00004647-200110000-00001", "volume": "21", "author": "D Attwell", "year": "2001", "unstructured": "Attwell D, Laughlin SB (2001) An energy budget for signaling in the grey matter of the brain. J Cereb Blood Flow Metab 21:1133\u20131145", "journal-title": "J Cereb Blood Flow Metab"}, {"key": "13_CR5", "doi-asserted-by": "crossref", "first-page": "208", "DOI": "10.3389/fnsys.2014.00208", "volume": "8", "author": "M Bellesi", "year": "2014", "unstructured": "Bellesi M, Riedner BA, Garcia-Molina GN et al (2014) Enhancement of sleep slow waves: underlying mechanisms and practical consequences. Front Syst Neurosci 8:208", "journal-title": "Front Syst Neurosci"}, {"key": "13_CR6", "doi-asserted-by": "crossref", "first-page": "1093", "DOI": "10.1126/science.1128134", "volume": "313", "author": "JR Whitlock", "year": "2006", "unstructured": "Whitlock JR, Heynen AJ, Shuler MG (2006) Learning induces long-term potentiation in the hippocampus. Science 313:1093\u20131097", "journal-title": "Science"}, {"key": "13_CR7", "doi-asserted-by": "crossref", "first-page": "373", "DOI": "10.1126/science.1241224", "volume": "342", "author": "L Xie", "year": "2013", "unstructured": "Xie L, Kang H, Xu Q et al (2013) Sleep drives metabolic clearance from the adult brain. Science 342:373\u2013377", "journal-title": "Science"}, {"key": "13_CR8", "doi-asserted-by": "crossref", "first-page": "s683", "DOI": "10.2741/1064", "volume": "8", "author": "P Achermann", "year": "2003", "unstructured": "Achermann P, Borbely AA (2003) Mathematical models of sleep regulation. Front Biosci 8:s683\u2013s693", "journal-title": "Front Biosci"}, {"key": "13_CR9", "first-page": "145", "volume": "7", "author": "JM Monti", "year": "1990", "unstructured": "Monti JM, Orellana C, Boussard M et al (1990) 5-HT receptor agonists 1-(2,5-methoxy-4-iodophenyl)-2-aminopro- pane (DOI) and 8-OH-DPAT increase wakefulness in the rat. Biogen Amines 7:145\u2013151", "journal-title": "Biogen Amines"}, {"key": "13_CR10", "unstructured": "ICSD 2 (2005) International Classification of Sleep Disorders: Diagnostic and Coding Manual, 2nd edn. American Academy of Sleep Medicine, Westchester, IL"}, {"key": "13_CR11", "author": "A Kales", "year": "1984", "unstructured": "Kales A, Kales JD (1984) Evaluation and treatment of insomnia. Oxford University Press, New York", "volume-title": "Evaluation and treatment of insomnia"}, {"key": "13_CR12", "first-page": "303", "volume": "3", "author": "JM Monti", "year": "1981", "unstructured": "Monti JM (1981) Sleep laboratory and clinical studies of the effects of triazolam, flunitrazepam and flurazepam in insomniac patients. Methods Find Exp Clin Pharmacol 3:303\u2013326", "journal-title": "Methods Find Exp Clin Pharmacol"}, {"issue": "Suppl", "key": "13_CR13", "first-page": "4", "volume": "52", "author": "DJ Greenblatt", "year": "1991", "unstructured": "Greenblatt DJ (1991) Benzodiazepine hypnotics: sorting the pharmacokinetic facts. J Clin Psychiatry 52(Suppl):4\u201310", "journal-title": "J Clin Psychiatry"}, {"key": "13_CR14", "unstructured": "Monti JM, Pandi-Perumal SR, Langer SZ (2008) Zolpidem: its use in the treatment of sleep disorders. In: Pandi-Perumal SR, Verster JC, Monti JM, Langer SZ (eds) Sleep disorders\u2014diagnosis and therapeutics. Informa Healthcare, London, pp 295\u2013323", "DOI": "10.3109/9780203091715-29", "doi-asserted-by": "crossref"}, {"key": "13_CR15", "doi-asserted-by": "crossref", "first-page": "79", "DOI": "10.1093/sleep/31.1.79", "volume": "31", "author": "AD Krystal", "year": "2008", "unstructured": "Krystal AD, Erman M, Zammit G et al (2008) Long-term efficacy and safety of zolpidem extended-release 12.5 mg, administered 3 to 7 nights per week for 24 weeks, in patients with chronic primary insomnia: a 6-month, randomized, double-blind, placebo-controlled, parallel-group, multicenter study. Sleep 31:79\u201390", "journal-title": "Sleep"}, {"key": "13_CR16", "doi-asserted-by": "crossref", "first-page": "123", "DOI": "10.4137/CMT.S2040", "volume": "1", "author": "JM Monti", "year": "2009", "unstructured": "Monti JM, Spence DW, Pandi-Perumal SR et al (2009) Pharmacotherapy of insomnia. Focus on zolpidem extended release. Clin Med Therap 1:123\u2013140", "journal-title": "Clin Med Therap"}, {"key": "13_CR17", "doi-asserted-by": "crossref", "first-page": "1021", "DOI": "10.2165/0023210-200822120-00005", "volume": "22", "author": "CR Dolder", "year": "2008", "unstructured": "Dolder CR, Nelson MH (2008) Hypnosedative-induced complex behaviors: incidence, mechanisms and management. CNS Drugs 22:1021\u20131036", "journal-title": "CNS Drugs"}, {"key": "13_CR18", "doi-asserted-by": "crossref", "first-page": "1088", "DOI": "10.1177/0269881111424455", "volume": "26", "author": "TA Roehrs", "year": "2012", "unstructured": "Roehrs TA, Randall S, Harris E et al (2012) Twelve months of nightly zolpidem does not lead to rebound insomnia or withdrawal symptoms: a prospective placebo-controlled study. J Psychopharmacol 26:1088\u20131095", "journal-title": "J Psychopharmacol"}, {"key": "13_CR19", "doi-asserted-by": "crossref", "first-page": "1633", "DOI": "10.1185/030079906X112741", "volume": "22", "author": "WV McCall", "year": "2006", "unstructured": "McCall WV, Erman M, Krystal AD et al (2006) A polysomnographic study of eszopiclone in elderly patients with insomnia. Curr Med Res Opin 22:1633\u20131642", "journal-title": "Curr Med Res Opin"}, {"key": "13_CR20", "unstructured": "Scharf M (1999) A new option for insomnia. Health News 5:4"}, {"key": "13_CR21", "doi-asserted-by": "crossref", "first-page": "41", "DOI": "10.1016/S1389-9457(99)00006-4", "volume": "1", "author": "JK Walsh", "year": "2000", "unstructured": "Walsh JK, Vogel GW, Scharf M et al (2000) A five week, polysomnographic assessment of zaleplon 10 mg for the treatment of primary insomnia. Sleep Med 1:41\u201349", "journal-title": "Sleep Med"}, {"key": "13_CR22", "first-page": "495", "volume": "3", "author": "G Zammit", "year": "2007", "unstructured": "Zammit G, Erman M, Wang-Weigand S et al (2007) Evaluation of the efficacy and safety of ramelteon in subjects with chronic insomnia. J Clin Sleep Med 3:495\u2013504", "journal-title": "J Clin Sleep Med"}, {"key": "13_CR23", "first-page": "1433", "volume": "34", "author": "AD Krystal", "year": "2011", "unstructured": "Krystal AD, Lankford A, Durrence HH (2011) Efficacy and safety of doxepin 3 mg and 6 mg in a 35-day sleep laboratory trial in adults with chronic primary insomnia. Sleep 34:1433\u20131434", "journal-title": "Sleep"}, {"key": "13_CR24", "doi-asserted-by": "crossref", "first-page": "477", "DOI": "10.1177/1060028015570467", "volume": "49", "author": "KV Patel", "year": "2015", "unstructured": "Patel KV, Aspesi AV, Evoy KE (2015) Suvorexant: a dual orexin receptor antagonist for the treatment of sleep onset and sleep maintenance insomnia. Ann Pharmacother 49:477\u2013483", "journal-title": "Ann Pharmacother"}, {"key": "13_CR25", "doi-asserted-by": "crossref", "first-page": "187", "DOI": "10.1016/j.smrv.2011.12.003", "volume": "16", "author": "CW Berridge", "year": "2012", "unstructured": "Berridge CW, Schmeichel BE, Espa\u00f1a RA (2012) Noradrenergic modulation of wakefulness/arousal. Sleep Med Rev 16:187\u2013197", "journal-title": "Sleep Med Rev"}, {"key": "13_CR26", "doi-asserted-by": "crossref", "first-page": "1087", "DOI": "10.1152/physrev.00032.2011", "volume": "92", "author": "RE Brown", "year": "2012", "unstructured": "Brown RE, Basheer R, McKenna JT et al (2012) Control of sleep and wakefulness. Physiol Rev 92:1087\u20131187", "journal-title": "Physiol Rev"}, {"key": "13_CR27", "doi-asserted-by": "crossref", "first-page": "269", "DOI": "10.1016/j.smrv.2010.11.003", "volume": "15", "author": "JM Monti", "year": "2011", "unstructured": "Monti JM (2011) Serotonin control of sleep-wake behavior. Sleep Med Rev 15:269\u2013281", "journal-title": "Sleep Med Rev"}, {"key": "13_CR28", "doi-asserted-by": "crossref", "first-page": "65", "DOI": "10.1016/j.smrv.2010.06.004", "volume": "15", "author": "MM Thakkar", "year": "2011", "unstructured": "Thakkar MM (2011) Histamine in the regulation of wakefulness. Sleep Med Rev 15:65\u201374", "journal-title": "Sleep Med Rev"}, {"key": "13_CR29", "doi-asserted-by": "crossref", "first-page": "291", "DOI": "10.1016/j.sleep.2007.03.013", "volume": "8", "author": "R Szymusiak", "year": "2007", "unstructured": "Szymusiak R, Gvilia I, McGinty D (2007) Hypothalamic control of sleep. Sleep Med 8:291\u2013301", "journal-title": "Sleep Med"}, {"key": "13_CR30", "doi-asserted-by": "crossref", "first-page": "63", "DOI": "10.1053/smrv.2000.0136", "volume": "5", "author": "F Reinoso-Su\u00e1rez", "year": "2001", "unstructured": "Reinoso-Su\u00e1rez F, de Andr\u00e9s I, Rodrigo-Angulo ML et al (2001) Brain structures and mechanisms involved in the generation of REM sleep. Sleep Med Rev 5:63\u201377", "journal-title": "Sleep Med Rev"}, {"key": "13_CR31", "doi-asserted-by": "crossref", "first-page": "293", "DOI": "10.1016/j.smrv.2012.10.002", "volume": "17", "author": "JM Monti", "year": "2013", "unstructured": "Monti JM, Torterolo P, Lagos P (2013) Melanin-concentrating hormone control of sleep-wake behavior. Sleep Med Rev 17:293\u2013298", "journal-title": "Sleep Med Rev"}, {"key": "13_CR32", "unstructured": "Hannon J, Hoyer D (2008) Molecular biology of 5-HT receptors. In: Monti JM, Pandi-Perumal SR, Jacobs BL, Nutt DJ (eds) Serotonin and sleep: molecular, functional and clinical aspects. Birk\u00e4user Verlag, Basel, pp 155\u2013182", "DOI": "10.1007/978-3-7643-8561-3_6", "doi-asserted-by": "crossref"}, {"key": "13_CR33", "doi-asserted-by": "crossref", "first-page": "187", "DOI": "10.1002/(SICI)1096-9861(19990628)409:2<187::AID-CNE2>3.0.CO;2-P", "volume": "409", "author": "V Cornea-H\u00e9bert", "year": "1999", "unstructured": "Cornea-H\u00e9bert V, Riad M, Wu C (1999) Cellular and subcellular distribution of the serotonin 5-HT2A receptor in the central nervous system of adult rat. J Comp Neurol 409:187\u2013209", "journal-title": "J Comp Neurol"}, {"key": "13_CR34", "doi-asserted-by": "crossref", "first-page": "11231", "DOI": "10.1523/JNEUROSCI.1724-05.2005", "volume": "25", "author": "D Popa", "year": "2005", "unstructured": "Popa D, Lena C, Favre V et al (2005) Contribution of 5-HT2 receptor subtypes to sleep-wakefulness and respiratory control, and functional adaptations in knock-out mice lacking 5-HT2A receptors. J Neurosci 25:11231\u201311238", "journal-title": "J Neurosci"}, {"key": "13_CR35", "unstructured": "Adrien J (2008) Sleep and waking in mutant mice that do not express various proteins involved in serotonergic neurotransmission such as the serotonergic transporter, monoamine oxidase A, and the 5-HT1A, 5-HT1B, 5-HT2A, 5-HT2C and 5-HT7 receptors. In: Monti JM, Pandi-Perumal SR, Jacobs BL, Nutt DJ (eds) Serotonin and sleep: molecular, functional and clinical aspects. Birk\u00e4user Verlag, Basel, pp 457\u2013475", "DOI": "10.1007/978-3-7643-8561-3_18", "doi-asserted-by": "crossref"}, {"key": "13_CR36", "doi-asserted-by": "crossref", "first-page": "411", "DOI": "10.1016/0028-3908(94)90071-X", "volume": "33", "author": "CJ Done", "year": "1994", "unstructured": "Done CJ, Sharp T (1994) Biochemical evidence for the regulation of central noradrenergic activity by 5-HT1A and 5-HT2 receptors: microdyalisis studies in the awake and anaesthetized rat. Neuropharmacology 33:411\u2013421", "journal-title": "Neuropharmacology"}, {"key": "13_CR37", "doi-asserted-by": "crossref", "first-page": "273", "DOI": "10.1016/0014-2999(94)00698-7", "volume": "273", "author": "CJ Schmidt", "year": "1995", "unstructured": "Schmidt CJ, Fadayel GM (1995) The selective 5-HT2A receptor antagonist MDL 100,907, increases dopamine efflux in the prefrontal cortex of the rat. Eur J Pharmacol 273:273\u2013279", "journal-title": "Eur J Pharmacol"}, {"key": "13_CR38", "doi-asserted-by": "crossref", "first-page": "285", "DOI": "10.1007/s00221-013-3434-3", "volume": "226", "author": "G Quesseveur", "year": "2013", "unstructured": "Quesseveur G, Rep\u00e9rant C, David DJ, Gardier AM, Sanchez C, Guiard BP (2013) 5-HT2A receptor inactivation potentiates the acute antidepressant-like activity of escitalopram: involvement of the noradrenergic system. Exp Brain Res 226:285\u2013295", "journal-title": "Exp Brain Res"}, {"key": "13_CR39", "doi-asserted-by": "crossref", "first-page": "360", "DOI": "10.1124/pr.59.07103", "volume": "59", "author": "KB Fink", "year": "2007", "unstructured": "Fink KB, G\u00f6thert M (2007) 5-HT receptor regulation of neurotransmitter release. Pharmacol Rev 59:360\u2013417", "journal-title": "Pharmacol Rev"}, {"key": "13_CR40", "doi-asserted-by": "crossref", "first-page": "2505", "DOI": "10.1016/0024-3205(84)90436-3", "volume": "35", "author": "RA Glennon", "year": "1984", "unstructured": "Glennon RA, Titeler M, McKenney JD (1984) Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents. Life Sci 35:2505\u20132511", "journal-title": "Life Sci"}, {"key": "13_CR41", "doi-asserted-by": "crossref", "first-page": "23", "DOI": "10.1016/0014-2999(84)90333-9", "volume": "102", "author": "M Shannon", "year": "1984", "unstructured": "Shannon M, Battaglia G, Glennon RA et al (1984) 5-HT1 and 5-HT2 binding properties of derivatives of the hallucinogen 1-(2,5-dimethoxyphenyl)-2-aminopropane (2,5-DMA). Eur J Pharmacol 102:23", "journal-title": "Eur J Pharmacol"}, {"key": "13_CR42", "doi-asserted-by": "crossref", "first-page": "436", "DOI": "10.1007/BF00439544", "volume": "97", "author": "C Dugovic", "year": "1989", "unstructured": "Dugovic C, Wauquier A, Leysen JE et al (1989) Functional role of 5-HT2 receptors in the regulation of sleep and wakefulness in the rat. Psychopharmacology 97:436\u2013442", "journal-title": "Psychopharmacology"}, {"key": "13_CR43", "doi-asserted-by": "crossref", "first-page": "39", "DOI": "10.1016/0014-2999(95)00272-M", "volume": "282", "author": "P J\u00e4k\u00e4l\u00e4", "year": "1995", "unstructured": "J\u00e4k\u00e4l\u00e4 P, Sirvi\u00f6 J, Koivisto E et al (1995) Modulation of rat neocortical high-voltage spindle activity by 5-HT1/5-HT2 receptor subtype specific drugs. Eur J Pharmacol 282:39\u201355", "journal-title": "Eur J Pharmacol"}, {"key": "13_CR44", "doi-asserted-by": "crossref", "first-page": "163", "DOI": "10.1016/j.ejphar.2006.09.027", "volume": "553", "author": "JM Monti", "year": "2006", "unstructured": "Monti JM, Jantos H (2006) Effects of the serotonin 5-HT2A/2C receptor agonist DOI and of the selective 5-HT2A or 5-HT2C receptor antagonists EMD 281014 and SB-243213, respectively, on sleep and waking in the rat. Eur J Pharmacol 553:163\u2013170", "journal-title": "Eur J Pharmacol"}, {"key": "13_CR45", "doi-asserted-by": "crossref", "first-page": "998", "DOI": "10.1038/sj.bjp.0705328", "volume": "139", "author": "LJ Boothman", "year": "2003", "unstructured": "Boothman LJ, Allers KA, Rasmussen K et al (2003) Evidence that central 5-HT2A and 5-HT2B/C receptors regulate 5-HT cell firing in the dorsal raphe nucleus of the anaesthetised rat. Br J Pharmacol 139:998\u20131004", "journal-title": "Br J Pharmacol"}, {"key": "13_CR46", "doi-asserted-by": "crossref", "first-page": "349", "DOI": "10.1016/0014-2999(91)90499-G", "volume": "199", "author": "JC Garratt", "year": "1984", "unstructured": "Garratt JC, Kidd EJ, Wright IK et al (1984) Inhibition of 5-hydroxytryptamine neuronal activity by the 5-HT agonist. Eur J Pharmacol 199:349\u2013355", "journal-title": "Eur J Pharmacol"}, {"key": "13_CR47", "doi-asserted-by": "crossref", "first-page": "34", "DOI": "10.1016/S0006-8993(00)02468-9", "volume": "873", "author": "R Liu", "year": "2000", "unstructured": "Liu R, Jolas T, Aghajanian G (2000) Serotonin 5-HT2 receptors activate local GABA inhibitory inputs to serotonergic neurons of the dorsal raphe nucleus. Brain Res 873:34\u201345", "journal-title": "Brain Res"}, {"key": "13_CR48", "doi-asserted-by": "crossref", "first-page": "891", "DOI": "10.1097/00001756-200506210-00004", "volume": "16", "author": "LJ Boothman", "year": "2005", "unstructured": "Boothman LJ, Sharp T (2005) A role for midbrain raphe gamma aminobutyric acid neurons in 5-hydroxytryptamine feedback control. Neuroreport 16:891\u2013896", "journal-title": "Neuroreport"}, {"key": "13_CR49", "doi-asserted-by": "crossref", "first-page": "177", "DOI": "10.1002/cne.903630203", "volume": "363", "author": "B Ford", "year": "1995", "unstructured": "Ford B, Holmes CJ, Mainville L et al (1995) GABAergic neurons in the rat pontomesencephalic tegmentum: codistribution with cholinergic and other tegmental neurons projecting to the posterior lateral hypothalamus. J Comp Neurol 363:177\u2013196", "journal-title": "J Comp Neurol"}, {"key": "13_CR50", "doi-asserted-by": "crossref", "first-page": "15", "DOI": "10.1016/j.jchemneu.2014.03.001", "volume": "58", "author": "RK Vasudeva", "year": "2014", "unstructured": "Vasudeva RK, Waterhouse BD (2014) Cellular profile of the dorsal raphe lateral wing subregion: relationship to the lateral dorsal tegmental nucleus. J Chem Neuroanat 58:15\u201323", "journal-title": "J Chem Neuroanat"}, {"key": "13_CR51", "doi-asserted-by": "crossref", "first-page": "9", "DOI": "10.1016/j.brainres.2003.09.026", "volume": "996", "author": "R Amici", "year": "2004", "unstructured": "Amici R, Sanford LD, Kearney K et al (2004) A serotonergic (5-HT2) receptor mechanism in the laterodorsal tegmental nucleus participates in regulating the pattern of rapid-eye-movement occurrence in the rat. Brain Res 996:9\u201318", "journal-title": "Brain Res"}, {"key": "13_CR52", "doi-asserted-by": "crossref", "first-page": "116", "DOI": "10.1016/j.brainres.2008.02.095", "volume": "1210", "author": "ML Rodrigo-Angulo", "year": "2008", "unstructured": "Rodrigo-Angulo ML, Heredero S, Rodr\u00edguez-Veiga E et al (2008) GABAergic and non-GABAergic, thalamic, hypothalamic and basal forebrain projections to the oral pontine reticular nucleus: their implication in REM sleep regulation. Brain Res 1210:116\u2013125", "journal-title": "Brain Res"}, {"key": "13_CR53", "doi-asserted-by": "crossref", "first-page": "11", "DOI": "10.1002/cne.903400103", "volume": "340", "author": "RP Vertes", "year": "1994", "unstructured": "Vertes RP, Kocsis B (1994) Projections of the dorsal raphe nucleus to the brainstem: PHA-L analysis of the rat. J Comp Neurol 340:11\u201326", "journal-title": "J Comp Neurol"}, {"key": "13_CR54", "doi-asserted-by": "crossref", "first-page": "340", "DOI": "10.1111/j.1460-9568.2008.06576.x", "volume": "29", "author": "HL Wang", "year": "2009", "unstructured": "Wang HL, Morales M (2009) Pedunculopontine and laterodorsal tegmental nuclei contain distinct populations of cholinergic, glutamatergic and GABAergic neurons in the rat. Eur J Neurosci 29:340\u2013358", "journal-title": "Eur J Neurosci"}, {"key": "13_CR55", "doi-asserted-by": "crossref", "first-page": "257", "DOI": "10.3109/00207459808986431", "volume": "93", "author": "R Kirov", "year": "1998", "unstructured": "Kirov R, Moyanova S (1998) Age-dependent effect of ketanserin on the sleep-waking phases in rats. Int J Neurosci 93:257\u2013264", "journal-title": "Int J Neurosci"}, {"key": "13_CR56", "doi-asserted-by": "crossref", "first-page": "55", "DOI": "10.1016/S0006-8993(97)01411-X", "volume": "786", "author": "S Moyanova", "year": "1998", "unstructured": "Moyanova S, Kortenska L, Kirov R (1998) High-voltage electroencephalogram spindles in rats, aging and 5-HT2 antagonism. Brain Res 786:55\u201363", "journal-title": "Brain Res"}, {"key": "13_CR57", "doi-asserted-by": "crossref", "first-page": "241", "DOI": "10.1016/0091-3057(92)90091-S", "volume": "41", "author": "S Silhol", "year": "1991", "unstructured": "Silhol S, Glin L, Gottesmann C (1991) Study of the 5-HT2 antagonist ritanserin on sleep-waking cycle in the rat. Physiol Behav 41:241\u2013243", "journal-title": "Physiol Behav"}, {"key": "13_CR58", "doi-asserted-by": "crossref", "first-page": "105", "DOI": "10.1016/S0006-8993(02)02698-7", "volume": "943", "author": "S Kantor", "year": "2002", "unstructured": "Kantor S, Jakus R, Bodizs R et al (2002) Acute and long-term effects of the 5-HT2 receptor antagonist ritanserin on EEG power spectra, motor activity and sleep: changes at the light-dark phase shift. Brain Res 943:105\u2013111", "journal-title": "Brain Res"}, {"key": "13_CR59", "doi-asserted-by": "crossref", "first-page": "294", "DOI": "10.1016/0006-8993(89)90573-8", "volume": "485", "author": "FC Tortella", "year": "1989", "unstructured": "Tortella FC, Echevarria E, Pastel RH et al (1989) Suppressant effects of selective 5-HT2 antagonists on rapid eye movement sleep in rats. Brain Res 485:294\u2013300", "journal-title": "Brain Res"}, {"key": "13_CR60", "doi-asserted-by": "crossref", "first-page": "119", "DOI": "10.1093/sleep/15.2.119", "volume": "15", "author": "JM Stutzmann", "year": "1992", "unstructured": "Stutzmann JM, Eon B, Lucas M (1992) RP 62203, a 5-hydroxytryptamine2 antagonist, enhances deep NREM sleep in rats. Sleep 15:119\u2013124", "journal-title": "Sleep"}, {"key": "13_CR61", "doi-asserted-by": "crossref", "first-page": "353", "DOI": "10.1016/0091-3057(94)00394-X", "volume": "51", "author": "AML Coenen", "year": "1995", "unstructured": "Coenen AML, Ates N, Skarsfeldt T et al (1995) Effects of sertindole on sleep-wake states, electroencephalogram, behavioral patterns, and epileptic activity of rats. Pharmacol Biochem Behav 51:353\u2013357", "journal-title": "Pharmacol Biochem Behav"}, {"key": "13_CR62", "doi-asserted-by": "crossref", "first-page": "164", "DOI": "10.1016/0006-8993(86)90299-4", "volume": "378", "author": "C Idzikowski", "year": "1986", "unstructured": "Idzikowski C, Mills FJ, Glennard R (1986) 5-Hydroxytryptamine-2-antagonist ritanserin increases human slow wave sleep. Brain Res 378:164\u2013168", "journal-title": "Brain Res"}, {"key": "13_CR63", "doi-asserted-by": "crossref", "first-page": "416", "DOI": "10.1007/BF00207228", "volume": "93", "author": "C Idzikowski", "year": "1987", "unstructured": "Idzikowski C, Cowen PJ, Mills FJ (1987) The effect of chronic ritanserin treatment on sleep and on the neuroendocrine response to L-tryptophan. Psychopharmacology 93:416\u2013420", "journal-title": "Psychopharmacology"}, {"key": "13_CR64", "doi-asserted-by": "crossref", "first-page": "193", "DOI": "10.1111/j.1365-2125.1991.tb05514.x", "volume": "31", "author": "C Idzikowski", "year": "1991", "unstructured": "Idzikowski C, Mills FJ, James RJ (1991) A dose-response study examining the effects of ritanserin on human slow wave sleep. Br J Pharmacol 31:193\u2013196", "journal-title": "Br J Pharmacol"}, {"key": "13_CR65", "doi-asserted-by": "crossref", "first-page": "213", "DOI": "10.1007/BF02245310", "volume": "108", "author": "F Kamali", "year": "1992", "unstructured": "Kamali F, Stanfield SC, Ashton CH et al (1992) Absence of withdrawal effects of ritanserin following chronic dosing in healthy volunteers. Psychopharmacology 108:213\u2013217", "journal-title": "Psychopharmacology"}, {"key": "13_CR66", "doi-asserted-by": "crossref", "first-page": "467", "DOI": "10.1016/0028-3908(94)90077-9", "volume": "33", "author": "AL Sharpley", "year": "1994", "unstructured": "Sharpley AL, Elliott JM, Attenburrow MJ (1994) Slow wave sleep in humans: role of 5-HT2A and 5-HT2C receptors. Neuropharmacology 33:467\u2013471", "journal-title": "Neuropharmacology"}, {"key": "13_CR67", "doi-asserted-by": "crossref", "first-page": "568", "DOI": "10.1007/BF02244239", "volume": "101", "author": "AL Sharpley", "year": "1990", "unstructured": "Sharpley AL, Solomon RA, Fernando AI (1990) Dose-related effects of selective 5-HT2 receptor antagonists on slow wave sleep in humans. Psychopharmacology 101:568\u2013569", "journal-title": "Psychopharmacology"}, {"key": "13_CR68", "doi-asserted-by": "crossref", "first-page": "455", "DOI": "10.1016/S0893-133X(99)00052-4", "volume": "21", "author": "HP Landolt", "year": "1999", "unstructured": "Landolt HP, Viola M, Burgess HJ et al (1999) Serotonin-2 receptors and human sleep: effect of a selective antagonist on EEG power spectra. Neuropsychopharmacology 21:455\u2013466", "journal-title": "Neuropsychopharmacology"}, {"key": "13_CR69", "doi-asserted-by": "crossref", "first-page": "219", "DOI": "10.1007/BF00442811", "volume": "99", "author": "K Adam", "year": "1989", "unstructured": "Adam K, Oswald I (1989) Effects of repeated ritanserin on middle-aged poor sleepers. Psychopharmacology 99:219\u2013221", "journal-title": "Psychopharmacology"}, {"key": "13_CR70", "unstructured": "Ruiz-Primo E, Haro R, Valencia M (1989) Polysomnographic effects of ritanserin in insomniacs. A crossed double-blind controlled study. Sleep Res 18:72"}, {"key": "13_CR71", "doi-asserted-by": "crossref", "first-page": "647", "DOI": "10.1093/sleep/16.7.647", "volume": "16", "author": "JM Monti", "year": "1993", "unstructured": "Monti JM, Alterwain P, Est\u00e9vez F et al (1993) The effects of ritanserin on mood and sleep in abstinent alcoholic patients. Sleep 16:647\u2013654", "journal-title": "Sleep"}, {"key": "13_CR72", "doi-asserted-by": "crossref", "first-page": "387", "DOI": "10.1007/BF02245128", "volume": "108", "author": "JM Roza Davis da", "year": "1992", "unstructured": "da Roza Davis JM, Sharpley AL, Cowen PJ (1992) Slow wave sleep and 5-HT2 receptor sensitivity in generalized anxiety disorder. Psychopharmacology 108:387\u2013389", "journal-title": "Psychopharmacology"}, {"key": "13_CR73", "doi-asserted-by": "crossref", "first-page": "395", "DOI": "10.1007/BF00216069", "volume": "96", "author": "T Paiva", "year": "1988", "unstructured": "Paiva T, Arriaga F, Wauquier A et al (1988) Effects of ritanserin on sleep disturbances of dysthymic patients. Psychopharmacology 96:395\u2013399", "journal-title": "Psychopharmacology"}, {"key": "13_CR74", "doi-asserted-by": "crossref", "first-page": "133", "DOI": "10.1111/j.1600-0447.1992.tb03241.x", "volume": "86", "author": "L Staner", "year": "1992", "unstructured": "Staner L, Kempenaers C, Simonnet MP (1992) 5-HT2 receptor antagonism and slow-wave sleep in major depression. Acta Psychiatr Scand 86:133\u2013137", "journal-title": "Acta Psychiatr Scand"}, {"key": "13_CR75", "first-page": "968", "volume": "277", "author": "JH Kehne", "year": "1996", "unstructured": "Kehne JH, Baron BM, Carr AA et al (1996) Preclinical characterization of the potential of the putative atypical antipsychotic MDL 100,907 as a potent 5-HT2A antagonist with a favorable CNS safety profile. J Pharmacol Exp Ther 277:968\u2013981", "journal-title": "J Pharmacol Exp Ther"}, {"key": "13_CR76", "doi-asserted-by": "crossref", "first-page": "229", "DOI": "10.1016/S0014-2999(03)01992-7", "volume": "473", "author": "GD Bartoszyk", "year": "2003", "unstructured": "Bartoszyk GD, van Amsterdam C, B\u00f6ttcher H (2003) EMD 281014, a new selective serotonin 5-HT2A receptor antagonist. Eur J Pharmacol 473:229\u2013230", "journal-title": "Eur J Pharmacol"}, {"key": "13_CR77", "doi-asserted-by": "crossref", "first-page": "34", "DOI": "10.1093/sleep/31.1.34", "volume": "31", "author": "SR Morairty", "year": "2008", "unstructured": "Morairty SR, Hedley L, Flores J et al (2008) Selective 5-HT2A and 5-HT6 receptor antagonists promote sleep in rats. Sleep 31:34\u201344", "journal-title": "Sleep"}, {"key": "13_CR78", "doi-asserted-by": "crossref", "first-page": "44", "DOI": "10.1016/j.brainresbull.2011.10.009", "volume": "87", "author": "S Hasegawa", "year": "2012", "unstructured": "Hasegawa S, Fikre-Merid M, Diksic M (2012) 5-HT2A receptor antagonist M100907 reduces serotonin synthesis: an autoradiographic study. Brain Res Bull 87:44\u201349", "journal-title": "Brain Res Bull"}, {"key": "13_CR79", "doi-asserted-by": "crossref", "first-page": "381", "DOI": "10.1016/j.bbr.2010.08.020", "volume": "216", "author": "JM Monti", "year": "2011", "unstructured": "Monti JM, Jantos H (2011) Effects of the 5-HT6 receptor antagonists SB-399885 and RO-4368554 and of the 5-HT2A receptor antagonist EMD 281014 on sleep and wakefulness in the rat during both phases of the light-dark cycle. Behav Brain Res 216:381\u2013388", "journal-title": "Behav Brain Res"}, {"key": "13_CR80", "first-page": "759", "volume": "262", "author": "M Rinaldi-Carmona", "year": "1992", "unstructured": "Rinaldi-Carmona M, Congy C, Santucci V et al (1992) Biochemical and pharmacological properties of SR 46349B, a new potent and selective 5-hydroxytryptamine2 receptor antagonist. J Pharmacol Exp Ther 262:759\u2013768", "journal-title": "J Pharmacol Exp Ther"}, {"key": "13_CR81", "doi-asserted-by": "crossref", "first-page": "119", "DOI": "10.1016/0024-3205(94)00782-9", "volume": "54", "author": "M Rinaldi-Carmona", "year": "1994", "unstructured": "Rinaldi-Carmona M, Congy C, Pointeau P et al (1994) Identification of binding sites for SR 463449B, a 5-hydroxytryptamine2 receptor antagonist, in rodent brain. Life Sci 54:119\u2013127", "journal-title": "Life Sci"}, {"key": "13_CR82", "doi-asserted-by": "crossref", "first-page": "19", "DOI": "10.1016/j.neuropharm.2012.12.008", "volume": "70", "author": "G Griebel", "year": "2013", "unstructured": "Griebel G, Beesk\u00e9 S, Jacquet A et al (2013) Further evidence for the sleep-promoting effects of 5-HT2A receptor antagonists and demonstration of synergistic effects with the hypnotic zolpidem in rats. Neuropharmacology 70:19\u201326", "journal-title": "Neuropharmacology"}, {"key": "13_CR83", "doi-asserted-by": "crossref", "first-page": "281", "DOI": "10.1124/jpet.109.160994", "volume": "322", "author": "HA Al-Shamma", "year": "2010", "unstructured": "Al-Shamma HA, Anderson C, Chuang E et al (2010) Nelotanserin, a novel selective human 5-hydroxytryptamine2A inverse agonist for the treatment of insomnia. J Pharmacol Exp Ther 322:281\u2013290", "journal-title": "J Pharmacol Exp Ther"}, {"key": "13_CR84", "doi-asserted-by": "crossref", "first-page": "1923", "DOI": "10.1021/jm9007328", "volume": "53", "author": "BR Teegarden", "year": "2010", "unstructured": "Teegarden BR, Li H, Jayakumar H, Strah-Pleynet S, Dosa PI, Selaya SD et al (2010) Discovery of 1-[3-(4-Bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxyphenyl]-3-(2,4-difluorophenyl)urea (Nelotanserin) and related 5-hydroxytryptamine2A inverse agonists for the treatment of insomnia. J Med Chem 53:1923\u20131936", "journal-title": "J Med Chem"}, {"key": "13_CR85", "doi-asserted-by": "crossref", "first-page": "910", "DOI": "10.1124/jpet.105.097006", "volume": "317", "author": "KE Vanover", "year": "2006", "unstructured": "Vanover KE, Weiner DM, Makhay M et al (2006) Pharmacological and behavioral profile of N-(4-fluorophenylmethyl)-N-(1-methylpiperidin-4-yl)-N\u2019-4-(2-methylpropylo-xymethyl) carbamide (2R,3R)-dihydroxybu- tanedionate (2,1) (ACP-103), a novel 5-hydroxytryotamine(2A) receptor inverse agonist. L Pharmacol Exp Ther 317:910\u2013918", "journal-title": "L Pharmacol Exp Ther"}, {"key": "13_CR86", "doi-asserted-by": "crossref", "first-page": "1663", "DOI": "10.1093/sleep/31.12.1663", "volume": "31", "author": "R Rosenberg", "year": "2008", "unstructured": "Rosenberg R, Seiden DJ, Hull SG et al (2008) APD125, a selective serotonin 5-HT2A receptor inverse agonist, significantly improves sleep maintenance in primary insomnia. Sleep 31:1663\u20131671", "journal-title": "Sleep"}, {"key": "13_CR87", "doi-asserted-by": "crossref", "first-page": "134", "DOI": "10.1016/j.sleep.2010.10.004", "volume": "12", "author": "S Ancoli-Israel", "year": "2011", "unstructured": "Ancoli-Israel S, Vanover KE, Weiner DM et al (2011) Pimavanserin tartrate, a 5-HT2A receptor inverse agonist, increases slow wave sleep as measured by polysomnography in healthy adult volunteers. Sleep Med 12:134\u2013141", "journal-title": "Sleep Med"}, {"key": "13_CR88", "doi-asserted-by": "crossref", "first-page": "1083", "DOI": "10.1016/S0028-3908(99)00010-6", "volume": "38", "author": "NM Barnes", "year": "1999", "unstructured": "Barnes NM, Sharp T (1999) A review of central 5-HT receptors and their functions. Neuropharmacology 38:1083\u20131152", "journal-title": "Neuropharmacology"}, {"key": "13_CR89", "doi-asserted-by": "crossref", "first-page": "11", "DOI": "10.2174/1568007043482598", "volume": "3", "author": "JE Leysen", "year": "2004", "unstructured": "Leysen JE (2004) 5-HT2 receptors. Curr Drug Targets CNS Neurol Disord 3:11\u201326", "journal-title": "Curr Drug Targets CNS Neurol Disord"}, {"key": "13_CR90", "author": "JE Leysen", "first-page": "51", "year": "1996", "unstructured": "Leysen JE, Gommeren W, Schotte A (1996) Serotonin receptor subtypes: possible roles and implications in antipsychotic drug action. In: Kane JM, M\u00f6ller H-J, Awouters F (eds) Serotonin and antipsychotic treatment. Marcel Dekker, New York, pp 51\u201375", "volume-title": "Serotonin and antipsychotic treatment"}], "container-title": ["5-HT2A Receptors in the Central Nervous System"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/978-3-319-70474-6_13", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 2, 14]], "date-time": "2018-02-14T08:41:55Z", "timestamp": 1518597715000}, "score": 24.91686, "issued": {"date-parts": [[2018]]}, "ISBN": ["9783319704722", "9783319704746"], "references-count": 90, "URL": "http://dx.doi.org/10.1007/978-3-319-70474-6_13", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T11:37:51Z", "timestamp": 1574509071512}, "publisher-location": "Berlin, Heidelberg", "reference-count": 81, "publisher": "Springer Berlin Heidelberg", "isbn-type": [{"value": "9783540667155", "type": "print"}, {"value": "9783642609213", "type": "electronic"}], "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2000, 1, 1]], "date-time": "2000-01-01T00:00:00Z", "timestamp": 946684800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2000]]}, "DOI": "10.1007/978-3-642-60921-3_15", "type": "book-chapter", "created": {"date-parts": [[2012, 10, 6]], "date-time": "2012-10-06T01:46:05Z", "timestamp": 1349487965000}, "page": "395-407", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Regulation of 5-HT2A Receptor at the Molecular Level"], "prefix": "10.1007", "author": [{"given": "M.", "family": "Toth", "sequence": "first", "affiliation": []}, {"given": "D.", "family": "Benjamin", "sequence": "additional", "affiliation": []}], "member": "297", "reference": [{"key": "15_CR1", "first-page": "349", "volume": "43", "author": "J Akiyoshi", "year": "1993", "unstructured": "Akiyoshi J, Hough C, Chuang DM (1993) Paradoxical increase of 5-hydroxytryptamine2 receptors and 5-hydroxytryptamine2 receptor mRNA in cerebellar granule cells after persistent 5-hydroxytryptamine2 receptor stimulation. Mol Pharmacol 43:349\u201355", "journal-title": "Mol Pharmacol"}, {"key": "15_CR2", "doi-asserted-by": "publisher", "first-page": "1038", "DOI": "10.1001/archpsyc.1990.01810230054009", "volume": "47", "author": "V Arango", "year": "1990", "unstructured": "Arango V, Ernsberger P, Marzuk PM, Chen JS, Tierney H, Stanley M, Reis DJ, Mann JJ (1990) Autoradiographic demonstration of increased serotonin 5-HT2 and beta-adrenergic receptor binding sites in the brain of suicide victims. Arch Gen Psychiatry 47:1038\u20131047", "journal-title": "Arch Gen Psychiatry"}, {"key": "15_CR3", "doi-asserted-by": "publisher", "first-page": "725", "DOI": "10.1016/0024-3205(89)90384-6", "volume": "44", "author": "RC Arora", "year": "1989", "unstructured": "Arora RC, Meltzer HY (1989) Increased serotonin2 (5-HT2) receptor binding as measured by 3H-lysergic acid diethylamide (3H-LSD) in the blood platelets of depressed patients. Life Sci 44:725\u2013734", "journal-title": "Life Sci"}, {"key": "15_CR4", "doi-asserted-by": "crossref", "first-page": "2297", "DOI": "10.1002/j.1460-2075.1987.tb02504.x", "volume": "6", "author": "A Baniahmad", "year": "1987", "unstructured": "Baniahmad A, Muller M, Steiner C, Renkawitz R (1987) Activity of two different silencer elements of the chicken lysozyme gene can be compensated by enhancer elements. EMBO J 6:2297\u20132302", "journal-title": "EMBO J"}, {"key": "15_CR5", "first-page": "11687", "volume": "269", "author": "EL Barker", "year": "1994", "unstructured": "Barker EL, Westphal RS, Schmidt D, Sanders-Bush E (1994) Constitutively active 5-hydroxytryptamine2C receptors reveal novel inverse agonist activity of receptor ligands. J Biol Chem 269:11687\u201311690", "journal-title": "J Biol Chem"}, {"key": "15_CR6", "doi-asserted-by": "publisher", "first-page": "287", "DOI": "10.1002/ddr.430260308", "volume": "26", "author": "D Benjamin", "year": "1992", "unstructured": "Benjamin D, Saiff EI, Nevins T, Lal H (1992) Mianserin-induced 5-HT2 receptor downregulation results in anxiolytic effects in the elevated plus-maze test. Drug Dev Res 26:287\u2013297", "journal-title": "Drug Dev Res"}, {"key": "15_CR7", "first-page": "663", "volume": "19", "author": "D Benjamin", "year": "1993", "unstructured": "Benjamin D, Saiff EI, Goldstein KR, Larson SA, De Adrianza A, Pohorecky LA (1993) Cortical 5-HT2 receptor binding is inversely related to dominance status in triad-housed rats. Soc Neurosci Abstr 19:663\u2013668", "journal-title": "Soc Neurosci Abstr"}, {"key": "15_CR8", "doi-asserted-by": "publisher", "first-page": "309", "DOI": "10.1016/0006-8993(85)90599-2", "volume": "332", "author": "A Biegon", "year": "1985", "unstructured": "Biegon A, Rainbow TC, McEwen BS (1985) Corticosterone modulation of neurotransmitter receptors in rat hippocampus: a quantitative autoradiographic study. Brain Res 332:309\u2013314", "journal-title": "Brain Res"}, {"key": "15_CR9", "first-page": "303", "volume": "221", "author": "MA Blackshear", "year": "1982", "unstructured": "Blackshear MA, Sanders-Bush E (1982) Serotonin receptor sensitivity after acute and chronic treatment with mianserin. J Pharmacol Exp Ther 221:303\u2013308", "journal-title": "J Pharmacol Exp Ther"}, {"key": "15_CR10", "doi-asserted-by": "publisher", "first-page": "421", "DOI": "10.1016/0014-2999(85)90407-8", "volume": "109", "author": "NS Buckholtz", "year": "1985", "unstructured": "Buckholtz NS, Freedman DX, Middaugh LD (1985) Daily LSD administration selectively decreases serotonin2 receptor binding in rat brain. Eur J Pharmacol 109:421\u2013425", "journal-title": "Eur J Pharmacol"}, {"key": "15_CR11", "doi-asserted-by": "publisher", "first-page": "2439", "DOI": "10.1016/0024-3205(88)90342-6", "volume": "42", "author": "NS Buckholtz", "year": "1988", "unstructured": "Buckholtz NS, Zhou D, Freedman DX (1988) Serotonin2 agonist administration down-regulates rat brain serotonin2 receptors. Life Sci 42:2439\u20132445", "journal-title": "Life Sci"}, {"key": "15_CR12", "doi-asserted-by": "publisher", "first-page": "272", "DOI": "10.1016/0006-8993(88)91621-6", "volume": "443", "author": "SC Cheetham", "year": "1988", "unstructured": "Cheetham SC, Crompton MR, Katona CL, Horton RW (1988) Brain 5-HT2 receptor binding sites in depressed suicide victims. Brain Res 443:272\u2013280", "journal-title": "Brain Res"}, {"key": "15_CR13", "doi-asserted-by": "publisher", "first-page": "37", "DOI": "10.1016/0968-0004(92)90425-9", "volume": "17", "author": "S Collins", "year": "1992", "unstructured": "Collins S, Caron MG, Lefkowitz RJ (1992) From ligand binding to gene expression: new insights into the regulation of G-protein-coupled receptors. Trends Biochem Sci 17:37\u201339", "journal-title": "Trends Biochem Sci"}, {"key": "15_CR14", "doi-asserted-by": "crossref", "first-page": "3669", "DOI": "10.1523/JNEUROSCI.06-12-03669.1986", "volume": "6", "author": "PJ Conn", "year": "1986", "unstructured": "Conn PJ, Sanders-Bush E (1986) Regulation of serotonin-stimulated phosphoinositide hydrolysis: relation to the serotonin 5-HT-2 binding site. J Neurosci 6:3669\u20133675", "journal-title": "J Neurosci"}, {"key": "15_CR15", "author": "SJ Cooper", "first-page": "53", "year": "1986", "unstructured": "Cooper SJ, Owen F, Chambers DR, Crow TJ, Johnson J, Poulter M (1986) Postmortem neurochemical findings in suicide and depression: a study of the serotoninergic system and imipramine binding in suicide victims. In: Deakin JFW (ed), The biology of depression. Gaskell, London pp 53\u201370", "volume-title": "The biology of depression"}, {"key": "15_CR16", "doi-asserted-by": "crossref", "first-page": "830", "DOI": "10.1093/ajcn/24.7.830", "volume": "24", "author": "G Curzon", "year": "1971", "unstructured": "Curzon G (1971) Effects of adrenal hormones and stress on brain serotonin. Am J Clin Nutr 24:830\u2013834", "journal-title": "Am J Clin Nutr"}, {"key": "15_CR17", "doi-asserted-by": "publisher", "first-page": "227", "DOI": "10.1016/0925-4927(92)90018-Y", "volume": "45", "author": "H D\u2019Haenen", "year": "1992", "unstructured": "D\u2019Haenen H, Bossuyt A, Mertens J, Bossuyt-Piron C, Gijsemans M, Kaufman L (1992) SPECT imaging of serotonin2 receptors in depression. Psychiatry Res 45:227\u2013237", "journal-title": "Psychiatry Res"}, {"key": "15_CR18", "doi-asserted-by": "publisher", "first-page": "513", "DOI": "10.1159/000124496", "volume": "42", "author": "ER Kloet De", "year": "1986", "unstructured": "De Kloet ER, Sybesma H, Reul HM (1986) Selective control by corticosterone of serotonin receptor capacity in raphe-hippocampal system. Neuroendocrinology 42:513\u2013521", "journal-title": "Neuroendocrinology"}, {"key": "15_CR19", "doi-asserted-by": "publisher", "first-page": "246", "DOI": "10.1002/jnr.490350304", "volume": "35", "author": "DC Deecher", "year": "1993", "unstructured": "Deecher DC, Wilcox BD, Dave V, Rossman PA, Kimelberg HK (1993) Detection of 5-hydroxytryptamine2 receptors by radioligand binding, northern blot analysis, and Ca2+ responses in rat primary astrocyte cultures. J Neurosci Res 35:246\u2013256", "journal-title": "J Neurosci Res"}, {"key": "15_CR20", "doi-asserted-by": "publisher", "first-page": "181", "DOI": "10.1016/0169-328X(93)90040-V", "volume": "20", "author": "D Ding", "year": "1993", "unstructured": "Ding D, Toth M, Zhou Z, Parks C, Hoffman B, Shenk T Glial (1993) Cell-specific expression of the serotonin 2 receptor gene: selective reactivation of a repressed promoter. Mol Brain Res 20:181\u2013191", "journal-title": "Mol Brain Res"}, {"key": "15_CR21", "first-page": "1125", "volume": "45", "author": "YL Du", "year": "1994", "unstructured": "Du YL, Wilcox BD, Teitler M, Jeffrey JJ (1994) Isolation and characterization of the rat 5-hydroxytryptamine type 2 receptor promoter: constitutive and inducible activity in myometrial smooth muscle cells. Mol Pharmacol 45:1125\u20131131", "journal-title": "Mol Pharmacol"}, {"key": "15_CR22", "doi-asserted-by": "publisher", "first-page": "1419", "DOI": "10.1016/0024-3205(89)90400-1", "volume": "44", "author": "AS Eison", "year": "1989", "unstructured": "Eison AS, Eison MS, Yocca FD, Gianutsos G (1989) Effects of imipramine and serotonin-2 agonists and antagonists on serotonin-2 and beta-adrenergic receptors following noradrenergic or serotonergic denervation. Life Sci 44:1419\u20131427", "journal-title": "Life Sci"}, {"key": "15_CR23", "doi-asserted-by": "publisher", "first-page": "1189", "DOI": "10.1016/0092-8674(89)90056-1", "volume": "57", "author": "BM Emerson", "year": "1989", "unstructured": "Emerson BM, Nickol JM, Fong TC (1989) Erythroid-specific activation and derepression of the chick \u03b2-globin promoter in vitro. Cell 57:1189\u20131200", "journal-title": "Cell"}, {"key": "15_CR24", "doi-asserted-by": "publisher", "first-page": "5976", "DOI": "10.1073/pnas.85.16.5976", "volume": "85", "author": "T Evans", "year": "1988", "unstructured": "Evans T, Reitman M, Felsenfeld G (1988) An erythroid-specific DNA-binding factor recognizes a regulatory sequence common to all chicken globin gene. Proc Natl Acad Sci USA 85:5976\u20135980", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "15_CR25", "first-page": "726", "volume": "43", "author": "RC Ferry", "year": "1993", "unstructured": "Ferry RC, Unsworth CD, Molinoff PB (1993) Effects of agonists, partial agonists, and antagonists on the regulation of 5-hydroxytryptamine receptors in P11 cells. Mol Pharmacol 43:726\u2013733", "journal-title": "Mol Pharmacol"}, {"key": "15_CR26", "first-page": "31850", "volume": "269", "author": "RC Ferry", "year": "1994", "unstructured": "Ferry RC, Unsworth CD, Artymyshyn RP, Molinoff PB (1994) Regulation of mRNA encoding 5-HT2a receptors in P11 cells through a post-transcriptional mechanism requiring activation of protein kinase. J Biol Chem 269:31850\u201331857", "journal-title": "J Biol Chem"}, {"key": "15_CR27", "first-page": "495", "volume": "3", "author": "RW Fuller", "year": "1990", "unstructured": "Fuller RW (1990) Serotonin receptors and neuroendocrine responses. Neuropsychopharmacology 3:495\u2013502", "journal-title": "Neuropsychopharmacology"}, {"key": "15_CR28", "doi-asserted-by": "publisher", "first-page": "201", "DOI": "10.1016/0169-328X(95)00043-R", "volume": "31", "author": "SJ Garlow", "year": "1995", "unstructured": "Garlow SJ, Ciaranello RD (1995) Transcriptional control of the rat serotonin-2 receptor gene. Brain Res Mol Brain Res 31:201\u2013209", "journal-title": "Brain Res Mol Brain Res"}, {"key": "15_CR29", "doi-asserted-by": "publisher", "first-page": "113", "DOI": "10.1016/0006-8993(93)91121-8", "volume": "615", "author": "SJ Garlow", "year": "1993", "unstructured": "Garlow SJ, Morilak DA, Dean RR, Roth BL, Ciaranello RD (1993) Production and characterization of a specific 5-HT2 receptor antibody. Brain Res 615:113\u2013120", "journal-title": "Brain Res"}, {"key": "15_CR30", "doi-asserted-by": "publisher", "first-page": "291", "DOI": "10.1006/mcne.1994.1034", "volume": "5", "author": "SJ Garlow", "year": "1994", "unstructured": "Garlow SJ, Chin AC, Marinovich AM, Heller MR, Ciaranello RD (1994) Cloning and functional promoter mapping of the rat serotonin-2 receptor gene. Mol Cell Neurosci 5:291\u2013300", "journal-title": "Mol Cell Neurosci"}, {"key": "15_CR31", "doi-asserted-by": "publisher", "first-page": "235", "DOI": "10.1111/j.1476-5381.1984.tb10140.x", "volume": "83", "author": "GM Goodwin", "year": "1984", "unstructured": "Goodwin GM, Green AR, Johnson P (1984) 5-HT2 receptor characteristics in frontal cortex and 5-HT2 receptor-mediated head-twitch behaviour following antidepressant treatment to mice. Br J Pharmacol 83:235\u2013242", "journal-title": "Br J Pharmacol"}, {"key": "15_CR32", "first-page": "19928", "volume": "264", "author": "JR Hadcock", "year": "1989", "unstructured": "Hadcock JR, Wang H, Malbon CC (1989) Agonist-induced destabilization of \u03b2-adrenergic receptor mRNA. Attenuation of glucocorticoid-induced up-regulation of \u03b2-adrenergic receptors. J Biol Chem 264:19928\u201319933", "journal-title": "J Biol Chem"}, {"key": "15_CR33", "first-page": "12657", "volume": "264", "author": "WP Hausdorff", "year": "1989", "unstructured": "Hausdorff WP, Bouvier M, O\u2019Dowd BF, Irons GP, Caron MG, Lefkowitz RJ (1989) Phosphorylation sites on two domains of the \u03b22-adrenergic receptor are involved in distinct pathways of receptor desensitization. J Biol Chem 264:12657\u201312666", "journal-title": "J Biol Chem"}, {"key": "15_CR34", "doi-asserted-by": "publisher", "first-page": "1553", "DOI": "10.1073/pnas.86.5.1553", "volume": "86", "author": "RS Herbst", "year": "1989", "unstructured": "Herbst RS, Friedman N, Darnell JE Jr, Babiss LE (1989) Positive and negative regulatory elements in the mouse albumin enhancer. Proc Natl Acad Sci USA 86:1553\u20131557", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "15_CR35", "first-page": "473", "volume": "3", "author": "BL Jacobs", "year": "1990", "unstructured": "Jacobs BL, Wilkinson LO, Fornal CA (1990) The role of brain serotonin. A neurophysiologic perspective. Neuropsychopharmacology 3:473\u2013479", "journal-title": "Neuropsychopharmacology"}, {"key": "15_CR36", "first-page": "194", "volume": "46", "author": "RG Kathol", "year": "1985", "unstructured": "Kathol RG, Delahunt JW, Hannah L (1985) Transition from bipolar affective disorder to intermittent Cushing\u2019s syndrome: case report. J Clin Psychiatry 46:194\u2013196", "journal-title": "J Clin Psychiatry"}, {"key": "15_CR37", "doi-asserted-by": "publisher", "first-page": "37", "DOI": "10.1016/0896-6273(92)90218-3", "volume": "9", "author": "SD Kraner", "year": "1992", "unstructured": "Kraner SD, Chong JA, Tsay H-J, Mandel G (1992) Silencing the type II sodium channel gene: a model for neural-specific gene regulation. Neuron 9:37\u201344", "journal-title": "Neuron"}, {"key": "15_CR38", "doi-asserted-by": "publisher", "first-page": "27", "DOI": "10.1007/BF02245281", "volume": "108", "author": "Y Kuroda", "year": "1992", "unstructured": "Kuroda Y, Mikuni M, Ogawa T, Takahashi K (1992) Effect of ACTH, adrenalectomy and the combination treatment on the density of 5-HT2 receptor binding sites in neocortex of rat forebrain and 5-HT2 receptor-mediated wet-dog shake behaviors. Psychopharmacology 108:27\u201332", "journal-title": "Psychopharmacology"}, {"key": "15_CR39", "doi-asserted-by": "publisher", "first-page": "195", "DOI": "10.1016/0304-3940(93)90706-Q", "volume": "155", "author": "Y Kuroda", "year": "1993", "unstructured": "Kuroda Y, Mikuni M, Nomura N, Takahashi K (1993) Differential effect of subchronic dexamethasone treatment on serotonin-2 and beta-adrenergic receptors in the rat cerebral cortex and hippocampus. Neurosci Lett 155:195\u2013198", "journal-title": "Neurosci Lett"}, {"key": "15_CR40", "doi-asserted-by": "publisher", "first-page": "405", "DOI": "10.1016/0092-8674(89)90024-X", "volume": "59", "author": "M Levine", "year": "1989", "unstructured": "Levine M, Manley JL (1989) Transcriptional repression of eukaryotic promoters. Cell 59:405\u2013408", "journal-title": "Cell"}, {"key": "15_CR41", "first-page": "361", "volume": "3", "author": "JE Leysen", "year": "1990", "unstructured": "Leysen JE (1990) Gaps and peculiarities in 5-HT2 receptor studies. Neuropsychopharmacology 3:361\u2013369", "journal-title": "Neuropsychopharmacology"}, {"key": "15_CR42", "doi-asserted-by": "publisher", "first-page": "434", "DOI": "10.1007/BF00178504", "volume": "88", "author": "JE Leysen", "year": "1986", "unstructured": "Leysen JE, VanGompel P, Gommeren W, Woestenborghs R, Janssen PFM (1986) Down regulation of serotonin-S2 receptor sites in rat brain by chronic treatment with the serotonin-S2 antagonists: ritanserin and setoperone. Psychopharmacology 88:434\u2013444", "journal-title": "Psychopharmacology"}, {"key": "15_CR43", "doi-asserted-by": "publisher", "first-page": "145", "DOI": "10.1016/0014-2999(89)90409-3", "volume": "163", "author": "JE Leysen", "year": "1989", "unstructured": "Leysen JE, Janssen PFM, Niemegeers CJE (1989) Rapid desensitization and down-regulation of 5-HT2 receptors by DOM treatment. Eur J Pharmacol 163:145\u2013149", "journal-title": "Eur J Pharmacol"}, {"key": "15_CR44", "doi-asserted-by": "publisher", "first-page": "954", "DOI": "10.1001/archpsyc.1986.01800100048007", "volume": "43", "author": "JJ Mann", "year": "1986", "unstructured": "Mann JJ, Stanley M, McBride PA, McEwen BS (1986) Increased serotonin2 and \u03b2-adrenergic receptor binding in the frontal cortices of suicide victims. Arch Gen Psychiatry 43:954\u2013959", "journal-title": "Arch Gen Psychiatry"}, {"key": "15_CR45", "first-page": "924", "volume": "85", "author": "RA Maue", "year": "1990", "unstructured": "Maue RA, Kraner SD, Goodman RH, Mandel G (1990) Neuron-specific expression of the rat brain type II Na+ channels by nerve growth factor. Proc Natl Acad Sci USA 85:924\u2013928", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "15_CR46", "doi-asserted-by": "publisher", "first-page": "1741", "DOI": "10.1016/0024-3205(86)90124-4", "volume": "38", "author": "PC May", "year": "1986", "unstructured": "May PC, Morgan DG, Finch CE (1986) Regional serotonin receptor studies: chronic methysergide treatment induces a selective and dose-dependent decrease in serotonin-2 receptors in mouse cerebral cortex. Life Sci 38:1741\u20131747", "journal-title": "Life Sci"}, {"key": "15_CR47", "doi-asserted-by": "publisher", "first-page": "67", "DOI": "10.1016/0165-0327(87)90075-9", "volume": "13", "author": "IG McKeith", "year": "1987", "unstructured": "McKeith IG, Marshall EF, Ferrier IN, Armstrong MM, Kennedy WN, Perry RH, Perry EK, Eccleston D (1987) 5-HT receptor binding in post-mortem brain from patients with affective disorder. J Affect Disord 13:67\u201374", "journal-title": "J Affect Disord"}, {"key": "15_CR48", "doi-asserted-by": "publisher", "first-page": "81", "DOI": "10.1016/0893-133X(89)90010-9", "volume": "2", "author": "DJ McKenna", "year": "1989", "unstructured": "McKenna DJ, Nazarali AJ, Himeno A, Saavedra JM (1989) Chronic treatment with (\u00b1) DOI, a psychotomimetic 5-HT2 agonist, downregulates 5-HT2 receptors in rat brain. Neuropsychopharmacology 2:81\u201387", "journal-title": "Neuropsychopharmacology"}, {"key": "15_CR49", "doi-asserted-by": "publisher", "first-page": "383", "DOI": "10.1016/0006-3223(94)00152-S", "volume": "37", "author": "CR McKittrick", "year": "1995", "unstructured": "McKittrick CR, Blanchard DC, Blanchard RJ, McEwen BS, Sakai RR (1995) Serotonin receptor binding in a colony model of chronic social stress. Biol Psychiatry 37:383\u2013393", "journal-title": "Biol Psychiatry"}, {"key": "15_CR50", "doi-asserted-by": "publisher", "first-page": "139", "DOI": "10.1016/0006-8993(90)90502-3", "volume": "524", "author": "G Mengod", "year": "1990", "unstructured": "Mengod G, Pompeiano M, Martinez-Mir MI, Palacios JM (1990) Localization of the mRNA for the 5-HT2 receptor by in situ hybridization histochemistry. Correlation with the distribution of receptor sites. Brain Res 524:139\u2013143", "journal-title": "Brain Res"}, {"key": "15_CR51", "doi-asserted-by": "publisher", "first-page": "847", "DOI": "10.1016/0092-8674(87)90512-5", "volume": "50", "author": "PJ Mitchell", "year": "1987", "unstructured": "Mitchell PJ, Wang C, Tjian R (1987) Positive and negative regulation of transcription in vitro: enhancer binding protein AP2 is inhibited by SV40 T antigen. Cell 50:847\u2013861", "journal-title": "Cell"}, {"key": "15_CR52", "doi-asserted-by": "publisher", "first-page": "45", "DOI": "10.1016/0896-6273(92)90219-4", "volume": "9", "author": "N Mori", "year": "1992", "unstructured": "Mori N, Schoenherr C, Vandenbergh DJ, Anderson DJ (1992) A common silencer element in the SCG10 and type II Na+ channel genes binds a factor present in non-neuronal but not in neuronal cells. Neuron 9:45\u201354", "journal-title": "Neuron"}, {"key": "15_CR53", "doi-asserted-by": "publisher", "first-page": "583", "DOI": "10.1016/0896-6273(90)90116-W", "volume": "4", "author": "N Mori", "year": "1990", "unstructured": "Mori N, Stein R, Sigmund O, Anderson DJ (1990) A cell type-preferred silencer element that controls the neural-specific expression of the SCG10 gene. Neuron 4:583\u2013594", "journal-title": "Neuron"}, {"key": "15_CR54", "doi-asserted-by": "publisher", "first-page": "49", "DOI": "10.1016/0006-8993(93)90747-B", "volume": "627", "author": "DA Morilak", "year": "1993", "unstructured": "Morilak DA, Ciaranello RD (1993) 5-HT2 receptor immunoreactivity on cholinergic neurons of the pontomesencephalic tegmentum shown by double immunofluorescence. Brain Res 627:49\u201354", "journal-title": "Brain Res"}, {"key": "15_CR55", "doi-asserted-by": "publisher", "first-page": "701", "DOI": "10.1016/0306-4522(93)90241-7", "volume": "54", "author": "DA Morilak", "year": "1993", "unstructured": "Morilak DA, Garlow SJ, Ciaranello RD (1993) Immunocytochemical localization and description of neurons expressing serotonin2 receptors in the rat brain. Neuroscience 54:701\u2013717", "journal-title": "Neuroscience"}, {"key": "15_CR56", "doi-asserted-by": "publisher", "first-page": "7653", "DOI": "10.1073/pnas.83.20.7653", "volume": "83", "author": "L Muglia", "year": "1986", "unstructured": "Muglia L, Rothman-Denes LB (1986) Cell type-specific negative regulatory element in the control region of the rat alpha-fetoprotein gene. Proc Natl Acad Sci USA 83:7653\u20137657", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "15_CR57", "first-page": "457", "volume": "3", "author": "DL Murphy", "year": "1990", "unstructured": "Murphy DL (1990) Neuropsychiatric disorders and the multiple human brain serotonin receptor subtypes and subsystems. Neuropsychopharmacology 3:457\u2013471", "journal-title": "Neuropsychopharmacology"}, {"key": "15_CR58", "first-page": "13", "volume": "50", "author": "CB Nemeroff", "year": "1989", "unstructured": "Nemeroff CB (1989) Clinical significance of psychoneuroendocrinology in psychiatry: focus on the thyroid and adrenal. J Clin Psychiatry 50:13\u201319", "journal-title": "J Clin Psychiatry"}, {"key": "15_CR59", "doi-asserted-by": "publisher", "first-page": "384", "DOI": "10.1001/archpsyc.1992.01820050048008", "volume": "49", "author": "CB Nemeroff", "year": "1992", "unstructured": "Nemeroff CB, Krishnan RR, Reed D, Leder R, Beam C, Dunnick NR (1992) Adrenal gland enlargement in major depression. Arch Gen Psychiatry 49:384\u2013390", "journal-title": "Arch Gen Psychiatry"}, {"key": "15_CR60", "doi-asserted-by": "publisher", "first-page": "1256", "DOI": "10.1016/S0140-6736(83)91310-7", "volume": "ii", "author": "F Owen", "year": "1983", "unstructured": "Owen F, Cross AJ, Crow TJ, Deakin JF, Ferrier IN, Lofthouse R, Poulter M (1983) Brain 5-HT-2 receptors and suicide. Lancet ii:1256", "journal-title": "Lancet"}, {"key": "15_CR61", "doi-asserted-by": "publisher", "first-page": "88", "DOI": "10.1126/science.6251550", "volume": "210", "author": "SJ Peroutka", "year": "1980", "unstructured": "Peroutka SJ, Snyder SH (1980) Long-term antidepressant treatment decreases spiroperidol-labeled serotonin receptor binding. Science 210:88\u201390", "journal-title": "Science"}, {"key": "15_CR62", "doi-asserted-by": "publisher", "first-page": "163", "DOI": "10.1016/0169-328X(94)90223-2", "volume": "23", "author": "M Pompeiano", "year": "1994", "unstructured": "Pompeiano M, Palacios JM, Mengod G (1994) Distribution of the serotonin 5-HT2 receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors. Mol Brain Res 23:163\u2013178", "journal-title": "Mol Brain Res"}, {"key": "15_CR63", "doi-asserted-by": "publisher", "first-page": "169", "DOI": "10.1016/0922-4106(91)90093-W", "volume": "207", "author": "BL Roth", "year": "1991", "unstructured": "Roth BL, Ciaranello RD (1991) Chronic mianserin treatment decreases 5-HT2 receptor binding without altering 5-HT2 receptor mRNA levels. Eur J Pharmacol 207:169\u2013172", "journal-title": "Eur J Pharmacol"}, {"key": "15_CR64", "doi-asserted-by": "publisher", "first-page": "51", "DOI": "10.1016/0165-3806(91)90236-C", "volume": "58", "author": "BL Roth", "year": "1991", "unstructured": "Roth BL, Hamblin M, Ciaranello RD (1991) Developmental regulation of 5-HT2 and 5-HT1C mRNA and receptor levels. Dev Brain Res 58:51\u201358", "journal-title": "Dev Brain Res"}, {"key": "15_CR65", "doi-asserted-by": "publisher", "first-page": "213", "DOI": "10.1001/archpsyc.1995.03950150045009", "volume": "52", "author": "RT Rubin", "year": "1995", "unstructured": "Rubin RT, Phillips JJ, Sadow TF, McCracken JT (1995) Adrenal gland volume in major depression: increase during the depressive episode and decrease with successful treatment. Arch Gen Psychiatry 52:213\u2013218", "journal-title": "Arch Gen Psychiatry"}, {"key": "15_CR66", "doi-asserted-by": "publisher", "first-page": "1099", "DOI": "10.1016/0006-3223(91)90252-H", "volume": "29", "author": "R Rupprecht", "year": "1991", "unstructured": "Rupprecht R, Kornhuber J, Wodarz N, Lugauer J, Gobel C, Haack D, Beck G, Muller OA, Rieder P, Beckman H (1991) Disturbed glucocorticoid receptor autoregulation and corticotropin response to dexamethasone in depressives pretreated with metyrapone. Biol Psychiatry 29:1099\u20131109", "journal-title": "Biol Psychiatry"}, {"key": "15_CR67", "doi-asserted-by": "publisher", "first-page": "253", "DOI": "10.1016/0303-7207(93)90016-D", "volume": "92", "author": "L Rydelek-Fitzgerald", "year": "1993", "unstructured": "Rydelek-Fitzgerald L, Wilcox BD, Teitler M, Jeffrey JJ (1993) Serotonin-mediated 5-HT2 receptor gene regulation in rat myometrial smooth muscle cells. Mol Cell Endocrinol 92:253\u2013259", "journal-title": "Mol Cell Endocrinol"}, {"key": "15_CR68", "first-page": "443.18", "volume": "21", "author": "E Saiff", "year": "1995", "unstructured": "Saiff E, Goska J, Sibille E, Toth M, Pohorecky LA, Benjamin D (1995) Differential regulation by corticosteroids of 5-HT2A receptors in P-11 and C-6 cells. Soc Neurosci Abstr 21:443.18", "journal-title": "Soc Neurosci Abstr"}, {"key": "15_CR69", "doi-asserted-by": "publisher", "first-page": "449", "DOI": "10.1016/0006-8993(80)90104-3", "volume": "189", "author": "R Samanin", "year": "1980", "unstructured": "Samanin R, Mennini J, Ferraris A, Bendotti C, Borsini R (1980) Hyper- and hyposensitivity of central serotonin receptors: [3H]-serotonin binding and functional studies in the rat. Brain Res 189:449\u2013457", "journal-title": "Brain Res"}, {"key": "15_CR70", "first-page": "411", "volume": "3", "author": "E Sanders-Bush", "year": "1990", "unstructured": "Sanders-Bush E (1990) Adaptive regulation of central serotonin receptors linked to phosphoinositide hydrolysis. Neuropsychopharmacology 3:411\u2013416", "journal-title": "Neuropsychopharmacology"}, {"key": "15_CR71", "doi-asserted-by": "crossref", "first-page": "2704", "DOI": "10.1128/MCB.11.5.2704", "volume": "11", "author": "SN Seal", "year": "1991", "unstructured": "Seal SN, Davis DL, Burch JBE (1991) Mutational studies reveal a complex set of positive and negative control elements within the chicken vitellogenin II promoter. Mol Cell Biol 11:2704\u20132717", "journal-title": "Mol Cell Biol"}, {"key": "15_CR72", "doi-asserted-by": "publisher", "first-page": "913", "DOI": "10.1016/0092-8674(87)90700-8", "volume": "48", "author": "DR Sibley", "year": "1987", "unstructured": "Sibley DR, Benovic JL, Caron MG, Lefkowitz RJ (1987) Regulation of transmembrane signaling by receptor phosphorylation. Cell 48:913\u2013922", "journal-title": "Cell"}, {"key": "15_CR73", "doi-asserted-by": "publisher", "first-page": "214", "DOI": "10.1016/S0140-6736(83)92590-4", "volume": "i", "author": "M Stanley", "year": "1983", "unstructured": "Stanley M, Mann JJ (1983) Increased serotonin-2 binding sites in frontal cortex of suicide victims. Lancet i:214\u2013216", "journal-title": "Lancet"}, {"key": "15_CR74", "doi-asserted-by": "publisher", "first-page": "177", "DOI": "10.1016/0896-6273(91)90256-Y", "volume": "7", "author": "K Struhl", "year": "1991", "unstructured": "Struhl K (1991) Mechanism for diversity in gene expression patterns. Neuron 7:177\u2013181", "journal-title": "Neuron"}, {"key": "15_CR75", "doi-asserted-by": "publisher", "first-page": "198", "DOI": "10.1016/0006-8993(90)91138-7", "volume": "527", "author": "T Torda", "year": "1990", "unstructured": "Torda T, Murgas K, Cechova E, Kiss A, Saavedra JM (1990) Adrenergic regulation of [3H]ketanserin binding sites during immobilization stress in the rat frontal cortex. Brain Res 527:198\u2013203", "journal-title": "Brain Res"}, {"key": "15_CR76", "first-page": "1095", "volume": "145", "author": "M Toth", "year": "1994", "unstructured": "Toth M, Shenk T (1994) Antagonist-mediated downregulation of serotonin2 receptor gene expression: modulation of transcription. Mol Pharmacol 145:1095\u20131100", "journal-title": "Mol Pharmacol"}, {"key": "15_CR77", "doi-asserted-by": "publisher", "first-page": "315", "DOI": "10.1016/0169-328X(94)90015-9", "volume": "27", "author": "M Toth", "year": "1994", "unstructured": "Toth M, Ding D, Shenk T (1994) The 5\u2019 flanking region of the serotonin2 receptor gene directs brain specific expression in transgenic animals. Mol Brain Res 27:315\u2013319", "journal-title": "Mol Brain Res"}, {"key": "15_CR78", "first-page": "200", "volume": "48", "author": "RS Westphal", "year": "1995", "unstructured": "Westphal RS, Backstrom JR, Sanders-Bush E (1995) Increased basal phosphorylation of the constitutively active serotonin 2C receptor accompanies agonist-mediated desensitization. Mol Pharmacol 48:200\u2013205", "journal-title": "Mol Pharmacol"}, {"key": "15_CR79", "doi-asserted-by": "publisher", "first-page": "4595", "DOI": "10.1016/0896-6273(90)90117-X", "volume": "4", "author": "CW Wuenschell", "year": "1990", "unstructured": "Wuenschell CW, Mori N, Anderson DJ (1990) Analysis of SCG10 gene expression in transgenic mice reveals that neural specificity is achieved through selective derepression. Neuron 4:4595\u20134602", "journal-title": "Neuron"}, {"key": "15_CR80", "doi-asserted-by": "publisher", "first-page": "489", "DOI": "10.1016/0006-3223(90)90440-D", "volume": "27", "author": "M Yates", "year": "1990", "unstructured": "Yates M, Leake A, Candy JM, Fairbairn AF, McKeith IG, Ferrier IN (1990) 5HT2 receptor changes in major depression. Biol Psychiatry 27:489\u2013496", "journal-title": "Biol Psychiatry"}, {"key": "15_CR81", "doi-asserted-by": "crossref", "first-page": "4885", "DOI": "10.1523/JNEUROSCI.15-07-04885.1995", "volume": "15", "author": "QS Zhu", "year": "1995", "unstructured": "Zhu QS, Chen K, Shih JC (1995) Characterization of the human 5-HT2A receptor gene promoter. J Neurosci 15:4885\u201348895", "journal-title": "J Neurosci"}], "container-title": ["Serotoninergic Neurons and 5-HT Receptors in the CNS", "Handbook of Experimental Pharmacology"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/978-3-642-60921-3_15", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 17]], "date-time": "2019-05-17T15:32:28Z", "timestamp": 1558107148000}, "score": 24.391987, "issued": {"date-parts": [[2000]]}, "ISBN": ["9783540667155", "9783642609213"], "references-count": 81, "URL": "http://dx.doi.org/10.1007/978-3-642-60921-3_15", "relation": {"cites": []}, "ISSN": ["0171-2004"], "issn-type": [{"value": "0171-2004", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T18:45:14Z", "timestamp": 1574189114544}, "reference-count": 0, "publisher": "Springer Science and Business Media LLC", "issue": "1", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[1999, 1, 1]], "date-time": "1999-01-01T00:00:00Z", "timestamp": 915148800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Naunyn-Schmiedeberg's Arch Pharmacol"], "published-print": {"date-parts": [[1999, 1]]}, "DOI": "10.1007/pl00005315", "type": "journal-article", "created": {"date-parts": [[2006, 4, 10]], "date-time": "2006-04-10T11:31:28Z", "timestamp": 1144668688000}, "page": "1-6", "source": "Crossref", "is-referenced-by-count": 71, "title": ["Comparisons of hallucinogenic phenylisopropylamine binding affinities at cloned human 5-HT2A, 5-HT2B and 5-HT2C receptors"], "prefix": "10.1007", "volume": "359", "author": [{"given": "D. L.", "family": "Nelson", "sequence": "first", "affiliation": []}, {"given": "V. L.", "family": "Lucaites", "sequence": "additional", "affiliation": []}, {"given": "D. B.", "family": "Wainscott", "sequence": "additional", "affiliation": []}, {"given": "R. A.", "family": "Glennon", "sequence": "additional", "affiliation": []}], "member": "297", "container-title": ["Naunyn-Schmiedeberg's Archives of Pharmacology"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/PL00005315.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1007/PL00005315/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/PL00005315", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 22]], "date-time": "2019-05-22T13:01:44Z", "timestamp": 1558530104000}, "score": 23.807135, "subtitle": [""], "issued": {"date-parts": [[1999, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1999, 1]]}, "issue": "1"}, "alternative-id": ["93590001.210"], "URL": "http://dx.doi.org/10.1007/pl00005315", "ISSN": ["0028-1298"], "issn-type": [{"value": "0028-1298", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T08:02:33Z", "timestamp": 1575187353175}, "reference-count": 64, "publisher": "Springer Science and Business Media LLC", "issue": "3", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[1995, 10, 1]], "date-time": "1995-10-01T00:00:00Z", "timestamp": 812505600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Psychopharmacology"], "published-print": {"date-parts": [[1995, 10]]}, "DOI": "10.1007/bf02246076", "type": "journal-article", "created": {"date-parts": [[2005, 11, 15]], "date-time": "2005-11-15T05:36:56Z", "timestamp": 1132033016000}, "page": "364-372", "source": "Crossref", "is-referenced-by-count": 35, "title": ["The role of the 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs III: the mechanistic basis for supersensitivity to the LSD stimulus following serotonin depletion"], "prefix": "10.1007", "volume": "121", "author": [{"given": "D.", "family": "Fiorella", "sequence": "first", "affiliation": []}, {"given": "S.", "family": "Helsley", "sequence": "additional", "affiliation": []}, {"given": "D. S.", "family": "Lorrain", "sequence": "additional", "affiliation": []}, {"given": "R. A.", "family": "Rabin", "sequence": "additional", "affiliation": []}, {"given": "J. C.", "family": "Winter", "sequence": "additional", "affiliation": []}], "member": "297", "reference": [{"key": "BF02246076_CR1", "doi-asserted-by": "crossref", "first-page": "706", "DOI": "10.1126/science.161.3842.706", "volume": "161", "author": "G Aghajanian", "year": "1968", "unstructured": "Aghajanian G, Foote WE, Sheard MH (1968) Lysergic acid diethylamide: Sensitive neuronal units in the midbrain raphe. Science 161:706\u2013708", "journal-title": "Science"}, {"key": "BF02246076_CR2", "doi-asserted-by": "crossref", "first-page": "861", "DOI": "10.1016/0006-2952(64)90030-9", "volume": "13", "author": "JB Appel", "year": "1964", "unstructured": "Appel JB, Freedman DX (1964) Chemically-induced alterations in the behavioral effects of LSD-25. Biochem Pharmacol 13:861\u2013869", "journal-title": "Biochem Pharmacol"}, {"key": "BF02246076_CR3", "doi-asserted-by": "crossref", "first-page": "387", "DOI": "10.1007/BF00402765", "volume": "18", "author": "JB Appel", "year": "1970", "unstructured": "Appel JB, Lovell RA, Freedman DX (1970a) Alterations in the behavioral effects of lysergic acid diethylamide by pretreatment withp-chlorophenylalanine and alpha-methyl-p-tyrosine. Psychopharmacologia 18:387\u2013406", "journal-title": "Psychopharmacologia"}, {"key": "BF02246076_CR4", "first-page": "237", "volume": "5", "author": "JB Appel", "year": "1970", "unstructured": "Appel JB, Sheard MH, Freedman DX (1970b) Alterations in the behavioral effects of LSD by midbrain raphe lesions. Commun Behav Biol 5:237\u2013241", "journal-title": "Commun Behav Biol"}, {"key": "BF02246076_CR5", "first-page": "541", "volume": "1", "author": "JB Appel", "year": "1977", "unstructured": "Appel JB, Joseph JA, Utsey E, Hernardez LL, Boggan WO (1977) Sensitivity to psychoactive drugs and the serotonergic neuronal system. Commun Psychopharmacol 1:541\u2013551", "journal-title": "Commun Psychopharmacol"}, {"key": "BF02246076_CR6", "doi-asserted-by": "crossref", "first-page": "529", "DOI": "10.1016/0149-7634(82)90036-7", "volume": "6", "author": "JB Appel", "year": "1982", "unstructured": "Appel JB, White FJ, Holohean AM (1982) Analyzing mechanisms of hallucinogenic drug action with drug discrimination procedures. Neurosci Biobehav Rev 6:529\u2013536", "journal-title": "Neurosci Biobehav Rev"}, {"key": "BF02246076_CR7", "first-page": "3", "volume": "391", "author": "HG Baumgarten", "year": "1973", "unstructured": "Baumgarten HG (1973) Evaluation of the effects of 5,7-DHT on serotonin and CA neurons in the rat CNS. Acta Physiol Scand Suppl 391:3\u20139", "journal-title": "Acta Physiol Scand Suppl"}, {"key": "BF02246076_CR8", "doi-asserted-by": "crossref", "first-page": "214", "DOI": "10.1016/0163-1047(91)80140-A", "volume": "55", "author": "HHG Berendsen", "year": "1991", "unstructured": "Berendsen HHG, Broekkamp CLE, Van Delft AML (1991) Depletion of brain serotonin differentially affects behaviors induced by 5-HT1A, 5-HT1C and 5-HT2 receptor activation in rats. Behav Neural Biol 55:214\u2013226", "journal-title": "Behav Neural Biol"}, {"key": "BF02246076_CR9", "doi-asserted-by": "crossref", "first-page": "587", "DOI": "10.1042/bj2060587", "volume": "206", "author": "MJ Berridge", "year": "1982", "unstructured": "Berridge MJ, Downes PC, Hanley MR (1982) Lithium amplifies agonist-dependent phosphatidylinositol responses in brain and salivary glands. J Biochem 206:587\u2013595", "journal-title": "J Biochem"}, {"key": "BF02246076_CR10", "doi-asserted-by": "crossref", "first-page": "348", "DOI": "10.1016/0006-8993(75)90561-2", "volume": "91", "author": "L Bertilsson", "year": "1975", "unstructured": "Bertilsson L, Koslow SH, Costa E (1975) 5-hydroxytryptamine depletion in mesencephalic nuclei of rat brain following a single injection ofp-chloroamphetamine. Brain Res 91:348\u2013350", "journal-title": "Brain Res"}, {"key": "BF02246076_CR11", "doi-asserted-by": "crossref", "first-page": "833", "DOI": "10.1111/j.1471-4159.1975.tb03878.x", "volume": "24", "author": "A Bjorkland", "year": "1975", "unstructured": "Bjorkland A, Baumgarten HB, Rensch A (1975) 5,7-Dihydroxytryptamine: improvement of its selectivity for serotonin neurons in the CNS by pretreatment with desipramine. J Neurochem 24:833\u2013835", "journal-title": "J Neurochem"}, {"key": "BF02246076_CR12", "doi-asserted-by": "crossref", "first-page": "325", "DOI": "10.1016/0014-2999(81)90103-5", "volume": "76", "author": "MA Blackshear", "year": "1981", "unstructured": "Blackshear MA, Steranka LR, Sanders-Bush E (1981) Multiple serotonin receptors: regional distribution and effect of raphe lesions. Eur J Pharmacol 76:325\u2013334", "journal-title": "Eur J Pharmacol"}, {"key": "BF02246076_CR13", "doi-asserted-by": "crossref", "first-page": "429", "DOI": "10.1016/0091-3057(75)90052-0", "volume": "3", "author": "RG Browne", "year": "1975", "unstructured": "Browne RG, Ho BT (1975) Role of serotonin in the discriminative stimulus properties of mescaline. Pharmacol Biochem Behav 3:429\u2013435", "journal-title": "Pharmacol Biochem Behav"}, {"key": "BF02246076_CR14", "first-page": "891", "volume": "258", "author": "KD Burris", "year": "1991", "unstructured": "Burris KD, Breeding M, Sanders-Bush E (1991) (+)Lysergic acid diethylamide, but not its non-hallucinogenic congeners, is a potent serotonin 5-HT1C receptor agonist. J Pharmacol Exp Ther 258:891\u2013896", "journal-title": "J Pharmacol Exp Ther"}, {"key": "BF02246076_CR15", "doi-asserted-by": "crossref", "first-page": "27", "DOI": "10.1016/0014-2999(94)90690-4", "volume": "257", "author": "PM Callahan", "year": "1994", "unstructured": "Callahan PM, Cunningham KA (1994) Involvement of 5-HT2C receptors in mediating the discriminative stimulus properties ofm-chlorophenylpiperazine. Eur J Pharmacol 257:27\u201338", "journal-title": "Eur J Pharmacol"}, {"key": "BF02246076_CR16", "doi-asserted-by": "crossref", "first-page": "117", "DOI": "10.1007/BF00429082", "volume": "33", "author": "OG Cameron", "year": "1973", "unstructured": "Cameron OG, Appel JB (1973) A behavioral and pharmacological analysis of some of the discriminable properties ofd-LSD in rats. Psychopharmacologia 33:117\u2013134", "journal-title": "Psychopharmacologia"}, {"key": "BF02246076_CR17", "doi-asserted-by": "crossref", "first-page": "65", "DOI": "10.1016/0028-3908(77)90049-1", "volume": "16", "author": "FC Colpaert", "year": "1977", "unstructured": "Colpaert FC, Niemegeers CJE, Kuyps JJMD, Janssen PAJ (1977) Narcotic cue and narcotic state: differential involvement in brain 5-hydroxytryptamine. Neuropharmacology 16:65\u201370", "journal-title": "Neuropharmacology"}, {"key": "BF02246076_CR18", "first-page": "2190", "volume": "5", "author": "R Commissaris", "year": "1979", "unstructured": "Commissaris R, Lyness WH, Rech RH, Moore KE (1979) Central aminergic neuronal systems and the behavioral effects of hallucinogens. Soc Neurosci Abstr 5:2190", "journal-title": "Soc Neurosci Abstr"}, {"key": "BF02246076_CR19", "doi-asserted-by": "crossref", "first-page": "3669", "DOI": "10.1523/JNEUROSCI.06-12-03669.1986", "volume": "6", "author": "PJ Conn", "year": "1986", "unstructured": "Conn PJ, Sanders-Bush E (1986) Regulation of serotonin-stimulated phosphoinositide hydrolysis: relation to the serotonin 5-HT2 binding site. J Neurosci 6:3669\u20133675", "journal-title": "J Neurosci"}, {"key": "BF02246076_CR20", "first-page": "552", "volume": "242", "author": "PJ Conn", "year": "1987", "unstructured": "Conn PJ, Sanders-Bush E (1987) Relative efficacies of piperazines at the phosphoinositide hydrolysis-linked serotonergic (5-HT2 and 5- HT1C) receptors. J Pharmacol Exp Ther 242:552\u2013557", "journal-title": "J Pharmacol Exp Ther"}, {"key": "BF02246076_CR21", "doi-asserted-by": "crossref", "first-page": "396", "DOI": "10.1016/0006-8993(87)90641-X", "volume": "400", "author": "PJ Conn", "year": "1987", "unstructured": "Conn PJ, Janowsky A, Sanders-Bush E (1987) Denervation supersensitivity of the 5-HT1C receptors in rat choroid plexus. Brain Res 400:396\u2013398", "journal-title": "Brain Res"}, {"key": "BF02246076_CR22", "doi-asserted-by": "crossref", "first-page": "222", "DOI": "10.1007/BF02246164", "volume": "119", "author": "D Fiorella", "year": "1995", "unstructured": "Fiorella D, Rabin RA, Winter JC (1995a) The role of the 5-HT2A and 5-HT2C receptors in the stimulus effects ofm-chlorophenylpiperazine. Psychopharmacology 119:222\u2013230", "journal-title": "Psychopharmacology"}, {"key": "BF02246076_CR23", "doi-asserted-by": "crossref", "first-page": "239", "DOI": "10.1007/BF02246166", "volume": "119", "author": "D Fiorella", "year": "1995", "unstructured": "Fiorella D, Palumbo PA, Rabin RA, Winter JC (1995b) The time dependent stimulus effects of (\u2212)2,5-dimethoxy-4-methylamphetamine: implications for drug-induced stimulus controls as a method for the study of hallucinogenic drugs. Psychopharmacology 119:239\u2013245", "journal-title": "Psychopharmacology"}, {"key": "BF02246076_CR24", "unstructured": "Fiorella D, Rabin RA, Winter JC (1995c) The role of the 5-HT2A and 5- HT2C receptors in the stimulus effects of hallucinogenic drugs I: Antagonist correlation analysis. Psychopharmacology (in press)", "DOI": "10.1007/BF02246074", "doi-asserted-by": "crossref"}, {"key": "BF02246076_CR25", "unstructured": "Fiorella D, Rabin RA, Winter JC (1995d) The role of the 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs II: Reassessment of LSD false positives. Psychopharmacology (in press)", "DOI": "10.1007/BF02246075", "doi-asserted-by": "crossref"}, {"key": "BF02246076_CR26", "first-page": "160", "volume": "134", "author": "DX Freedman", "year": "1961", "unstructured": "Freedman DX (1961) Effects of LSD-25 on brain serotonin. J Pharmacol Exp Ther 134:160\u2013166", "journal-title": "J Pharmacol Exp Ther"}, {"key": "BF02246076_CR27", "doi-asserted-by": "crossref", "first-page": "346", "DOI": "10.1111/j.1749-6632.1978.tb31533.x", "volume": "305L", "author": "K Fuxe", "year": "1978", "unstructured": "Fuxe K, Ogren S, Agnati LF, Jonsson G, Gustafsson J (1978) 5,7-Dihydroxytryptamine as a tool to study the functional role of central 5-hydroxytryptamine neurons. Ann NY Acad Sci 305L:346\u2013369", "journal-title": "Ann NY Acad Sci"}, {"key": "BF02246076_CR28", "first-page": "509", "volume": "3", "author": "RA Glennon", "year": "1990", "unstructured": "Glennon RA (1990) Do hallucinogens act as 5-HT2 agonists or antagonists? Neuropsychopharmacology 3:509\u2013517", "journal-title": "Neuropsychopharmacology"}, {"key": "BF02246076_CR29", "unstructured": "Glennon RA (1994) Classical hallucinogens: an introductory overview. In: Lin GC, Glennon RA (eds) Hallucinogens, an update. NIDA Research Monograph 146, Washington, DC, pp 4\u201332"}, {"key": "BF02246076_CR30", "doi-asserted-by": "crossref", "first-page": "1009", "DOI": "10.1016/0091-3057(91)90121-H", "volume": "40", "author": "RA Glennon", "year": "1991", "unstructured": "Glennon RA, Dukat M (1991) Serotonin receptors and their ligands: a lack of selective agents. Pharmacol Biochem Behav 40:1009\u20131016", "journal-title": "Pharmacol Biochem Behav"}, {"key": "BF02246076_CR31", "doi-asserted-by": "crossref", "first-page": "937", "DOI": "10.1016/0091-3057(85)90096-6", "volume": "23", "author": "RA Glennon", "year": "1985", "unstructured": "Glennon RA, Hauck AE (1985) Mechanistic studies on DOM as a discriminative stimulus. Pharmacol Biochem Behav 23:937\u2013941", "journal-title": "Pharmacol Biochem Behav"}, {"key": "BF02246076_CR32", "doi-asserted-by": "crossref", "first-page": "2493", "DOI": "10.1016/0024-3205(91)90603-9", "volume": "48", "author": "RA Glennon", "year": "1991", "unstructured": "Glennon RA, Darmani NA, Martin BR (1991) Multiple populations of serotonin receptors may modulate the behavioral effects of serotonergic agents. Life Sci 48:2493\u20132498", "journal-title": "Life Sci"}, {"key": "BF02246076_CR33", "doi-asserted-by": "crossref", "first-page": "129", "DOI": "10.1007/BF01245974", "volume": "64", "author": "H Hall", "year": "1985", "unstructured": "Hall H, Wedel I (1985) The effects of manipulation of presynaptic 5-HT nerve terminals on postsynaptic 5-HT1 and 5-HT2 binding sites of the rat brain. J Neural Transm 64:129\u2013143", "journal-title": "J Neural Transm"}, {"key": "BF02246076_CR34", "doi-asserted-by": "crossref", "first-page": "841", "DOI": "10.1126/science.47181", "volume": "187", "author": "JA Harvey", "year": "1975", "unstructured": "Harvey JA, McMaster SE, Yunger LM (1975)p-Chloroamphetamine: selective neurotoxic action in brain. Science 187:841\u2013843", "journal-title": "Science"}, {"key": "BF02246076_CR35", "doi-asserted-by": "crossref", "first-page": "2519", "DOI": "10.1021/jm00069a010", "volume": "36", "author": "AM Ismaiel", "year": "1993", "unstructured": "Ismaiel AM, De Los Angeles J, Titeler M, Ingher S, Glennon RA (1993) Antagonism of the 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane stimulus with a newly identified 5-HT2- versus 5-HT1C-selective antagonist. J Med Chem 36:2519\u20132525", "journal-title": "J Med Chem"}, {"key": "BF02246076_CR36", "first-page": "386", "volume": "75", "author": "BL Jacobs", "year": "1987", "unstructured": "Jacobs BL (1987) How hallucinogenic drugs work. Am Sci 75:386\u2013392", "journal-title": "Am Sci"}, {"key": "BF02246076_CR37", "doi-asserted-by": "crossref", "first-page": "33", "DOI": "10.1007/BF00428822", "volume": "42", "author": "TUC Jarbe", "year": "1975", "unstructured": "Jarbe TUC, Johansson JO, Henriksson DG (1975) Drug discrimination in rats: the effects of phencyclidine and ditran. Psychopharmacologia 42:33\u201339", "journal-title": "Psychopharmacologia"}, {"key": "BF02246076_CR38", "first-page": "274", "volume": "3", "author": "E Jequier", "year": "1967", "unstructured": "Jequier E, Lovenberg W, Sjoerdsma A (1967) Tryptophan hydroxylase inhibition: the mechanism by whichp-chlorophenylalanine depletes rat brain serotonin. Mol Pharmacol 3:274\u2013278", "journal-title": "Mol Pharmacol"}, {"key": "BF02246076_CR39", "doi-asserted-by": "crossref", "first-page": "35", "DOI": "10.1016/0091-3057(76)90285-9", "volume": "5", "author": "JA Joseph", "year": "1976", "unstructured": "Joseph JA, Appel JB (1976) Alterations in the behavioral effects of LSD by motivational and neurohumoral variables. Pharmacol Biochem Behav 5:35\u201337", "journal-title": "Pharmacol Biochem Behav"}, {"key": "BF02246076_CR40", "doi-asserted-by": "crossref", "first-page": "499", "DOI": "10.1016/0091-3057(77)90108-3", "volume": "6", "author": "JA Joseph", "year": "1977", "unstructured": "Joseph JA, Appel JB (1977) Behavioral sensitivity of LSD: dependency upon the pattern of central 5-HT depletion. Pharmacol Biochem Behav 6:499\u2013504", "journal-title": "Pharmacol Biochem Behav"}, {"key": "BF02246076_CR41", "doi-asserted-by": "crossref", "first-page": "39", "DOI": "10.1007/BF02253715", "volume": "101", "author": "HO Kalkman", "year": "1990", "unstructured": "Kalkman HO (1990) Discriminative stimulus properties of 8-OH-DPAT in rats are not altered by pretreatment withpara-chlorophenylalanine. Psychopharmacology 101:39\u201342", "journal-title": "Psychopharmacology"}, {"key": "BF02246076_CR42", "first-page": "499", "volume": "154", "author": "BK Koe", "year": "1966", "unstructured": "Koe BK, Weisman A (1966)p-Chlorophenylalanine: a specific depletor of brain serotonin. J Pharmacol Exp Ther 154:499\u2013516", "journal-title": "J Pharmacol Exp Ther"}, {"key": "BF02246076_CR43", "doi-asserted-by": "crossref", "first-page": "645", "DOI": "10.1111/j.1749-6632.1978.tb31554.x", "volume": "305", "author": "C Kohler", "year": "1978", "unstructured": "Kohler C, Ross SB, Sebro B, Ogren SO (1978) Long-term biochemical and behavioral effects ofp-chloroamphetamine in the rat. Ann NY Acad Sci 305:645\u2013663", "journal-title": "Ann NY Acad Sci"}, {"key": "BF02246076_CR44", "first-page": "361", "volume": "3", "author": "Leysen", "year": "1990", "unstructured": "Leysen (1990) Gaps and peculiarities in 5-HT2 receptor studies. Neuropsychopharmacology 3:361\u2013369", "journal-title": "Neuropsychopharmacology"}, {"key": "BF02246076_CR45", "first-page": "87", "volume": "5", "author": "DS Lorrain", "year": "1993", "unstructured": "Lorrain DS, Hull EM (1993) Nitric oxide increases dopamine and serotonin release in the medial preoptic area. Neuro Report 5:87\u201389", "journal-title": "Neuro Report"}, {"key": "BF02246076_CR46", "first-page": "265", "volume": "193", "author": "OH Lowry", "year": "1951", "unstructured": "Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265\u2013275", "journal-title": "J Biol Chem"}, {"key": "BF02246076_CR47", "doi-asserted-by": "crossref", "first-page": "83", "DOI": "10.1016/S0149-7634(05)80055-7", "volume": "16", "author": "I Lucki", "year": "1992", "unstructured": "Lucki I (1992) 5-HT1 receptors and behavior. Neurosci Biobehav Rev 16:83\u201393", "journal-title": "Neurosci Biobehav Rev"}, {"key": "BF02246076_CR48", "first-page": "155", "volume": "249", "author": "I Lucki", "year": "1989", "unstructured": "Lucki I, Ward HR, Frazer A (1989) Effect of 1-(m-chlorophenyl) piperazine and 1-(m-trifluoromethylphenyl) piperazine on locomotor activity. J pharmacol Exp Ther 249:155\u2013164", "journal-title": "J pharmacol Exp Ther"}, {"key": "BF02246076_CR49", "doi-asserted-by": "crossref", "first-page": "190", "DOI": "10.1111/j.1749-6632.1978.tb31523.x", "volume": "305", "author": "JL Meek", "year": "1978", "unstructured": "Meek JL (1978) Studies of serotonin neurotoxins in discrete brain nuclei. Ann NY Acad Sci 305:190\u2013196", "journal-title": "Ann NY Acad Sci"}, {"key": "BF02246076_CR50", "first-page": "333", "volume": "196", "author": "LH Neckers", "year": "1976", "unstructured": "Neckers LH, Bertilsson L, Koslow SH, Meek JL (1976) Reduction of tryptophan hydroxylase activity and 5-hydroxytryptamine concentrations in certain rat brain nuclei afterp-chloroamphetamine. J Pharmacol Exp Ther 196:333\u2013338", "journal-title": "J Pharmacol Exp Ther"}, {"key": "BF02246076_CR51", "doi-asserted-by": "crossref", "first-page": "151", "DOI": "10.1016/0361-9230(90)90266-3", "volume": "25", "author": "MR Pranzatelli", "year": "1990", "unstructured": "Pranzatelli MR (1990) Neonatal 5,7-DHT lesions upregulate (3H)mesulergine-labelled spinal 5-HT1C binding sites in the rat. Brain Res Bull 25:151\u2013153", "journal-title": "Brain Res Bull"}, {"key": "BF02246076_CR52", "doi-asserted-by": "crossref", "first-page": "377", "DOI": "10.1016/0014-2999(83)90559-9", "volume": "90", "author": "M Quick", "year": "1983", "unstructured": "Quick M, Azmita E (1983) Selective destruction of serotonergic fibers of the fornix-fimbria and cingulum bundle increases 5HT1, but not 5HT2 receptors in rat midbrain. Eur J Pharmacol 90:377\u2013384", "journal-title": "Eur J Pharmacol"}, {"key": "BF02246076_CR53", "doi-asserted-by": "crossref", "first-page": "1433", "DOI": "10.1016/0024-3205(65)90022-6", "volume": "4", "author": "O Resnick", "year": "1965", "unstructured": "Resnick O, Krus DM, Raskin M (1965) Accentuation of the psychological effects of LSD-25 in normal subjects treated with reserpine. Life Sci 4:1433\u20137", "journal-title": "Life Sci"}, {"key": "BF02246076_CR54", "doi-asserted-by": "crossref", "first-page": "137", "DOI": "10.1007/BF00167210", "volume": "244", "author": "I Sahin-Erdemli", "year": "1991", "unstructured": "Sahin-Erdemli I, Schoeffter P, Hoyer D (1991) Competitive antagonism by recognized 5-HT2 receptor antagonists at 5-HT1C receptors in pig choroid plexus. Naunyn-Schmiedeberg's Arch Pharmacol 244:137\u2013142", "journal-title": "Naunyn-Schmiedeberg's Arch Pharmacol"}, {"key": "BF02246076_CR55", "first-page": "169", "volume": "247", "author": "E Sanders-Bush", "year": "1988", "unstructured": "Sanders-Bush E, Breeding M (1988) Putative selective 5-HT2 receptor antagonists block serotonin 5-HT1C receptors. J Pharmacol Exp Ther 247:169\u2013173", "journal-title": "J Pharmacol Exp Ther"}, {"key": "BF02246076_CR56", "first-page": "924", "volume": "246", "author": "E Sanders-Bush", "year": "1988", "unstructured": "Sanders-Bush E, Burris KD, Knoth K (1988) Lysergic acid diethylamide and 2,5-dimethoxy-4-methamphetamine are partial agonists at serotonin receptors linked to phosphoinositide hydrolysis. J Pharmacol Exp Ther 246:924\u2013928", "journal-title": "J Pharmacol Exp Ther"}, {"key": "BF02246076_CR57", "doi-asserted-by": "crossref", "first-page": "889", "DOI": "10.1016/0306-3623(91)90226-V", "volume": "22", "author": "MD Schechter", "year": "1991", "unstructured": "Schechter MD (1991) Effect of serotonin depletion byp-chlorophenylalanine upon discriminative behaviors. Gen Pharmacol 22:889\u2013893", "journal-title": "Gen Pharmacol"}, {"key": "BF02246076_CR58", "doi-asserted-by": "crossref", "first-page": "417", "DOI": "10.1007/BF00402536", "volume": "24", "author": "MD Schechter", "year": "1972", "unstructured": "Schechter MD, Rosecrans JA (1972) Nicotine as a discriminative stimulus in rats depleted of norepinephrine or 5-hydroxytryptamine. Psychopharmacologia 24:417\u2013429", "journal-title": "Psychopharmacologia"}, {"key": "BF02246076_CR59", "doi-asserted-by": "crossref", "first-page": "99", "DOI": "10.1016/0014-2999(94)90643-2", "volume": "264", "author": "R Schreiber", "year": "1994", "unstructured": "Schreiber R, Brocco M, Millan MJ (1994) Blockade of the discriminative stimulus effects of DOI and MDL 100,907 and the \u201catypical\u201d antipsychotics, clozapine and risperidone. Eur J Pharmacol 264:99\u2013102", "journal-title": "Eur J Pharmacol"}, {"key": "BF02246076_CR60", "doi-asserted-by": "crossref", "first-page": "213", "DOI": "10.1007/BF00176847", "volume": "94", "author": "M Titeler", "year": "1988", "unstructured": "Titeler M, Lyon RA, Glennon RA (1988) Radioligand binding evidence implicates the brain 5-HT2 receptors as a site of action for LSD and phenylisopropylamine hallucinogens. Psychopharmacology 94:213\u2013216", "journal-title": "Psychopharmacology"}, {"key": "BF02246076_CR61", "doi-asserted-by": "crossref", "first-page": "301", "DOI": "10.1016/0922-4106(90)90190-9", "volume": "188", "author": "I Wijngaarden Van", "year": "1990", "unstructured": "Van Wijngaarden I, Tulp MTM, Soudijin W (1990) The concept of selectivity in 5-HT research. Eur J Pharmacol 188:301\u2013312", "journal-title": "Eur J Pharmacol"}, {"key": "BF02246076_CR62", "doi-asserted-by": "crossref", "first-page": "569", "DOI": "10.1016/0091-3057(80)90282-8", "volume": "13", "author": "FJ White", "year": "1980", "unstructured": "White FJ, Simmons MA, West KB, Holohean AM, Appel JB (1980) The effect of serotonin depletion on the discriminability of LSD. Pharmacol Biochem Behav 13:569\u2013574", "journal-title": "Pharmacol Biochem Behav"}, {"key": "BF02246076_CR63", "unstructured": "Winter JC (1994) The stimulus effects of serotonergic hallucinogens in animals. In: Lin GC, Glennon RA (eds) Hallucinogens, an update. NIDA Research Monograph 146, Washington, DC, pp 157\u2013182"}, {"key": "BF02246076_CR64", "doi-asserted-by": "crossref", "first-page": "221", "DOI": "10.1016/0091-3057(93)90108-6", "volume": "45", "author": "JC Winter", "year": "1993", "unstructured": "Winter JC, Rabin RA (1993) The stimulus effects ofm-chlorophenylpiperazine in the rat. Pharmacol Biochem Behav 45:221\u2013225", "journal-title": "Pharmacol Biochem Behav"}], "container-title": ["Psychopharmacology"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/BF02246076.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1007/BF02246076/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/BF02246076", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 15]], "date-time": "2019-05-15T17:33:34Z", "timestamp": 1557941614000}, "score": 23.807135, "issued": {"date-parts": [[1995, 10]]}, "references-count": 64, "journal-issue": {"published-print": {"date-parts": [[1995, 10]]}, "issue": "3"}, "alternative-id": ["BF02246076"], "URL": "http://dx.doi.org/10.1007/bf02246076", "relation": {"cites": []}, "ISSN": ["0033-3158", "1432-2072"], "issn-type": [{"value": "0033-3158", "type": "print"}, {"value": "1432-2072", "type": "electronic"}], "subject": ["Pharmacology"]}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T08:02:33Z", "timestamp": 1575187353281}, "reference-count": 51, "publisher": "Springer Science and Business Media LLC", "issue": "3", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[1995, 10, 1]], "date-time": "1995-10-01T00:00:00Z", "timestamp": 812505600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Psychopharmacology"], "published-print": {"date-parts": [[1995, 10]]}, "DOI": "10.1007/bf02246074", "type": "journal-article", "created": {"date-parts": [[2005, 11, 15]], "date-time": "2005-11-15T05:36:56Z", "timestamp": 1132033016000}, "page": "347-356", "source": "Crossref", "is-referenced-by-count": 88, "title": ["The role of the 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs I: Antagonist correlation analysis"], "prefix": "10.1007", "volume": "121", "author": [{"given": "D.", "family": "Fiorella", "sequence": "first", "affiliation": []}, {"given": "R. A.", "family": "Rabin", "sequence": "additional", "affiliation": []}, {"given": "J. C.", "family": "Winter", "sequence": "additional", "affiliation": []}], "member": "297", "reference": [{"key": "BF02246074_CR1", "first-page": "959", "volume": "22", "author": "JB Appel", "year": "1986", "unstructured": "Appel JB, Cunningham KA (1986) The use of drug discrimination procedures to characterize hallucinogenic drug actions. Psychopharmacol Bull 22:959\u2013967", "journal-title": "Psychopharmacol Bull"}, {"key": "BF02246074_CR2", "doi-asserted-by": "crossref", "first-page": "529", "DOI": "10.1016/0149-7634(82)90036-7", "volume": "6", "author": "JB Appel", "year": "1982", "unstructured": "Appel JB, White FJ, Holohean AM (1982) Analyzing mechanisms of hallucinogenic drug action with drug discrimination procedures. Neurosci Biobehav Rev 6:529\u2013536", "journal-title": "Neurosci Biobehav Rev"}, {"key": "BF02246074_CR3", "first-page": "631", "volume": "12", "author": "PR Burt", "year": "1976", "unstructured": "Burt PR, Creese I, Snyder SH (1976) Binding interactions of lysergic acid and diethylamide related agents with dopaminergic receptors in brain. Mol Pharmacol 12:631\u2013638", "journal-title": "Mol Pharmacol"}, {"key": "BF02246074_CR4", "doi-asserted-by": "crossref", "first-page": "1001", "DOI": "10.1016/0028-3908(83)90216-2", "volume": "22", "author": "FC Colpaert", "year": "1983", "unstructured": "Colpaert FC, Janssen PAJ (1983) A characterization of LSD-antagonist effects of pirenpirone in the rat. Neuropharmacology 22:1001\u20131005", "journal-title": "Neuropharmacology"}, {"key": "BF02246074_CR5", "first-page": "206", "volume": "221", "author": "FC Colpaert", "year": "1982", "unstructured": "Colpaert FC, Niemegeers CJE, Janssen PAJ (1982) A drug discrimination analysis of lysergic acid diethylamide (LSD): in vivo agonist and antagonist effects of purported 5-hydroxytryptamine antagonists and of pirenpirone, a LSD antagonist. J Pharmacol Exp Ther 221:206\u2013214", "journal-title": "J Pharmacol Exp Ther"}, {"key": "BF02246074_CR6", "first-page": "552", "volume": "242", "author": "PJ Conn", "year": "1987", "unstructured": "Conn PJ, Sanders-Bush E (1987) Relative efficacies of piperazines at the phosphoinositide hydrolysis-linked serotonergic (5-HT2 and 5- HT1C) receptors. J Pharmacol Exp Ther 242:552\u2013557", "journal-title": "J Pharmacol Exp Ther"}, {"key": "BF02246074_CR7", "doi-asserted-by": "crossref", "first-page": "1715", "DOI": "10.1016/0024-3205(75)90118-6", "volume": "17", "author": "I Creese", "year": "1976", "unstructured": "Creese I, Burt, DA, Snyder SH (1976) The dopamine receptor: differential binding ofd-LSD and related agents to agonist and antagonist states. Life Sci 17:1715\u20131720", "journal-title": "Life Sci"}, {"key": "BF02246074_CR8", "doi-asserted-by": "crossref", "first-page": "67", "DOI": "10.1007/BF00690929", "volume": "91", "author": "KA Cunningham", "year": "1987", "unstructured": "Cunningham KA, Appel JB (1987) Neuropharmacological reassessment of the discriminative stimulus properties of lysergic acid diethylamide (LSD). Psychopharmacology 91:67\u201373", "journal-title": "Psychopharmacology"}, {"key": "BF02246074_CR9", "doi-asserted-by": "crossref", "first-page": "222", "DOI": "10.1007/BF02246164", "volume": "119", "author": "D Fiorella", "year": "1995", "unstructured": "Fiorella D, Rabin RA, Winter JC (1995a) The role of the 5-HT2A and 5-HT2C receptors in the stimulus effects ofm-chlorophenyl-piperazine. Psychopharmacology 119:222\u2013230", "journal-title": "Psychopharmacology"}, {"key": "BF02246074_CR10", "doi-asserted-by": "crossref", "first-page": "239", "DOI": "10.1007/BF02246166", "volume": "119", "author": "D Fiorella", "year": "1995", "unstructured": "Fiorella D, Palumbo PA, Rabin RA, Winter JC (1995b) The time dependent stimulus effects of (\u2212)2,5-dimethoxy-4-methylamphetamine: implications for drug-induced stimulus control as a method for the study of hallucinogenic drugs. Psychopharmacology 119:239\u2013245", "journal-title": "Psychopharmacology"}, {"key": "BF02246074_CR11", "doi-asserted-by": "crossref", "first-page": "330", "DOI": "10.1001/archpsyc.1968.01740030074008", "volume": "18", "author": "DX Freedman", "year": "1968", "unstructured": "Freedman DX (1968) On the use and abuse of LSD. Arch Gen Psychiatry 18:330\u2013347", "journal-title": "Arch Gen Psychiatry"}, {"key": "BF02246074_CR12", "doi-asserted-by": "crossref", "first-page": "408", "DOI": "10.1146/annurev.me.20.020169.002205", "volume": "20", "author": "DX Freedman", "year": "1969", "unstructured": "Freedman DX (1969) The psychopharmacology of hallucinogenic agents. Annu Rev Med 20:408\u2013418", "journal-title": "Annu Rev Med"}, {"key": "BF02246074_CR13", "first-page": "628", "volume": "223", "author": "RL Friedman", "year": "1984", "unstructured": "Friedman RL, Barrett RJ, Sanders-Bush E (1984) Discriminative stimulus properties of quipazine: mediation by serotonin2 binding sites. J Pharmacol Exp Ther 223:628\u2013635", "journal-title": "J Pharmacol Exp Ther"}, {"key": "BF02246074_CR14", "unstructured": "Glennon RA (1994) Classical hallucinogens: an introductory overview. In: Lin GC, Glennon RA (eds) Hallucinogens, an update. NIDA Research Monograph #146, Washington, DC, pp 4\u201332"}, {"key": "BF02246074_CR15", "first-page": "509", "volume": "3", "author": "RA Glennon", "year": "1990", "unstructured": "Glennon RA (1990) Do hallucinogens act as 5-HT2 agonists or antagonists? Neuropsychopharmacology 3:509\u2013517", "journal-title": "Neuropsychopharmacology"}, {"key": "BF02246074_CR16", "doi-asserted-by": "crossref", "first-page": "1009", "DOI": "10.1016/0091-3057(91)90121-H", "volume": "40", "author": "RA Glennon", "year": "1991", "unstructured": "Glennon RA, Dukat M (1991) Serotonin receptors and their ligands: a lack of selective agents. Pharmacol Biochem Behav 40:1009\u20131016", "journal-title": "Pharmacol Biochem Behav"}, {"key": "BF02246074_CR17", "author": "RA Glennon", "first-page": "69", "year": "1982", "unstructured": "Glennon RA, Rosecrans JA, Young R (1982) The use of the drug discrimination paradigm for studying hallucinogenic agents. In: Colpaert FC, Slangen JL (eds) Drug discrimination: applications in CNS pharmacology. Elsevier Biomedical Press, Amsterdam, pp 69\u201396", "volume-title": "Drug discrimination: applications in CNS pharmacology"}, {"key": "BF02246074_CR18", "doi-asserted-by": "crossref", "first-page": "2505", "DOI": "10.1016/0024-3205(84)90436-3", "volume": "35", "author": "RA Glennon", "year": "1984", "unstructured": "Glennon RA, Titeler M, McKenney JD (1984a) Evidence for 5HT2 involvement in the mechanism of action of hallucinogenic agents. Life Sci 35:2505\u20132511", "journal-title": "Life Sci"}, {"key": "BF02246074_CR19", "doi-asserted-by": "crossref", "first-page": "289", "DOI": "10.1002/med.2610030305", "volume": "3", "author": "RA Glennon", "year": "1984", "unstructured": "Glennon RA, Rosecrans JA, Young R (1984b) Drug-induced discrimination: a description of the paradigm and a review of its specific application to the study of hallucinogenic agents. Med Res Rev 3:289\u2013376", "journal-title": "Med Res Rev"}, {"key": "BF02246074_CR20", "doi-asserted-by": "crossref", "first-page": "734", "DOI": "10.1021/jm00082a014", "volume": "35", "author": "RA Glennon", "year": "1992", "unstructured": "Glennon RA, Raghupathi R, Bartyzel P, Tietler M, Leonhardt S (1992a) Binding of phenylalkylamine derivatives at 5-HT1C and 5-HT2 serotonin receptors: evidence for a lack of selectivity. J Med Chem 35:734\u2013740", "journal-title": "J Med Chem"}, {"key": "BF02246074_CR21", "first-page": "131", "volume": "119", "author": "RA Glennon", "year": "1992", "unstructured": "Glennon RA, Teitler M, Sanders-Bush E (1992b) Hallucinogens and serotonergic mechanisms. NIDA Res Monogr 119:131\u2013135", "journal-title": "NIDA Res Monogr"}, {"key": "BF02246074_CR22", "doi-asserted-by": "crossref", "first-page": "64", "DOI": "10.1007/BF00401468", "volume": "22", "author": "ID Hirshhorn", "year": "1971", "unstructured": "Hirshhorn ID, Winter JC (1971) Mescaline and lysergic acid diethylamide (LSD) as discriminative stimuli. Psychopharmacologia 22:64\u201371", "journal-title": "Psychopharmacologia"}, {"key": "BF02246074_CR23", "doi-asserted-by": "crossref", "first-page": "62", "DOI": "10.1007/BF00401535", "volume": "14", "author": "LE Hollister", "year": "1969", "unstructured": "Hollister LE, Macnicol MF, Gillespie HK (1969) An hallucinogenic amphetamine analog (DOM) in man. Psychopharmacology 14:62\u201373", "journal-title": "Psychopharmacology"}, {"key": "BF02246074_CR24", "doi-asserted-by": "crossref", "first-page": "595", "DOI": "10.1016/0014-2999(82)90349-1", "volume": "81", "author": "AM Holohean", "year": "1982", "unstructured": "Holohean AM, White FJ Appel JB (1982) Dopaminergic and serotonergic mediation of the discriminable effects of ergot alkaloids. Eur J Pharmacol 81:595\u2013602", "journal-title": "Eur J Pharmacol"}, {"key": "BF02246074_CR25", "doi-asserted-by": "crossref", "first-page": "59", "DOI": "10.3109/10799898809048978", "volume": "8", "author": "D Hoyer", "year": "1988", "unstructured": "Hoyer D (1988) Functional correlates of serotonin 5-HT1 recognition sites. J Recept Res 8:59\u201381", "journal-title": "J Recept Res"}, {"key": "BF02246074_CR26", "doi-asserted-by": "crossref", "first-page": "2519", "DOI": "10.1021/jm00069a010", "volume": "36", "author": "AM Ismaiel", "year": "1993", "unstructured": "Ismaiel AM, De Los Angeles J, Teitler M, Ingher S, Glennon RA (1993) Antagonism of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane stimulus with a newly identified 5-HT2-versus 5-HT1C-selective antagonist. J Med Chem 36:2519\u20132525", "journal-title": "J Med Chem"}, {"key": "BF02246074_CR27", "doi-asserted-by": "crossref", "first-page": "480", "DOI": "10.1002/cpt196344480", "volume": "4", "author": "E Jacobsen", "year": "1963", "unstructured": "Jacobsen E (1963) The clinical pharmacology of the hallucinogens. Clin Pharmacol Ther 4:480\u2013503", "journal-title": "Clin Pharmacol Ther"}, {"key": "BF02246074_CR28", "doi-asserted-by": "crossref", "first-page": "257", "DOI": "10.1016/0028-3908(78)90109-0", "volume": "17", "author": "DM Kuhn", "year": "1978", "unstructured": "Kuhn DM, White FJ, Appel JB (1978) The discriminative stimulus properties of LSD: mechanism of action. Neuropharmacology 17:257\u2013263", "journal-title": "Neuropharmacology"}, {"key": "BF02246074_CR29", "first-page": "551", "volume": "3", "author": "K Kulig", "year": "1990", "unstructured": "Kulig K (1990) Emergency aspects of drug abuse: LSD. Emerg Med Clin N Am 3:551\u2013558", "journal-title": "Emerg Med Clin N Am"}, {"key": "BF02246074_CR30", "author": "JE Leysen", "first-page": "86", "year": "1985", "unstructured": "Leysen JE (1985) Serotonin receptor binding sites. In: Green AR (ed) Neuropharmacology of serotonin. Oxford Press, Oxford, pp 86\u201387", "volume-title": "Neuropharmacology of serotonin"}, {"key": "BF02246074_CR31", "first-page": "361", "volume": "3", "author": "JE Leysen", "year": "1990", "unstructured": "Leysen JE (1990) Gaps and peculiarities in 5-HT2 receptor studies. Neuropsychopharmacology 3:361\u2013369", "journal-title": "Neuropsychopharmacology"}, {"key": "BF02246074_CR32", "doi-asserted-by": "crossref", "first-page": "145", "DOI": "10.1016/0014-2999(89)90409-3", "volume": "163", "author": "JE Leysen", "year": "1989", "unstructured": "Leysen JE, Janssen PFM, Niemegeers CJE (1989) Rapid desensitization and down-regulation of 5-HT2 receptors by DOM treatment. Eur J Pharmacol 163:145\u2013149", "journal-title": "Eur J Pharmacol"}, {"key": "BF02246074_CR33", "doi-asserted-by": "crossref", "first-page": "206", "DOI": "10.1007/BF00442251", "volume": "97", "author": "TF Meert", "year": "1989", "unstructured": "Meert TF, de Haes P, Janssen PAJ (1989) Risperidone (R 654 766), a potent and complete LSD antagonist in drug discrimination by rats. Psychopharmacology 97:206\u2013212", "journal-title": "Psychopharmacology"}, {"key": "BF02246074_CR34", "doi-asserted-by": "crossref", "first-page": "371", "DOI": "10.1016/0014-2999(80)90178-8", "volume": "67", "author": "RC Meibach", "year": "1980", "unstructured": "Meibach RC, Maayani S, Green JP (1980) Characterization and radioautography of [3H]LSD binding by rat brain slices in vitro: the effect of 5-hydroxytryptamine. Eur J Pharmacol 67:371\u2013382", "journal-title": "Eur J Pharmacol"}, {"key": "BF02246074_CR35", "doi-asserted-by": "crossref", "first-page": "171", "DOI": "10.1016/0166-4328(85)90090-7", "volume": "16", "author": "EB Nielsen", "year": "1985", "unstructured": "Nielsen EB, Ginn SR, Cinningham KA, Appel JB (1985) Antagonism of the LSD cue by putative serotonin antagonists: relationship to inhibition of in vivo3H-spiroperidol binding. Behav Brain Res 16:171\u2013176", "journal-title": "Behav Brain Res"}, {"key": "BF02246074_CR36", "doi-asserted-by": "crossref", "first-page": "3", "DOI": "10.1016/S0076-6879(75)37003-1", "volume": "37", "author": "D Rodbard", "year": "1975", "unstructured": "Rodbard D, Frazier GR (1975) Statistical analysis of radioligand assay data. Methods Enzymol 37:3\u201322", "journal-title": "Methods Enzymol"}, {"key": "BF02246074_CR37", "doi-asserted-by": "crossref", "first-page": "137", "DOI": "10.1007/BF00167210", "volume": "344", "author": "Sahin-Erdemli", "year": "1991", "unstructured": "Sahin-Erdemli, Schoeffter P, Hoyer D (1991) Competitive antagonism by recognized 5-HT2 receptor antagonists at 5-HT1C receptors in pig choroid plexus. Naunyn-Schmiedeberg's Arch Pharmacol 344:137\u2013142", "journal-title": "Naunyn-Schmiedeberg's Arch Pharmacol"}, {"key": "BF02246074_CR38", "first-page": "924", "volume": "246", "author": "E Sanders-Bush", "year": "1988", "unstructured": "Sanders-Bush E, Burris KD, Knoth K (1988) Lysergic acid diethylamide and 2,5-dimethoxy-4-methamphetamine are partial agonists at serotonin receptors linked to phosphoinositide hydrolysis. J Pharmacol Exp Ther 246:924\u2013928", "journal-title": "J Pharmacol Exp Ther"}, {"key": "BF02246074_CR39", "first-page": "169", "volume": "247", "author": "E Sanders-Bush", "year": "1988", "unstructured": "Sanders-Bush E, Breeding M (1988) Putative selective 5-HT2 antagonists block serotonin 5-HT1C receptors. J Pharmacol Exp Ther 247:169\u2013173", "journal-title": "J Pharmacol Exp Ther"}, {"key": "BF02246074_CR40", "doi-asserted-by": "crossref", "first-page": "99", "DOI": "10.1016/0014-2999(94)90643-2", "volume": "264", "author": "R Schreiber", "year": "1994", "unstructured": "Schreiber R, Brocco M, Millan MJ (1994) Blockade of the discriminative stimulus effects of DOI by MDL 100,907 and the atypical antipsychotics, clozapine and risperidone. Eur J Pharmacol 264:99\u2013102", "journal-title": "Eur J Pharmacol"}, {"key": "BF02246074_CR41", "doi-asserted-by": "crossref", "first-page": "271", "DOI": "10.1111/j.2042-7158.1973.tb10642.x", "volume": "25", "author": "A Shulgin", "year": "1973", "unstructured": "Shulgin A (1973) Stereospecific requirements for hallucinogens. J Pharm Pharmacol 25:271\u2013272", "journal-title": "J Pharm Pharmacol"}, {"key": "BF02246074_CR42", "unstructured": "Shulgin A, Shulgin A (1991) The chemical story. In: Joy D (ed) PIHKAL. Transform Press, pp. 453\u2013924"}, {"key": "BF02246074_CR43", "author": "PB Silverman", "first-page": "189", "year": "1978", "unstructured": "Silverman PB, Ho BT (1978) Stimulus properties of DOM: Commonality with other hallucinogens. In: Colpaert FC, Rosecrans JA (eds) Stimulus properties of drugs: ten years of progress. Elsevier, North Holland Biomedical Press, Amsterdam, pp 189\u2013198", "volume-title": "Stimulus properties of drugs: ten years of progress"}, {"key": "BF02246074_CR44", "doi-asserted-by": "crossref", "first-page": "669", "DOI": "10.1126/science.158.3801.669", "volume": "158", "author": "SA Snyder", "year": "1968", "unstructured": "Snyder SA, Faillace L, Hollister L (1968) 2,5-Dimethoxy-4-methylamphetamine (STP): a new hallucinogenic drug. Science 158:669\u2013670", "journal-title": "Science"}, {"key": "BF02246074_CR45", "doi-asserted-by": "crossref", "first-page": "213", "DOI": "10.1007/BF00176847", "volume": "94", "author": "M Titeler", "year": "1988", "unstructured": "Titeler M, Lyon RA, Glennon RA (1988) Radioligand binding evidence implicates the brain 5-HT2 receptors as a site of action for LSD and phenylisopropylamine hallucinogens. Psychopharmacology 94:213\u2013216", "journal-title": "Psychopharmacology"}, {"key": "BF02246074_CR46", "first-page": "454", "volume": "13", "author": "DC U'Prichard", "year": "1977", "unstructured": "U'Prichard DC, Greenberg DA, Snyder SH (1977) Binding characteristics of radiolabeled agonist and antagonist at central nervous system alpha noradrenergic receptors. Mol Pharmacol 13:454\u2013473", "journal-title": "Mol Pharmacol"}, {"key": "BF02246074_CR47", "doi-asserted-by": "crossref", "first-page": "301", "DOI": "10.1016/0922-4106(90)90190-9", "volume": "188", "author": "V Wijngaarden", "year": "1990", "unstructured": "Wijngaarden V, Tulp MTM, Soudijin W (1990) The concept of selectivity in 5-HT research. Eur J Pharmacol 188:301\u2013312", "journal-title": "Eur J Pharmacol"}, {"key": "BF02246074_CR48", "first-page": "250", "volume": "214", "author": "JC Winter", "year": "1975", "unstructured": "Winter JC (1975) Blockade of the stimulus properties of mescaline by a serotonin antagonist. Arch Int Pharmacol 214:250\u2013253", "journal-title": "Arch Int Pharmacol"}, {"key": "BF02246074_CR49", "first-page": "416", "volume": "204", "author": "JC Winter", "year": "1978", "unstructured": "Winter JC (1978) Stimulus properties of phenethylamine hallucinogens and lysergic acid diethylamide: the role of 5-hydroxytryptamine. J Pharmacol Exp Ther 204:416\u2013423", "journal-title": "J Pharmacol Exp Ther"}, {"key": "BF02246074_CR50", "unstructured": "Winter JC (1994) The stimulus effects of serotonergic hallucinogens in animals. In: Lin GC, Glennon RA (eds) Hallucinogens, an update. NIDA Monograph #146, Washington, DC, pp 157\u2013182"}, {"key": "BF02246074_CR51", "doi-asserted-by": "crossref", "first-page": "617", "DOI": "10.1016/0091-3057(88)90074-3", "volume": "30", "author": "JC Winter", "year": "1988", "unstructured": "Winter JC, Rabin RA (1988) Interactions between serotonergic agonists and antagonists in rats trained with LSD as a discriminative stimulus. Pharmacol Biochem Behav 30:617\u2013624", "journal-title": "Pharmacol Biochem Behav"}], "container-title": ["Psychopharmacology"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/BF02246074.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1007/BF02246074/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/BF02246074", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 15]], "date-time": "2019-05-15T17:33:34Z", "timestamp": 1557941614000}, "score": 23.311054, "issued": {"date-parts": [[1995, 10]]}, "references-count": 51, "journal-issue": {"published-print": {"date-parts": [[1995, 10]]}, "issue": "3"}, "alternative-id": ["BF02246074"], "URL": "http://dx.doi.org/10.1007/bf02246074", "relation": {"cites": []}, "ISSN": ["0033-3158", "1432-2072"], "issn-type": [{"value": "0033-3158", "type": "print"}, {"value": "1432-2072", "type": "electronic"}], "subject": ["Pharmacology"]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T22:27:53Z", "timestamp": 1574288873692}, "reference-count": 59, "publisher": "Springer Science and Business Media LLC", "issue": "8", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2009, 3, 25]], "date-time": "2009-03-25T00:00:00Z", "timestamp": 1237939200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Neuropsychopharmacol"], "published-print": {"date-parts": [[2009, 7]]}, "DOI": "10.1038/npp.2009.29", "type": "journal-article", "created": {"date-parts": [[2009, 3, 25]], "date-time": "2009-03-25T15:36:02Z", "timestamp": 1237995362000}, "page": "1958-1967", "source": "Crossref", "is-referenced-by-count": 81, "title": ["5-HT2A and 5-HT2C Receptors Exert Opposing Effects on Locomotor Activity in Mice"], "prefix": "10.1038", "volume": "34", "author": [{"given": "Adam L", "family": "Halberstadt", "sequence": "first", "affiliation": []}, {"given": "Iris", "family": "van der Heijden", "sequence": "additional", "affiliation": []}, {"given": "Michael A", "family": "Ruderman", "sequence": "additional", "affiliation": []}, {"given": "Victoria B", "family": "Risbrough", "sequence": "additional", "affiliation": []}, {"given": "Jay A", "family": "Gingrich", "sequence": "additional", "affiliation": []}, {"given": "Mark A", "family": "Geyer", "sequence": "additional", "affiliation": []}, {"given": "Susan B", "family": "Powell", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2009, 3, 25]]}, "reference": [{"key": "BFnpp200929_CR1", "doi-asserted-by": "publisher", "first-page": "121", "DOI": "10.1016/0278-5846(85)90074-0", "volume": "9", "author": "L Adams", "year": "1985", "unstructured": "Adams L, Geyer MA (1985). Effects of DOM and DMT in a proposed animal model of hallucinogenic activity. Prog Neuropsychopharmacol Biol Psychiatry 9: 121\u2013132.", "journal-title": "Prog Neuropsychopharmacol Biol Psychiatry"}, {"key": "BFnpp200929_CR2", "author": "GK Aghajanian", "first-page": "15", "year": "2002", "unstructured": "Aghajanian GK, Sanders-Bush E (2002). Serotonin. Neuropsychopharmacology: The Fifth Generation of progress. Lippincott Williams & Wilkins: Philadelphia. pp 15\u201334.", "volume-title": "Neuropsychopharmacology: The Fifth Generation of progress"}, {"key": "BFnpp200929_CR3", "doi-asserted-by": "publisher", "first-page": "861", "DOI": "10.1038/sj.bjp.0706935", "volume": "149", "author": "L Boothman", "year": "2006", "unstructured": "Boothman L, Raley J, Denk F, Hirani E, Sharp T (2006). In vivo evidence that 5-HT2C receptors inhibit 5-HT neuronal activity via a GABAergic mechanism. Br J Pharmacol 149: 861\u2013869.", "journal-title": "Br J Pharmacol"}, {"key": "BFnpp200929_CR4", "doi-asserted-by": "publisher", "first-page": "998", "DOI": "10.1038/sj.bjp.0705328", "volume": "139", "author": "LJ Boothman", "year": "2003", "unstructured": "Boothman LJ, Allers KA, Rasmussen K, Sharp T (2003). Evidence that central 5-HT2A and 5-HT2B/C receptors regulate 5-HT cell firing in the dorsal raphe nucleus of the anaesthetised rat. Br J Pharmacol 139: 998\u20131004.", "journal-title": "Br J Pharmacol"}, {"key": "BFnpp200929_CR5", "doi-asserted-by": "publisher", "first-page": "143", "DOI": "10.1016/S0376-8716(96)01297-5", "volume": "43", "author": "HD Chilcoat", "year": "1996", "unstructured": "Chilcoat HD, Schtitz CG (1996). Age-specific patterns of hallucinogen use in the US population: an analysis using generalized additive models. Drug Alcohol Depend 43: 143\u2013153.", "journal-title": "Drug Alcohol Depend"}, {"key": "BFnpp200929_CR6", "doi-asserted-by": "publisher", "first-page": "123", "DOI": "10.1016/S0028-3908(99)00086-6", "volume": "39", "author": "DA Clemett", "year": "2000", "unstructured": "Clemett DA, Punhani T, Duxon MS, Blackburn TP, Fone KC (2000). Immunohistochemical localisation of the 5-HT2C receptor protein in the rat CNS. Neuropharmacology 39: 123\u2013132.", "journal-title": "Neuropharmacology"}, {"key": "BFnpp200929_CR7", "doi-asserted-by": "publisher", "first-page": "187", "DOI": "10.1002/(SICI)1096-9861(19990628)409:2<187::AID-CNE2>3.0.CO;2-P", "volume": "409", "author": "V Cornea-H\u00e9bert", "year": "1999", "unstructured": "Cornea-H\u00e9bert V, Riad M, Wu C, Singh SK, Descarries L (1999). Cellular and subcellular distribution of the serotonin 5-HT2A receptor in the central nervous system of adult rat. J Comp Neurol 409: 187\u2013209.", "journal-title": "J Comp Neurol"}, {"key": "BFnpp200929_CR8", "doi-asserted-by": "publisher", "first-page": "901", "DOI": "10.1016/0091-3057(90)90098-3", "volume": "36", "author": "NA Darmani", "year": "1990", "unstructured": "Darmani NA, Martin BR, Pandey U, Glennon RA (1990a). Do functional relationships exist between 5-HT1A and 5-HT2 receptors? Pharmacol Biochem Behav 36: 901\u2013906.", "journal-title": "Pharmacol Biochem Behav"}, {"key": "BFnpp200929_CR9", "doi-asserted-by": "publisher", "first-page": "95", "DOI": "10.1016/0091-3057(90)90047-L", "volume": "37", "author": "NA Darmani", "year": "1990", "unstructured": "Darmani NA, Martin BR, Pandey U, Glennon RA (1990b). Pharmacological characterization of ear-scratch response in mice as a behavioral model for selective 5-HT2-receptor agonists and evidence for 5-HT1B- and 5-HT2-receptor interactions. Pharmacol Biochem Behav 37: 95\u201399.", "journal-title": "Pharmacol Biochem Behav"}, {"key": "BFnpp200929_CR10", "doi-asserted-by": "publisher", "first-page": "1495", "DOI": "10.1016/S0031-9384(96)00323-X", "volume": "60", "author": "NA Darmani", "year": "1996", "unstructured": "Darmani NA, Shaddy J, Gerdes CF (1996). Differential ontogenesis of three DOI-induced behaviors in mice. Physiol Behav 60: 1495\u20131500.", "journal-title": "Physiol Behav"}, {"key": "BFnpp200929_CR11", "doi-asserted-by": "publisher", "first-page": "587", "DOI": "10.1016/S0306-4522(98)00655-1", "volume": "91", "author": "G Di Giovanni", "year": "1999", "unstructured": "Di Giovanni G, De Deurwaerd\u00e9re P, Di Mascio M, Di Matteo V, Esposito E, Spampinato U (1999). Selective blockade of serotonin2C/2B receptors enhances mesolimbic and mesostriatal dopaminergic function: a combined in vivo electrophysiological and microdialysis study. Neuroscience 91: 587\u2013597.", "journal-title": "Neuroscience"}, {"key": "BFnpp200929_CR12", "doi-asserted-by": "publisher", "first-page": "265", "DOI": "10.1016/S0028-3908(98)00014-8", "volume": "37", "author": "V Di Matteo", "year": "1998", "unstructured": "Di Matteo V, Di Giovanni G, Di Mascio M, Esposito E (1998). Selective blockade of serotonin2C/2B receptors enhances dopamine release in the rat nucleus accumbens. Neuropharmacology 37: 265\u2013272.", "journal-title": "Neuropharmacology"}, {"key": "BFnpp200929_CR13", "doi-asserted-by": "publisher", "first-page": "496", "DOI": "10.1007/s00213-005-0009-4", "volume": "181", "author": "WE Fantegrossi", "year": "2005", "unstructured": "Fantegrossi WE, Harrington AW, Eckler JR, Arshad S, Rabin RA, Winter JC et al (2005). Hallucinogen-like actions of 2,5-dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) in mice and rats. Psychopharmacology 181: 496\u2013503.", "journal-title": "Psychopharmacology"}, {"key": "BFnpp200929_CR14", "doi-asserted-by": "publisher", "first-page": "122", "DOI": "10.1016/j.pbb.2005.12.015", "volume": "83", "author": "WE Fantegrossi", "year": "2006", "unstructured": "Fantegrossi WE, Harrington AW, Kiessel CL, Eckler JR, Rabin RA, Winter JC et al (2006). Hallucinogen-like actions of 5-methoxy-N,N-diisopropyltryptamine in mice and rats. Pharmacol Biochem Behav 83: 122\u2013129.", "journal-title": "Pharmacol Biochem Behav"}, {"key": "BFnpp200929_CR15", "doi-asserted-by": "publisher", "first-page": "358", "DOI": "10.1016/j.pbb.2007.09.007", "volume": "88", "author": "WE Fantegrossi", "year": "2008", "unstructured": "Fantegrossi WE, Reissig CJ, Katz EB, Yarosh HL, Rice KC, Winter JC (2008). Hallucinogen-like effects of N,N-dipropyltryptamine (DPT): possible mediation by serotonin 5-HT1A and 5-HT2A receptors in rodents. Pharmacol Biochem Behav 88: 358\u2013365.", "journal-title": "Pharmacol Biochem Behav"}, {"key": "BFnpp200929_CR16", "doi-asserted-by": "publisher", "first-page": "347", "DOI": "10.1007/BF02246074", "volume": "121", "author": "D Fiorella", "year": "1995", "unstructured": "Fiorella D, Rabin RA, Winter JC (1995). The role of the 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs I: antagonist correlation analysis. Psychopharmacology 121: 347\u2013356.", "journal-title": "Psychopharmacology"}, {"key": "BFnpp200929_CR17", "doi-asserted-by": "publisher", "first-page": "277", "DOI": "10.1016/0091-3057(86)90266-2", "volume": "25", "author": "MA Geyer", "year": "1986", "unstructured": "Geyer MA, Russo PV, Masten VL (1986). Multivariate assessment of locomotor behavior: pharmacological and behavioral analyses. Pharmacol Biochem Behav 25: 277\u2013288.", "journal-title": "Pharmacol Biochem Behav"}, {"key": "BFnpp200929_CR18", "doi-asserted-by": "publisher", "first-page": "445", "DOI": "10.1016/j.tips.2008.06.006", "volume": "29", "author": "MA Geyer", "year": "2008", "unstructured": "Geyer MA, Vollenweider FX (2008). Serotonin research: contributions to understanding psychosis. Trends Pharmacol Sci 29: 445\u2013453.", "journal-title": "Trends Pharmacol Sci"}, {"key": "BFnpp200929_CR19", "doi-asserted-by": "publisher", "first-page": "613", "DOI": "10.1097/00008877-200112000-00005", "volume": "12", "author": "SD Gleason", "year": "2001", "unstructured": "Gleason SD, Lucaites VL, Shannon HE, Nelson DL, Leander JD (2001). m-CPP hypolocomotion is selectively antagonized by compounds with high affinity for 5-HT2C receptors but not 5-HT2A or 5-HT2B receptors. Behav Pharmacol 12: 613\u2013620.", "journal-title": "Behav Pharmacol"}, {"key": "BFnpp200929_CR20", "doi-asserted-by": "publisher", "first-page": "315", "DOI": "10.1016/S0028-3908(98)00188-9", "volume": "38", "author": "A Gobert", "year": "1999", "unstructured": "Gobert A, Millan MJ (1999). Serotonin (5-HT)2A receptor activation enhances dialysate levels of dopamine and noradrenaline, but not 5-HT, in the frontal cortex of freely-moving rats. Neuropharmacology 38: 315\u2013317.", "journal-title": "Neuropharmacology"}, {"key": "BFnpp200929_CR21", "doi-asserted-by": "publisher", "first-page": "439", "DOI": "10.1016/j.neuron.2007.01.008", "volume": "53", "author": "J Gonz\u00e1lez-Maeso", "year": "2007", "unstructured": "Gonz\u00e1lez-Maeso J, Weisstaub NV, Zhou M, Chan P, Ivic L, Ang R et al (2007). Hallucinogens recruit specific cortical 5-HT2A receptor-mediated signaling pathways to affect behavior. Neuron 53: 439\u2013452.", "journal-title": "Neuron"}, {"key": "BFnpp200929_CR22", "doi-asserted-by": "publisher", "first-page": "8836", "DOI": "10.1523/JNEUROSCI.23-26-08836.2003", "volume": "23", "author": "J Gonz\u00e1lez-Maeso", "year": "2003", "unstructured": "Gonz\u00e1lez-Maeso J, Yuen T, Ebersole BJ, Wurmbach E, Lira A, Zhou M et al (2003). Transcriptome fingerprints distinguish hallucinogenic and nonhallucinogenic 5-hydroxytryptamine 2A receptor agonist effects in mouse somatosensory cortex. J Neurosci 23: 8836\u20138843.", "journal-title": "J Neurosci"}, {"key": "BFnpp200929_CR23", "doi-asserted-by": "publisher", "first-page": "581", "DOI": "10.1016/S0896-6273(00)80712-6", "volume": "22", "author": "R Grailhe", "year": "1999", "unstructured": "Grailhe R, Waeber C, Dulawa SC, Hornung JP, Zhuang X, Brunner D et al. (1999). Increased exploratory activity and altered response to LSD in mice lacking the 5-HT5A receptor. Neuron 22: 581\u2013591.", "journal-title": "Neuron"}, {"key": "BFnpp200929_CR24", "doi-asserted-by": "publisher", "first-page": "65", "DOI": "10.1016/j.bbr.2007.07.011", "volume": "185", "author": "R Hameleers", "year": "2007", "unstructured": "Hameleers R, Blokland A, Steinbusch HW, Visser-Vandewalle V, Temel Y (2007). Hypomobility after DOI administration can be reversed by subthalamic nucleus deep brain stimulation. Behav Brain Res 185: 65\u201367.", "journal-title": "Behav Brain Res"}, {"key": "BFnpp200929_CR25", "doi-asserted-by": "publisher", "first-page": "735", "DOI": "10.1073/pnas.95.2.735", "volume": "95", "author": "RL Jakab", "year": "1998", "unstructured": "Jakab RL, Goldman-Rakic PS (1998). 5-Hydroxytryptamine2A serotonin receptors in the primate cerebral cortex: possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites. Proc Natl Acad Sci USA 95: 735\u2013740.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "BFnpp200929_CR26", "doi-asserted-by": "publisher", "first-page": "69", "DOI": "10.1007/s002130050740", "volume": "140", "author": "K Krebs-Thomson", "year": "1998", "unstructured": "Krebs-Thomson K, Geyer MA (1998). Evidence for a functional interaction between 5-HT1A and 5-HT2 receptors in rats. Psychopharmacology (Berl) 140: 69\u201374.", "journal-title": "Psychopharmacology (Berl)"}, {"key": "BFnpp200929_CR27", "doi-asserted-by": "publisher", "first-page": "339", "DOI": "10.1016/S0893-133X(97)00164-4", "volume": "18", "author": "K Krebs-Thomson", "year": "1998", "unstructured": "Krebs-Thomson K, Paulus MP, Geyer MA (1998). Effects of hallucinogens on locomotor and investigatory activity and patterns: influence of 5-HT2A and 5-HT2C receptors. Neuropsychopharmacology 18: 339\u2013351.", "journal-title": "Neuropsychopharmacology"}, {"key": "BFnpp200929_CR28", "doi-asserted-by": "publisher", "first-page": "137", "DOI": "10.1016/0014-2999(94)90502-9", "volume": "259", "author": "GJ Marek", "year": "1994", "unstructured": "Marek GJ, Aghajanian GK (1994). Excitation of interneurons in piriform cortex by 5-hydroxytryptamine: blockade by MDL 100,907, a highly selective 5-HT2A receptor antagonist. Eur J Pharmacol 259: 137\u2013141.", "journal-title": "Eur J Pharmacol"}, {"key": "BFnpp200929_CR29", "doi-asserted-by": "publisher", "first-page": "486", "DOI": "10.1124/jpet.106.106989", "volume": "320", "author": "KL Marquis", "year": "2007", "unstructured": "Marquis KL, Sabb AL, Logue SF, Brennan JA, Piesla MJ, Comery TA et al (2007). WAY-163909 [(7bR,10aR)-1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta-[b][1,4]diazepino[6,7,1hi]indole]: a novel 5-hydroxytryptamine 2C receptor-selective agonist with preclinical antipsychotic-like activity. J Pharmacol Exp Ther 320: 486\u2013496.", "journal-title": "J Pharmacol Exp Ther"}, {"key": "BFnpp200929_CR30", "first-page": "913", "volume": "286", "author": "JR Martin", "year": "1998", "unstructured": "Martin JR, B\u00f6s M, Jenck F, Moreau J-L, Mutel V, Sleight AJ et al (1998). 5-HT2C receptor agonists: pharmacological characteristics and therapeutic potential. J Pharmacol Exp Ther 286: 913\u2013924.", "journal-title": "J Pharmacol Exp Ther"}, {"key": "BFnpp200929_CR31", "doi-asserted-by": "publisher", "first-page": "953", "DOI": "10.1016/S0028-3908(98)00078-1", "volume": "37", "author": "MJ Milan", "year": "1988", "unstructured": "Milan MJ, Dekeyne A, Gobert A (1988). Serotonin (5-HT)2C receptors tonically inhibit dopamine (DA) and noradrenaline (NA), but not 5-HT, release in the frontal cortex in vivo. Neuropharmacology 37: 953\u2013955.", "journal-title": "Neuropharmacology"}, {"key": "BFnpp200929_CR32", "doi-asserted-by": "publisher", "first-page": "69", "DOI": "10.1007/BF02316866", "volume": "105", "author": "SM Mittman", "year": "1991", "unstructured": "Mittman SM, Geyer MA (1991). Dissociation of multiple effects of acute LSD on exploratory behavior in rats by ritanserin and propranolol. Psychopharmacology 105: 69\u201376.", "journal-title": "Psychopharmacology"}, {"key": "BFnpp200929_CR33", "doi-asserted-by": "publisher", "first-page": "107", "DOI": "10.1016/S0306-4522(02)00580-8", "volume": "116", "author": "LA Miner", "year": "2003", "unstructured": "Miner LA, Backstrom JR, Sanders-Bush E, Sesack SR (2003). Ultrastructural localization of serotonin2A receptors in the middle layers of the rat prelimbic prefrontal cortex. Neuroscience 116: 107\u2013117.", "journal-title": "Neuroscience"}, {"key": "BFnpp200929_CR34", "doi-asserted-by": "publisher", "first-page": "1614", "DOI": "10.1021/cr078224o", "volume": "108", "author": "DE Nichols", "year": "2008", "unstructured": "Nichols DE, Nichols CD (2008). Serotonin receptors. Chem Rev 108: 1614\u20131641.", "journal-title": "Chem Rev"}, {"key": "BFnpp200929_CR35", "doi-asserted-by": "publisher", "first-page": "6", "DOI": "10.1007/BF02244547", "volume": "104", "author": "MP Paulus", "year": "1991", "unstructured": "Paulus MP, Geyer MA (1991). A temporal and spatial acaling hypothesis for the behavioral effects of psychostimulants. Psychopharmacology 104: 6\u201316.", "journal-title": "Psychopharmacology"}, {"key": "BFnpp200929_CR36", "doi-asserted-by": "publisher", "first-page": "118", "DOI": "10.1007/BF00443425", "volume": "97", "author": "PA Pierce", "year": "1989", "unstructured": "Pierce PA, Peroutka SJ (1989). Hallucinogenic drug interactions with neurotransmitter receptor binding sites in human cortex. Psychopharmacology 97: 118\u2013122.", "journal-title": "Psychopharmacology"}, {"key": "BFnpp200929_CR37", "doi-asserted-by": "publisher", "first-page": "311", "DOI": "10.1016/S0893-133X(01)00333-5", "volume": "26", "author": "G Porras", "year": "2002", "unstructured": "Porras G, Di Matteo V, Fracasso C, Lucas G, De Deurwaerd\u00e8re P, Caccia S et al (2002). 5-HT2A and 5-HT2C/2B receptor subtypes modulate dopamine release induced in vivo by amphetamine and morphine in both the rat nucleus accumbens and striatum. Neuropsychopharmacology 26: 311\u2013324.", "journal-title": "Neuropsychopharmacology"}, {"key": "BFnpp200929_CR38", "doi-asserted-by": "publisher", "first-page": "300", "DOI": "10.1007/BF00404607", "volume": "11", "author": "A Randrup", "year": "1967", "unstructured": "Randrup A, Munkvad I (1967). Stereotyped activities produced by amphetamine in several animal species and man. Psychopharmacologia 11: 300\u2013310.", "journal-title": "Psychopharmacologia"}, {"key": "BFnpp200929_CR39", "doi-asserted-by": "publisher", "first-page": "2349", "DOI": "10.1038/sj.npp.1301161", "volume": "31", "author": "VB Risbrough", "year": "2006", "unstructured": "Risbrough VB, Masten VL, Caldwell S, Paulus MP, Low MJ, Geyer MA (2006). Differential contributions of dopamine D1, D2, and D3 receptors to MDMA-induced effects on locomotor behavior patterns in mice. Neuropsychopharmacology 31: 2349\u20132358.", "journal-title": "Neuropsychopharmacology"}, {"key": "BFnpp200929_CR40", "doi-asserted-by": "publisher", "first-page": "240", "DOI": "10.1016/j.brainres.2005.12.052", "volume": "1073\u20131074", "author": "S Rosenzweig-Lipson", "year": "2006", "unstructured": "Rosenzweig-Lipson S, Zhang J, Mazandarani H, Harrison BL, Sabb A, Sabalski J et al (2006). Antiobesity-like effects of the 5-HT2C receptor agonist WAY-161503. Brain Res 1073\u20131074: 240\u2013251.", "journal-title": "Brain Res"}, {"key": "BFnpp200929_CR41", "doi-asserted-by": "publisher", "first-page": "65", "DOI": "10.1016/0014-2999(92)90819-P", "volume": "223", "author": "CJ Schmidt", "year": "1992", "unstructured": "Schmidt CJ, Fadayel GM, Sullivan CK, Taylor VL (1992). 5-HT2 receptors exert a state-dependent regulation of dopaminergic function: studies with MDL 100,907 and the amphetamine analogue, 3,4-methylenedioxymethamphetamine. Eur J Pharmacol 223: 65\u201374.", "journal-title": "Eur J Pharmacol"}, {"key": "BFnpp200929_CR42", "first-page": "101", "volume": "273", "author": "R Schreiber", "year": "1995", "unstructured": "Schreiber R, Brocco M, Audinot V, Gobert A, Veiga S, Millan MJ (1995). (1-(2,5-Dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT)2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists. J Pharmacol Exp Ther 273: 101\u2013112.", "journal-title": "J Pharmacol Exp Ther"}, {"key": "BFnpp200929_CR43", "doi-asserted-by": "publisher", "first-page": "99", "DOI": "10.1016/0014-2999(94)90643-2", "volume": "264", "author": "R Schreiber", "year": "1994", "unstructured": "Schreiber R, Brocco M, Millan MJ (1994). Blockade of the discriminative stimulus effect of DOI by MDL 100,907 and the \u2018atypical\u2019 antipsychotics, clozapine and risperidone. Eur J Pharmacol 264: 99\u2013102.", "journal-title": "Eur J Pharmacol"}, {"key": "BFnpp200929_CR44", "doi-asserted-by": "publisher", "first-page": "629", "DOI": "10.1016/j.tips.2007.10.009", "volume": "28", "author": "T Sharp", "year": "2007", "unstructured": "Sharp T, Boothman L, Raley J, Qu\u00e9r\u00e9e P (2007). Important messages in the \u2018post\u2019: recent discoveries in 5-HT neurone feedback control. Trends Pharmacol Sci 28: 629\u2013636.", "journal-title": "Trends Pharmacol Sci"}, {"key": "BFnpp200929_CR45", "doi-asserted-by": "publisher", "first-page": "62", "DOI": "10.1016/0006-8993(90)91199-Q", "volume": "506", "author": "PW Sheldon", "year": "1990", "unstructured": "Sheldon PW, Aghajanian GK (1990). Serotonin (5-HT) induces IPSPs in pyramidal layer cells of rat piriform cortex: evidence for the involvement of a 5-HT2-activated interneuron. Brain Res 506: 62\u201369.", "journal-title": "Brain Res"}, {"key": "BFnpp200929_CR46", "doi-asserted-by": "publisher", "first-page": "208", "DOI": "10.1002/syn.890090307", "volume": "9", "author": "PW Sheldon", "year": "1991", "unstructured": "Sheldon PW, Aghajanian GK (1991). Excitatory responses to serotonin (5-HT) in neurons of the rat piriform cortex: evidence for mediation by 5-HT1C receptors in pyramidal cells and 5-HT2 receptors in interneurons. Synapse 9: 208\u2013218.", "journal-title": "Synapse"}, {"key": "BFnpp200929_CR47", "doi-asserted-by": "publisher", "first-page": "839", "DOI": "10.1097/00008877-199512000-00010", "volume": "6", "author": "TA Sipes", "year": "1995", "unstructured": "Sipes TA, Geyer MA (1995). DOI disruption of prepulse inhibition in the rat is mediated by 5-HT2A and not by 5-HT2C receptors. Behav Pharmacol 6: 839\u2013842.", "journal-title": "Behav Pharmacol"}, {"key": "BFnpp200929_CR48", "doi-asserted-by": "publisher", "first-page": "248", "DOI": "10.1007/s002130051000", "volume": "144", "author": "RL Smith", "year": "1999", "unstructured": "Smith RL, Barrett RJ, Sanders-Bush E (1999). Mechanism of tolerance development to 2,5-dimethoxy-4-iodoamphetamine in rats: down-regulation of the 5-HT2A, but not 5-HT2C, receptor. Psychopharmacology 144: 248\u2013254.", "journal-title": "Psychopharmacology"}, {"key": "BFnpp200929_CR49", "doi-asserted-by": "publisher", "first-page": "61", "DOI": "10.1007/s00213-002-1252-6", "volume": "166", "author": "RL Smith", "year": "2003", "unstructured": "Smith RL, Barrett RJ, Sanders-Bush E (2003). Discriminative stimulus properties of 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane [(+/\u2212)DOI] in C57BL/6J mice. Psychopharmacology 166: 61\u201368.", "journal-title": "Psychopharmacology"}, {"key": "BFnpp200929_CR50", "doi-asserted-by": "publisher", "first-page": "323", "DOI": "10.1016/S0091-3057(98)00110-5", "volume": "61", "author": "RL Smith", "year": "1998", "unstructured": "Smith RL, Canton H, Barrett RJ, Sanders-Bush E (1998). Agonist properties of N,N-dimethyltryptamine at serotonin 5-HT2A and 5-HT2C receptors. Pharmacol Biochem Behav 61: 323\u2013330.", "journal-title": "Pharmacol Biochem Behav"}, {"key": "BFnpp200929_CR51", "doi-asserted-by": "publisher", "first-page": "213", "DOI": "10.1007/BF00176847", "volume": "94", "author": "M Titeler", "year": "1988", "unstructured": "Titeler M, Lyon RA, Glennon RA (1988). Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens. Psychopharmacology 94: 213\u2013216.", "journal-title": "Psychopharmacology"}, {"key": "BFnpp200929_CR52", "doi-asserted-by": "publisher", "first-page": "643", "DOI": "10.1016/S0091-3057(01)00552-4", "volume": "69", "author": "SP Vickers", "year": "2001", "unstructured": "Vickers SP, Easton N, Malcolm CS, Allen NH, Porter RH, Bickerdike MJ et al (2001). Modulation of 5-HT2A receptor-mediated head-twitch behaviour in the rat by 5-HT2C receptor agonists. Pharmacol Biochem Behav 69: 643\u2013652.", "journal-title": "Pharmacol Biochem Behav"}, {"key": "BFnpp200929_CR53", "doi-asserted-by": "publisher", "first-page": "3897", "DOI": "10.1097/00001756-199812010-00024", "volume": "9", "author": "FX Vollenweider", "year": "1998", "unstructured": "Vollenweider FX, Vollenweider-Scherpenhuyzen MFI, B\u00e4bler A, Vogel H, Hell D (1998). Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action. Neuroreport 9: 3897\u20133902.", "journal-title": "Neuroreport"}, {"key": "BFnpp200929_CR54", "doi-asserted-by": "publisher", "first-page": "533", "DOI": "10.1016/S0278-5846(99)00014-7", "volume": "23", "author": "JG Wettstein", "year": "1999", "unstructured": "Wettstein JG, Host M, Hitchcock JM (1999). Selectivity of action of typical and atypical antipsychotic drugs as antagonists of the behavioral effects of 1-[2,5-dimethoxy-4-iodophenyl]-2-aminopropane (DOI). Prog Neuropsychopharmacol Biol Psychiatry 23: 533\u2013544.", "journal-title": "Prog Neuropsychopharmacol Biol Psychiatry"}, {"key": "BFnpp200929_CR55", "doi-asserted-by": "publisher", "first-page": "79", "DOI": "10.1002/(SICI)1098-2396(199709)27:1<79::AID-SYN8>3.0.CO;2-A", "volume": "27", "author": "DL Willins", "year": "1997", "unstructured": "Willins DL, Deutch AY, Roth BL (1997). Serotonin 5-HT2A receptors are expressed on pyramidal cells and interneurons in the rat cortex. Synapse 27: 79\u201382.", "journal-title": "Synapse"}, {"key": "BFnpp200929_CR56", "first-page": "699", "volume": "282", "author": "DL Willins", "year": "1997", "unstructured": "Willins DL, Meltzer HY (1997). Direct injection of 5-HT2A receptor agonists into the medial prefrontal cortex produces a head-twitch response in rats. J Pharmacol Exp Ther 282: 699\u2013706.", "journal-title": "J Pharmacol Exp Ther"}, {"key": "BFnpp200929_CR57", "doi-asserted-by": "publisher", "first-page": "417", "DOI": "10.1007/BF02244617", "volume": "100", "author": "LL Wing", "year": "1990", "unstructured": "Wing LL, Tapson GS, Geyer MA (1990). 5HT-2 mediation of acute behavioral effects of hallucinogens in rats. Psychopharmacology 100: 417\u2013425.", "journal-title": "Psychopharmacology"}, {"key": "BFnpp200929_CR58", "doi-asserted-by": "publisher", "first-page": "376", "DOI": "10.1007/s00213-004-1884-9", "volume": "176", "author": "CA Winstanley", "year": "2004", "unstructured": "Winstanley CA, Theobald DE, Dalley JW, Glennon JC, Robbins TW (2004). 5-HT2A and 5-HT2C receptor antagonists have opposing effects on a measure of impulsivity: interactions with global 5-HT depletion. Psychopharmacology (Berl) 176: 376\u2013385.", "journal-title": "Psychopharmacology (Berl)"}, {"key": "BFnpp200929_CR59", "doi-asserted-by": "publisher", "first-page": "499", "DOI": "10.1016/S0361-9230(99)00278-6", "volume": "51", "author": "T Xu", "year": "2000", "unstructured": "Xu T, Pandey SC (2000). Cellular localization of serotonin2A (5HT2A) receptors in the rat brain. Brain Res Bull 51: 499\u2013505.", "journal-title": "Brain Res Bull"}], "container-title": ["Neuropsychopharmacology"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/npp200929.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/npp200929", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/npp200929.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 4, 23]], "date-time": "2019-04-23T18:40:18Z", "timestamp": 1556044818000}, "score": 22.91924, "issued": {"date-parts": [[2009, 3, 25]]}, "references-count": 59, "journal-issue": {"published-print": {"date-parts": [[2009, 7]]}, "issue": "8"}, "alternative-id": ["BFnpp200929"], "URL": "http://dx.doi.org/10.1038/npp.2009.29", "relation": {"cites": []}, "ISSN": ["0893-133X", "1740-634X"], "issn-type": [{"value": "0893-133X", "type": "print"}, {"value": "1740-634X", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T16:54:57Z", "timestamp": 1574096097910}, "reference-count": 38, "publisher": "Elsevier BV", "issue": "1-2", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2002, 5, 1]], "date-time": "2002-05-01T00:00:00Z", "timestamp": 1020211200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Pharmacology Biochemistry and Behavior"], "published-print": {"date-parts": [[2002, 5]]}, "DOI": "10.1016/s0091-3057(01)00767-5", "type": "journal-article", "created": {"date-parts": [[2002, 10, 15]], "date-time": "2002-10-15T00:25:14Z", "timestamp": 1034641514000}, "page": "371-378", "source": "Crossref", "is-referenced-by-count": 20, "title": ["A novel behavioral model that discriminates between 5-HT2A and 5-HT2C receptor activation"], "prefix": "10.1016", "volume": "72", "author": [{"given": "Kuldip D", "family": "Dave", "sequence": "first", "affiliation": []}, {"given": "John A", "family": "Harvey", "sequence": "additional", "affiliation": []}, {"given": "Vincent J", "family": "Aloyo", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Pharmacology Biochemistry and Behavior"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0091305701007675?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0091305701007675?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 4, 29]], "date-time": "2019-04-29T11:21:07Z", "timestamp": 1556536867000}, "score": 22.912197, "issued": {"date-parts": [[2002, 5]]}, "references-count": 38, "journal-issue": {"published-print": {"date-parts": [[2002, 5]]}, "issue": "1-2"}, "alternative-id": ["S0091305701007675"], "URL": "http://dx.doi.org/10.1016/s0091-3057(01)00767-5", "ISSN": ["0091-3057"], "issn-type": [{"value": "0091-3057", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T11:20:17Z", "timestamp": 1574162417610}, "reference-count": 30, "publisher": "Elsevier BV", "issue": "1-2", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1994, 8, 1]], "date-time": "1994-08-01T00:00:00Z", "timestamp": 775699200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Neuroscience Letters"], "published-print": {"date-parts": [[1994, 8]]}, "DOI": "10.1016/0304-3940(94)90057-4", "type": "journal-article", "created": {"date-parts": [[2003, 4, 25]], "date-time": "2003-04-25T05:09:59Z", "timestamp": 1051247399000}, "page": "111-115", "source": "Crossref", "is-referenced-by-count": 49, "title": ["Effect of the R(\u2212) and S(+) isomers of MDA and MDMA on phosphotidyl inositol turnover in cultured cells expressing 5-HT2A or 5-HT2C receptors"], "prefix": "10.1016", "volume": "177", "author": [{"given": "J.Frank", "family": "Nash", "sequence": "first", "affiliation": []}, {"given": "Bryan L", "family": "Roth", "sequence": "additional", "affiliation": []}, {"given": "Jesse D", "family": "Brodkin", "sequence": "additional", "affiliation": []}, {"given": "David E", "family": "Nichols", "sequence": "additional", "affiliation": []}, {"given": "Gary A", "family": "Gudelsky", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Neuroscience Letters"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:0304394094900574?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:0304394094900574?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 3, 22]], "date-time": "2019-03-22T00:22:56Z", "timestamp": 1553214176000}, "score": 22.78057, "issued": {"date-parts": [[1994, 8]]}, "references-count": 30, "journal-issue": {"published-print": {"date-parts": [[1994, 8]]}, "issue": "1-2"}, "alternative-id": ["0304394094900574"], "URL": "http://dx.doi.org/10.1016/0304-3940(94)90057-4", "ISSN": ["0304-3940"], "issn-type": [{"value": "0304-3940", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T22:13:03Z", "timestamp": 1574460783002}, "reference-count": 74, "publisher": "Springer Science and Business Media LLC", "issue": "2-3", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Psychopharmacology"], "published-print": {"date-parts": [[2011, 2]]}, "DOI": "10.1007/s00213-010-1996-3", "type": "journal-article", "created": {"date-parts": [[2010, 9, 2]], "date-time": "2010-09-02T07:11:15Z", "timestamp": 1283411475000}, "page": "321-335", "source": "Crossref", "is-referenced-by-count": 35, "title": ["Blockade of nucleus accumbens 5-HT2A and 5-HT2C receptors prevents the expression of cocaine-induced behavioral and neurochemical sensitization in rats"], "prefix": "10.1007", "volume": "213", "author": [{"given": "Avi E.", "family": "Zayara", "sequence": "first", "affiliation": []}, {"given": "Gregor", "family": "McIver", "sequence": "additional", "affiliation": []}, {"given": "Paola N.", "family": "Valdivia", "sequence": "additional", "affiliation": []}, {"given": "Kevin D.", "family": "Lominac", "sequence": "additional", "affiliation": []}, {"given": "Andrew C.", "family": "McCreary", "sequence": "additional", "affiliation": []}, {"given": "Karen K.", "family": "Szumlinski", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2010, 9, 3]]}, "reference": [{"key": "1996_CR1", "doi-asserted-by": "crossref", "first-page": "589", "DOI": "10.1016/S0028-3908(97)00051-8", "volume": "36", "author": "GK Aghajanian", "year": "1997", "unstructured": "Aghajanian GK, Marek GJ (1997) Serotonin induces excitatory postsynaptic potentials in apical dendrites of neocortical pyramidal cells. Neuropharmacology 36:589\u2013599", "journal-title": "Neuropharmacology"}, {"key": "1996_CR2", "doi-asserted-by": "crossref", "first-page": "318", "DOI": "10.1111/j.1471-4159.2004.02714.x", "volume": "91", "author": "A Auclair", "year": "2004", "unstructured": "Auclair A, Blanc G, Glowinski J, Tassin JP (2004a) Role of serotonin 2A receptors in the D-amphetamine-induced release of dopamine: comparison with previous data on alpha1b-adrenergic receptors. J Neurochem 91:318\u2013326", "journal-title": "J Neurochem"}, {"key": "1996_CR3", "doi-asserted-by": "crossref", "first-page": "3073", "DOI": "10.1111/j.1460-9568.2004.03805.x", "volume": "20", "author": "A Auclair", "year": "2004", "unstructured": "Auclair A, Drouin C, Cotecchia S, Glowinski J, Tassin JP (2004b) 5-HT2A and alpha1b-adrenergic receptors entirely mediate dopamine release, locomotor response and behavioural sensitization to opiates and psychostimulants. Eur J Neurosci 20:3073\u20133084", "journal-title": "Eur J Neurosci"}, {"key": "1996_CR4", "doi-asserted-by": "crossref", "first-page": "969", "DOI": "10.1016/j.neuropharm.2008.06.014", "volume": "55", "author": "KA Berg", "year": "2008", "unstructured": "Berg KA, Clarke WP, Cunningham KA, Spampinato U (2008) Fine-tuning sertonin2C receptor function in the brain: molecular and functional implications. Neuropharmacology 55:969\u2013976", "journal-title": "Neuropharmacology"}, {"key": "1996_CR5", "doi-asserted-by": "crossref", "first-page": "553", "DOI": "10.1007/s00441-006-0286-1", "volume": "326", "author": "J Bockaert", "year": "2006", "unstructured": "Bockaert J, Claeysen S, Becamel C, Dumuis A, Marin P (2006) Neuronal 5-HT metabotropic receptors: fine-tuning of their structure, signaling, and roles in synaptic modulation. Cell Tissue Res 326:553\u2013572", "journal-title": "Cell Tissue Res"}, {"key": "1996_CR6", "doi-asserted-by": "crossref", "first-page": "621", "DOI": "10.1016/S0028-3908(97)00049-X", "volume": "36", "author": "DW Bonhaus", "year": "1997", "unstructured": "Bonhaus DW, Weinhardt KK, Taylor M, DeSouza A, McNeeley PM, Szczepanski K, Fontana DJ, Trinh J, Rocha CL, Dawson MW, Flippin LA, Eglen RM (1997) RS-102221: a novel high affinity and selective, 5-HT2C receptor antagonist. Neuropharmacology 36:621\u2013629", "journal-title": "Neuropharmacology"}, {"key": "1996_CR7", "doi-asserted-by": "crossref", "first-page": "1625", "DOI": "10.1046/j.1471-4159.2000.0751625.x", "volume": "75", "author": "BJ Bowers", "year": "2000", "unstructured": "Bowers BJ, Henry MB, Thielen RJ, McBride WJ (2000) Serotonin 5-HT(2) receptor stimulation of dopamine release in the posterior but not anterior nucleus accumbens of the rat. J Neurochem 75:1625\u20131633", "journal-title": "J Neurochem"}, {"key": "1996_CR8", "doi-asserted-by": "crossref", "first-page": "547", "DOI": "10.1016/j.pnpbp.2004.01.007", "volume": "28", "author": "PA Broderick", "year": "2004", "unstructured": "Broderick PA, Olabisi OA, Rahni DN, Zhou Y (2004) Cocaine acts on accumbens monoamines and locomotor behavior via a 5-HT2A/2C receptor mechanism as shown by ketanserin: 24-h follow-up studies. Prog Neuropsychopharmacol Biol Psychiatry 28:547\u2013557", "journal-title": "Prog Neuropsychopharmacol Biol Psychiatry"}, {"key": "1996_CR9", "doi-asserted-by": "crossref", "first-page": "1952", "DOI": "10.1523/JNEUROSCI.20-05-01952.2000", "volume": "20", "author": "P Brown", "year": "2000", "unstructured": "Brown P, Molliver ME (2000) Dual serotonin (5-HT) projections to the nucleus accumbens core and shell: relation of the 5-HT transporter to amphetamine-induced neurotoxicity. J Neurosci 20:1952\u20131963", "journal-title": "J Neurosci"}, {"key": "1996_CR10", "doi-asserted-by": "crossref", "first-page": "1971", "DOI": "10.2174/156802606778522131", "volume": "6", "author": "MJ Bubar", "year": "2006", "unstructured": "Bubar MJ, Cunningham KA (2006) Serotonin 5-HT2A and 5-HT2C receptors as potential targets for modulation of psychostimulant use and dependence. Curr Top Med Chem 6:1971\u20131985", "journal-title": "Curr Top Med Chem"}, {"key": "1996_CR11", "first-page": "1414", "volume": "274", "author": "PM Callahan", "year": "1995", "unstructured": "Callahan PM, Cunningham KA (1995) Modulation of the discriminative stimulus properties of cocaine by 5-HT1B and 5-HT2C receptors. J Pharmacol Exp Ther 274:1414\u20131424", "journal-title": "J Pharmacol Exp Ther"}, {"key": "1996_CR12", "doi-asserted-by": "crossref", "first-page": "123", "DOI": "10.1016/S0028-3908(99)00086-6", "volume": "39", "author": "DA Clemett", "year": "2000", "unstructured": "Clemett DA, Punhani T, Duxon MS, Blackburn TP, Fone KC (2000) Immunohistochemical localisation of the 5-HT2C receptor protein in the rat CNS. Neuropharmacology 39:123\u2013132", "journal-title": "Neuropharmacology"}, {"key": "1996_CR13", "doi-asserted-by": "crossref", "first-page": "103", "DOI": "10.1016/S0006-8993(98)00168-1", "volume": "793", "author": "V Compan", "year": "1998", "unstructured": "Compan V, Segu L, Buhot MC, Daszuta A (1998a) Selective increases in serotonin 5-HT1B/1D and 5-HT2A/2C binding sites in adult rat basal ganglia following lesions of serotonergic neurons. Brain Res 793:103\u2013111", "journal-title": "Brain Res"}, {"key": "1996_CR14", "doi-asserted-by": "crossref", "first-page": "264", "DOI": "10.1016/S0006-8993(98)00316-3", "volume": "795", "author": "V Compan", "year": "1998", "unstructured": "Compan V, Segu L, Buhot MC, Daszuta A (1998b) Differential effects of serotonin (5-HT) lesions and synthesis blockade on neuropeptide-Y immunoreactivity and 5-HT1A, 5-HT1B/1D and 5-HT2A/2C receptor binding sites in the rat cerebral cortex. Brain Res 795:264\u2013276", "journal-title": "Brain Res"}, {"key": "1996_CR15", "first-page": "106", "volume": "3", "author": "L Angelis de", "year": "2002", "unstructured": "de Angelis L (2002) 5-HT2A antagonists in psychiatric disorders. Curr Opin Investig Drugs 3:106\u2013112", "journal-title": "Curr Opin Investig Drugs"}, {"key": "1996_CR16", "doi-asserted-by": "crossref", "first-page": "1033", "DOI": "10.1046/j.1471-4159.1999.0731033.x", "volume": "73", "author": "P Deurwaerd\u00e8re De", "year": "1999", "unstructured": "De Deurwaerd\u00e8re P, Spampinato U (1999) Role of serotonin(2A) and serotonin(2B/2C) receptor subtypes in the control of accumbal and striatal dopamine release elicited in vivo by dorsal raphe nucleus electrical stimulation. J Neurochem 73:1033\u20131042", "journal-title": "J Neurochem"}, {"key": "1996_CR17", "doi-asserted-by": "crossref", "first-page": "587", "DOI": "10.1016/S0306-4522(98)00655-1", "volume": "91", "author": "G Giovanni Di", "year": "1999", "unstructured": "Di Giovanni G, De Deurwaerd\u00e9re P, Di Mascio M, Di Matteo V, Esposito E, Spampinato U (1999) Selective blockade of serotonin-2C/2B receptors enhances mesolimbic and mesostriatal dopaminergic function: a combined in vivo electrophysiological and microdialysis study. Neuroscience 91:587\u2013597", "journal-title": "Neuroscience"}, {"key": "1996_CR18", "doi-asserted-by": "crossref", "first-page": "53", "DOI": "10.1002/(SICI)1098-2396(200001)35:1<53::AID-SYN7>3.0.CO;2-2", "volume": "35", "author": "G Giovanni Di", "year": "2000", "unstructured": "Di Giovanni G, Di Matteo V, Di Mascio M, Esposito E (2000) Preferential modulation of mesolimbic vs. nigrostriatal dopaminergic function by serotonin(2C/2B) receptor agonists: a combined in vivo electrophysiological and microdialysis study. Synapse 35:53\u201361", "journal-title": "Synapse"}, {"key": "1996_CR19", "doi-asserted-by": "crossref", "first-page": "1909", "DOI": "10.2174/156802606778522113", "volume": "6", "author": "G Giovanni Di", "year": "2006", "unstructured": "Di Giovanni G, Di Matteo V, Pierucci M, Benigno A, Esposito E (2006) Central serotonin2C receptor: from physiology to pathology. Curr Top Med Chem 6:1909\u20131925", "journal-title": "Curr Top Med Chem"}, {"key": "1996_CR20", "doi-asserted-by": "crossref", "first-page": "265", "DOI": "10.1016/S0028-3908(98)00014-8", "volume": "37", "author": "V Matteo Di", "year": "1998", "unstructured": "Di Matteo V, Di Giovanni G, Di Mascio M, Esposito E (1998) Selective blockade of serotonin2C/2B receptors enhances dopamine release in the rat nucleus accumbens. Neuropharmacology 37:265\u2013272", "journal-title": "Neuropharmacology"}, {"key": "1996_CR21", "doi-asserted-by": "crossref", "first-page": "1195", "DOI": "10.1016/S0028-3908(99)00047-7", "volume": "38", "author": "V Matteo Di", "year": "1999", "unstructured": "Di Matteo V, Di Giovanni G, Di Mascio M, Esposito E (1999) SB 242084, a selective serotonin2C receptor antagonist, increases dopaminergic transmission in the mesolimbic system. Neuropharmacology 38:1195\u20131205", "journal-title": "Neuropharmacology"}, {"key": "1996_CR22", "doi-asserted-by": "crossref", "first-page": "45", "DOI": "10.1007/s002130000420", "volume": "150", "author": "V Matteo Di", "year": "2000", "unstructured": "Di Matteo V, Di Mascio M, Di Giovanni G, Esposito E (2000a) Acute administration of amitriptyline and mianserin increases dopamine release in the rat nucleus accumbens: possible involvement of serotonin2C receptors. Psychopharmacology (Berl) 150:45\u201351", "journal-title": "Psychopharmacology (Berl)"}, {"key": "1996_CR23", "doi-asserted-by": "crossref", "first-page": "85", "DOI": "10.1016/S0006-8993(00)02246-0", "volume": "865", "author": "V Matteo Di", "year": "2000", "unstructured": "Di Matteo V, Di Giovanni G, Di Mascio M, Esposito E (2000b) Biochemical and electrophysiological evidence that Ro 60-0175 inhibits mesolimbic dopaminergic function through serotonin2C receptors. Brain Res 865:85\u201390", "journal-title": "Brain Res"}, {"key": "1996_CR24", "doi-asserted-by": "crossref", "first-page": "418", "DOI": "10.1111/j.1471-4159.2004.02337.x", "volume": "89", "author": "V Matteo Di", "year": "2004", "unstructured": "Di Matteo V, Pierucci M, Esposito E (2004) Selective stimulation of serotonin2c receptors blocks the enhancement of striatal and accumbal dopamine release induced by nicotine administration. J Neurochem 89:418\u2013429", "journal-title": "J Neurochem"}, {"key": "1996_CR25", "doi-asserted-by": "crossref", "first-page": "233", "DOI": "10.1002/(SICI)1096-9861(19970728)384:2<233::AID-CNE5>3.0.CO;2-2", "volume": "384", "author": "K Eberle-Wang", "year": "1997", "unstructured": "Eberle-Wang K, Mikeladze Z, Uryu K, Chesselet MF (1997) Pattern of expression of the serotonin2C receptor messenger RNA in the basal ganglia of adult rats. J Comp Neurol 384:233\u2013247", "journal-title": "J Comp Neurol"}, {"key": "1996_CR26", "doi-asserted-by": "crossref", "first-page": "3312", "DOI": "10.1523/JNEUROSCI.22-09-03312.2002", "volume": "22", "author": "BJ Everitt", "year": "2002", "unstructured": "Everitt BJ, Wolf ME (2002) Psychomotor stimulant addiction: a neural systems perspective. J Neurosci 22:3312\u20133320", "journal-title": "J Neurosci"}, {"key": "1996_CR27", "doi-asserted-by": "crossref", "first-page": "745", "DOI": "10.1016/S0091-3057(01)00741-9", "volume": "71", "author": "M Filip", "year": "2002", "unstructured": "Filip M, Cunningham KA (2002) Serotonin 5-HT(2C) receptors in nucleus accumbens regulate expression of the hyperlocomotive and discriminative stimulus effects of cocaine. Pharmacol Biochem Behav 71:745\u2013756", "journal-title": "Pharmacol Biochem Behav"}, {"key": "1996_CR28", "doi-asserted-by": "crossref", "first-page": "734", "DOI": "10.1124/jpet.102.045716", "volume": "306", "author": "M Filip", "year": "2003", "unstructured": "Filip M, Cunningham KA (2003) Hyperlocomotive and discriminative stimulus effects of cocaine are under the control of serotonin(2C) (5-HT(2C)) receptors in rat prefrontal cortex. J Pharmacol Exp Ther 306:734\u2013743", "journal-title": "J Pharmacol Exp Ther"}, {"key": "1996_CR29", "doi-asserted-by": "crossref", "first-page": "1246", "DOI": "10.1124/jpet.104.068841", "volume": "310", "author": "M Filip", "year": "2004", "unstructured": "Filip M, Bubar MJ, Cunningham KA (2004) Contribution of serotonin (5-hydroxytryptamine; 5-HT) 5-HT2 receptor subtypes to the hyperlocomotor effects of cocaine: acute and chronic pharmacological analyses. J Pharmacol Exp Ther 310:1246\u20131254", "journal-title": "J Pharmacol Exp Ther"}, {"key": "1996_CR30", "first-page": "576", "volume": "27", "author": "PJ Fletcher", "year": "2002", "unstructured": "Fletcher PJ, Grottick AJ, Higgins GA (2002) Differential effects of the 5-HT(2A) receptor antagonist M100907 and the 5-HT2C receptor antagonist SB242084 on cocaine-induced locomotor activity, cocaine self-administration and cocaine-induced reinstatement of responding. Neuropsychopharmacology 27:576\u2013586", "journal-title": "Neuropsychopharmacology"}, {"key": "1996_CR31", "doi-asserted-by": "crossref", "first-page": "308", "DOI": "10.1038/sj.npp.1300319", "volume": "29", "author": "PJ Fletcher", "year": "2004", "unstructured": "Fletcher PJ, Chintoh AF, Sinyard J, Higgins GA (2004) Injection of the 5-HT2C receptor agonist Ro60-0175 into the ventral tegmental area reduces cocaine-induced locomotor activity and cocaine self-administration. Neuropsychopharmacology 29:308\u2013318", "journal-title": "Neuropsychopharmacology"}, {"key": "1996_CR32", "doi-asserted-by": "crossref", "first-page": "515", "DOI": "10.1007/s00213-006-0453-9", "volume": "187", "author": "PJ Fletcher", "year": "2006", "unstructured": "Fletcher PJ, Sinyard J, Higgins GA (2006) The effects of the 5-HT(2C) receptor antagonist SB242084 on locomotor activity induced by selective, or mixed, indirect serotonergic and dopaminergic agonists. Psychopharmacology (Berl) 187:515\u2013525", "journal-title": "Psychopharmacology (Berl)"}, {"key": "1996_CR33", "doi-asserted-by": "crossref", "first-page": "1402", "DOI": "10.1038/sj.npp.1301509", "volume": "33", "author": "PJ Fletcher", "year": "2008", "unstructured": "Fletcher PJ, Rizos Z, Sinyard J, Tampakeras M, Higgins GA (2008) The 5-HT2C receptor agonist Ro60-0175 reduces cocaine self-administration and reinstatement induced by the stressor yohimbine, and contextual cues. Neuropsychopharmacology 33:1402\u20131412", "journal-title": "Neuropsychopharmacology"}, {"key": "1996_CR34", "doi-asserted-by": "crossref", "first-page": "231", "DOI": "10.1016/0006-8993(89)91362-0", "volume": "504", "author": "SD Glick", "year": "1989", "unstructured": "Glick SD, Carlson JN (1989) Regional changes in brain dopamine and serotonin metabolism induced by conditioned circling in rats: effects of water deprivation, learning and individual differences in asymmetry. Brain Res 504:231\u2013237", "journal-title": "Brain Res"}, {"key": "1996_CR35", "doi-asserted-by": "crossref", "first-page": "205", "DOI": "10.1002/(SICI)1098-2396(20000601)36:3<205::AID-SYN5>3.0.CO;2-D", "volume": "36", "author": "A Gobert", "year": "2000", "unstructured": "Gobert A, Rivet JM, Lejeune F, Newman-Tancredi A, Adhumeau-Auclair A, Nicolas JP et al (2000) Serotonin2C receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: a combined dialysis and electrophysiological analysis in the rat. Synapse 36:205\u2013221", "journal-title": "Synapse"}, {"key": "1996_CR36", "first-page": "1183", "volume": "295", "author": "AJ Grottick", "year": "2000", "unstructured": "Grottick AJ, Fletcher PJ, Higgins GA (2000) Studies to investigate the role of 5-HT2C receptors on cocaine- and food-maintained behavior. J Pharmacol Exp Ther 295:1183\u20131191", "journal-title": "J Pharmacol Exp Ther"}, {"key": "1996_CR37", "doi-asserted-by": "crossref", "first-page": "7509", "DOI": "10.1523/JNEUROSCI.22-17-07509.2002", "volume": "22", "author": "H Hasuo", "year": "2002", "unstructured": "Hasuo H, Matsuoka T, Akasu T (2002) Activation of presynaptic 5-hydroxytryptamine 2A receptors facilitates excitatory synaptic transmission via protein kinase C in the dorsolateral septal nucleus. J Neurosci 22:7509\u20137517", "journal-title": "J Neurosci"}, {"key": "1996_CR38", "first-page": "389", "volume": "9", "author": "PW Kalivas", "year": "2007", "unstructured": "Kalivas PW (2007) Cocaine and amphetamine-like psychostimulants: neurocircuitry and glutamate neuroplasticity. Dialogues Clin Neurosci 9:389\u2013397", "journal-title": "Dialogues Clin Neurosci"}, {"key": "1996_CR39", "doi-asserted-by": "crossref", "first-page": "49", "DOI": "10.1177/026988119801200107", "volume": "12", "author": "PW Kalivas", "year": "1998", "unstructured": "Kalivas PW, Pierce RC, Cornish J, Sorg BA (1998) A role for sensitization in craving and relapse in cocaine addiction. J Psychopharmacol 12:49\u201353", "journal-title": "J Psychopharmacol"}, {"key": "1996_CR40", "first-page": "968", "volume": "277", "author": "JH Kehne", "year": "1996", "unstructured": "Kehne JH, Baron BM, Carr AA, Chaney SF, Elands J, Feldman DJ, Frank RA, van Giersbergen PL, McCloskey TC, Johnson MP, McCarty DR, Poirot M, Senyah Y, Siegel BW, Widmaier C (1996) Preclinical characterization of the potential of the putative atypical antipsychotic MDL 100, 907 as a potent 5-HT2A antagonist with a favorable CNS safety profile. J Pharmacol Exp Ther 277:968\u2013981", "journal-title": "J Pharmacol Exp Ther"}, {"key": "1996_CR41", "doi-asserted-by": "crossref", "first-page": "609", "DOI": "10.1016/S0028-3908(97)00038-5", "volume": "36", "author": "GA Kennett", "year": "1997", "unstructured": "Kennett GA, Wood MD, Bright F, Trail B, Riley G, Holland V, Avenell KY, Stean T, Upton N, Bromidge S, Forbes IT, Brown AM, Middlemiss DN, Blackburn TP (1997) SB 242084, a selective and brain penetrant 5-HT2C receptor antagonist. Neuropharmacology 36:609\u2013620", "journal-title": "Neuropharmacology"}, {"key": "1996_CR42", "doi-asserted-by": "crossref", "first-page": "34", "DOI": "10.1016/S0006-8993(00)02468-9", "volume": "873", "author": "R Liu", "year": "2000", "unstructured": "Liu R, Jolas T, Aghajanian G (2000) Serotonin 5-HT(2) receptors activate local GABA inhibitory inputs to serotonergic neurons of the dorsal raphe nucleus. Brain Res 873:34\u201345", "journal-title": "Brain Res"}, {"key": "1996_CR43", "doi-asserted-by": "crossref", "first-page": "12", "DOI": "10.1002/syn.1095", "volume": "42", "author": "JF Lopez-Gimenez", "year": "2001", "unstructured": "Lopez-Gimenez JF, Mengod G, Palacios JM, Vilaro MT (2001) Regional distribution and cellular localization of 5-HT2C receptor mRNA in monkey brain: comparison with [3H]mesulergine binding sites and choline acetyltransferase mRNA. Synapse 42:12\u201326", "journal-title": "Synapse"}, {"key": "1996_CR44", "doi-asserted-by": "crossref", "first-page": "137", "DOI": "10.1016/0014-2999(94)90502-9", "volume": "259", "author": "GJ Marek", "year": "1994", "unstructured": "Marek GJ, Aghajanian GK (1994) Excitation of interneurons in piriform cortex by 5-hydroxytryptamine: blockade by MDL 100, 907, a highly selective 5-HT2A receptor antagonist. Eur J Pharmacol 259:137\u2013141", "journal-title": "Eur J Pharmacol"}, {"key": "1996_CR45", "doi-asserted-by": "crossref", "first-page": "197", "DOI": "10.1016/S0014-2999(98)00945-5", "volume": "367", "author": "GJ Marek", "year": "1999", "unstructured": "Marek GJ, Aghajanian GK (1999) 5-HT2A receptor or alpha1-adrenoceptor activation induces excitatory postsynaptic currents in layer V pyramidal cells of the medial prefrontal cortex. Eur J Pharmacol 367:197\u2013206", "journal-title": "Eur J Pharmacol"}, {"key": "1996_CR46", "doi-asserted-by": "crossref", "first-page": "379", "DOI": "10.1016/S0306-4522(01)00199-3", "volume": "105", "author": "GJ Marek", "year": "2001", "unstructured": "Marek GJ, Wright RA, Gewirtz JC, Schoepp DD (2001) A major role for thalamocortical afferents in serotonergic hallucinogen receptor function in the rat neocortex. Neuroscience 105:379\u2013392", "journal-title": "Neuroscience"}, {"key": "1996_CR47", "doi-asserted-by": "crossref", "first-page": "256", "DOI": "10.1016/j.neulet.2006.05.021", "volume": "403", "author": "GJ Marek", "year": "2006", "unstructured": "Marek GJ, Wright RA, Schoepp DD (2006) 5-Hydroxytryptamine2A (5-HT2A) receptor regulation in rat prefrontal cortex: interaction of a phenethylamine hallucinogen and the metabotropic glutamate2/3 receptor agonist LY354740. Neurosci Lett 403:256\u2013260", "journal-title": "Neurosci Lett"}, {"key": "1996_CR48", "doi-asserted-by": "crossref", "first-page": "9856", "DOI": "10.1523/JNEUROSCI.21-24-09856.2001", "volume": "21", "author": "R Mart\u00edn-Ruiz", "year": "2001", "unstructured": "Mart\u00edn-Ruiz R, Puig MV, Celada P, Shapiro DA, Roth BL, Mengod G, Artigas F (2001) Control of serotonergic function in medial prefrontal cortex by serotonin-2A receptors through a glutamate-dependent mechanism. J Neurosci 21:9856\u20139866", "journal-title": "J Neurosci"}, {"key": "1996_CR49", "first-page": "357", "volume": "297", "author": "LR McMahon", "year": "2001", "unstructured": "McMahon LR, Cunningham KA (2001) Antagonism of 5-hydroxytryptamine(2a) receptors attenuates the behavioral effects of cocaine in rats. J Pharmacol Exp Ther 297:357\u2013363", "journal-title": "J Pharmacol Exp Ther"}, {"key": "1996_CR50", "doi-asserted-by": "crossref", "first-page": "7781", "DOI": "10.1523/JNEUROSCI.21-19-07781.2001", "volume": "21", "author": "LR McMahon", "year": "2001", "unstructured": "McMahon LR, Filip M, Cunningham KA (2001) Differential regulation of the mesoaccumbens circuit by serotonin 5-hydroxytryptamine 5-HT2A and 5-HT2C receptors. J Neurosci 21:7781\u20137787", "journal-title": "J Neurosci"}, {"key": "1996_CR51", "doi-asserted-by": "crossref", "first-page": "319", "DOI": "10.1038/sj.npp.1300329", "volume": "29", "author": "S Navailles", "year": "2004", "unstructured": "Navailles S, De Deurwaerd\u00e8re P, Porras G, Spampinato U (2004) In vivo evidence that 5-HT2C receptor antagonist but not agonist modulates cocaine-induced dopamine outflow in the rat nucleus accumbens and striatum. Neuropsychopharmacology 29:319\u2013326", "journal-title": "Neuropsychopharmacology"}, {"key": "1996_CR52", "doi-asserted-by": "crossref", "first-page": "237", "DOI": "10.1038/sj.npp.1301414", "volume": "33", "author": "S Navailles", "year": "2008", "unstructured": "Navailles S, Moison D, Cunningham KA, Spampinato U (2008) Differential regulation of the mesoaccumbens dopamine circuit by serotonin2C receptors in the ventral tegmental area and the nucleus accumbens: an in vivo microdialysis study with cocaine. Neuropsychopharmacology 33:237\u2013246", "journal-title": "Neuropsychopharmacology"}, {"key": "1996_CR53", "doi-asserted-by": "crossref", "first-page": "791", "DOI": "10.1097/FBP.0b013e3282f1c94b", "volume": "18", "author": "JL Neisewander", "year": "2007", "unstructured": "Neisewander JL, Acosta JI (2007) Stimulation of 5-HT2C receptors attenuates cue and cocaine-primed reinstatement of cocaine-seeking behavior in rats. Behav Pharmacol 18:791\u2013800", "journal-title": "Behav Pharmacol"}, {"key": "1996_CR54", "doi-asserted-by": "crossref", "first-page": "237", "DOI": "10.1016/S0091-3057(98)00240-8", "volume": "63", "author": "MF O\u2019Neill", "year": "1999", "unstructured": "O\u2019Neill MF, Heron-Maxwell CL, Shaw G (1999) 5-HT2 receptor antagonism reduces hyperactivity induced by amphetamine, cocaine, and MK-801 but not D1 agonist C-APB. Pharmacol Biochem Behav 63:237\u2013243", "journal-title": "Pharmacol Biochem Behav"}, {"key": "1996_CR55", "doi-asserted-by": "crossref", "first-page": "1611", "DOI": "10.1111/j.1471-4159.1993.tb09794.x", "volume": "61", "author": "LH Parsons", "year": "1993", "unstructured": "Parsons LH, Justice JB Jr (1993) Serotonin and dopamine sensitization in the nucleus accumbens, ventral tegmental area, and dorsal raphe nucleus following repeated cocaine administration. J Neurochem 61:1611\u20131619", "journal-title": "J Neurochem"}, {"key": "1996_CR56", "doi-asserted-by": "crossref", "first-page": "601", "DOI": "10.1016/S0306-4522(99)00011-1", "volume": "92", "author": "M Pasqualetti", "year": "1999", "unstructured": "Pasqualetti M, Ori M, Castagna M, Marazziti D, Cassano GB, Nardi I (1999) Distribution and cellular localization of the serotonin type 2C receptor messenger RNA in human brain. Neuroscience 92:601\u2013611", "journal-title": "Neuroscience"}, {"key": "1996_CR57", "author": "G Paxinos", "year": "2000", "unstructured": "Paxinos G, Watson C (2000) The rat brain in stereotaxic coordinates. Academic, New York", "volume-title": "The rat brain in stereotaxic coordinates"}, {"key": "1996_CR58", "doi-asserted-by": "crossref", "first-page": "109", "DOI": "10.1124/jpet.103.062208", "volume": "309", "author": "M Pierucci", "year": "2004", "unstructured": "Pierucci M, Di Matteo V, Esposito E (2004) Stimulation of serotonin2C receptors blocks the hyperactivation of midbrain dopamine neurons induced by nicotine administration. J Pharmacol Exp Ther 309:109\u2013118", "journal-title": "J Pharmacol Exp Ther"}, {"key": "1996_CR59", "doi-asserted-by": "crossref", "first-page": "311", "DOI": "10.1016/S0893-133X(01)00333-5", "volume": "26", "author": "G Porras", "year": "2002", "unstructured": "Porras G, Di Matteo V, Fracasso C, Lucas G, De Deurwaerd\u00e8re P, Caccia S, Esposito E, Spampinato U (2002) 5-HT2A and 5-HT2C/2B receptor subtypes modulate dopamine release induced in vivo by amphetamine and morphine in both the rat nucleus accumbens and striatum. Neuropsychopharmacology 26:311\u2013324", "journal-title": "Neuropsychopharmacology"}, {"key": "1996_CR60", "author": "RM Post", "first-page": "257", "year": "1988", "unstructured": "Post RM, Weiss SRB (1988) Sensitization and kindling: implications for the evolution of psychiatric symptomatology. In: Kalivas PW, Barnes CD (eds) Sensitization in the nervous system. Telford, New Jersey, pp 257\u2013291", "volume-title": "Sensitization in the nervous system"}, {"issue": "Suppl 2", "key": "1996_CR61", "first-page": "S91", "volume": "95", "author": "TE Robinson", "year": "2000", "unstructured": "Robinson TE, Berridge KC (2000) The psychology and neurobiology of addiction: an incentive-sensitization view. Addiction 95(Suppl 2):S91\u2013S117", "journal-title": "Addiction"}, {"key": "1996_CR62", "doi-asserted-by": "crossref", "first-page": "10039", "DOI": "10.1523/JNEUROSCI.22-22-10039.2002", "volume": "22", "author": "BA Rocha", "year": "2002", "unstructured": "Rocha BA, Goulding EH, O\u2019Dell LE, Mead AN, Coufal NG, Parsons LH, Tecott LH (2002) Enhanced locomotor, reinforcing, and neurochemical effects of cocaine in serotonin 5-hydroxytryptamine 2C receptor mutant mice. J Neurosci 22:10039\u201310045", "journal-title": "J Neurosci"}, {"key": "1996_CR63", "doi-asserted-by": "crossref", "first-page": "65", "DOI": "10.1016/0014-2999(92)90819-P", "volume": "223", "author": "CJ Schmidt", "year": "1992", "unstructured": "Schmidt CJ, Fadayel GM, Sullivan CK, Taylor VL (1992) 5-HT2 receptors exert a state-dependent regulation of dopaminergic function: studies with MDL 100, 907 and the amphetamine analogue, 3,4-methylenedioxymethamphetamine. Eur J Pharmacol 223:65\u201374", "journal-title": "Eur J Pharmacol"}, {"key": "1996_CR64", "doi-asserted-by": "crossref", "first-page": "8846", "DOI": "10.1523/JNEUROSCI.20-23-08846.2000", "volume": "20", "author": "JL Scruggs", "year": "2000", "unstructured": "Scruggs JL, Patel S, Bubser M, Deutch AY (2000) DOI-Induced activation of the cortex: dependence on 5-HT2A heteroceptors on thalamocortical glutamatergic neurons. J Neurosci 20:8846\u20138852", "journal-title": "J Neurosci"}, {"key": "1996_CR65", "doi-asserted-by": "crossref", "first-page": "137", "DOI": "10.1016/S0304-3940(03)00547-0", "volume": "346", "author": "JL Scruggs", "year": "2003", "unstructured": "Scruggs JL, Schmidt D, Deutch AY (2003) The hallucinogen 1-[2,5-dimethoxy-4-iodophenyl]-2-aminopropane (DOI) increases cortical extracellular glutamate levels in rats. Neurosci Lett 346:137\u2013140", "journal-title": "Neurosci Lett"}, {"key": "1996_CR66", "first-page": "27", "volume": "47", "author": "P Seeman", "year": "2002", "unstructured": "Seeman P (2002) Atypical antipsychotics: mechanism of action. Can J Psychiatry 47:27\u201338", "journal-title": "Can J Psychiatry"}, {"key": "1996_CR67", "doi-asserted-by": "crossref", "first-page": "328", "DOI": "10.1002/1098-2396(20001201)38:3<328::AID-SYN12>3.0.CO;2-T", "volume": "38", "author": "C Stein", "year": "2000", "unstructured": "Stein C, Davidowa H, Albrecht D (2000) 5-HT(1A) receptor-mediated inhibition and 5-HT(2) as well as 5-HT(3) receptor-mediated excitation in different subdivisions of the rat amygdala. Synapse 38:328\u2013337", "journal-title": "Synapse"}, {"key": "1996_CR68", "doi-asserted-by": "crossref", "first-page": "329", "DOI": "10.1007/s00213-002-1274-0", "volume": "165", "author": "KK Szumlinski", "year": "2003", "unstructured": "Szumlinski KK, Frys KA, Kalivas PW (2003) Pretreatment with serotonin 5-HT(3) receptor antagonists produces no observable blockade of long-term motor sensitization to cocaine in rats. Psychopharmacology (Berl) 165:329\u2013336", "journal-title": "Psychopharmacology (Berl)"}, {"key": "1996_CR69", "doi-asserted-by": "crossref", "first-page": "1675", "DOI": "10.1038/sj.npp.1300473", "volume": "29", "author": "KK Szumlinski", "year": "2004", "unstructured": "Szumlinski KK, Frys KA, Kalivas PW (2004) Dissociable roles for the dorsal and median raph\u00e9 in the facilitatory effect of 5-HT1A receptor stimulation upon cocaine-induced locomotion and sensitization. Neuropsychopharmacology 29:1675\u20131687", "journal-title": "Neuropsychopharmacology"}, {"key": "1996_CR70", "doi-asserted-by": "crossref", "first-page": "1365", "DOI": "10.1038/sj.npp.1301473", "volume": "33", "author": "KK Szumlinski", "year": "2008", "unstructured": "Szumlinski KK, Ary AW, Lominac KD, Klugmann M, Kippin TE (2008) Accumbens Homer2 overexpression facilitates alcohol-induced neuroplasticity in C57BL/6J mice. Neuropsychopharmacology 33:1365\u20131378", "journal-title": "Neuropsychopharmacology"}, {"key": "1996_CR71", "doi-asserted-by": "crossref", "first-page": "99", "DOI": "10.1007/s002130000493", "volume": "151", "author": "LJ Vanderschuren", "year": "2000", "unstructured": "Vanderschuren LJ, Kalivas PW (2000) Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology (Berl) 151:99\u2013120", "journal-title": "Psychopharmacology (Berl)"}, {"key": "1996_CR72", "doi-asserted-by": "crossref", "first-page": "156", "DOI": "10.1002/syn.20104", "volume": "55", "author": "SJ Wang", "year": "2005", "unstructured": "Wang SJ (2005) Potential antidepressant LY 367265 presynaptically inhibits the release of glutamate in rat cerebral cortex. Synapse 55:156\u2013163", "journal-title": "Synapse"}, {"key": "1996_CR73", "doi-asserted-by": "crossref", "first-page": "1528", "DOI": "10.1002/jnr.21060", "volume": "84", "author": "SJ Wang", "year": "2006", "unstructured": "Wang SJ, Wang KY, Wang WC, Sihra TS (2006) Unexpected inhibitory regulation of glutamate release from rat cerebrocortical nerve terminals by presynaptic 5-hydroxytryptamine-2A receptors. J Neurosci Res 84:1528\u20131542", "journal-title": "J Neurosci Res"}, {"key": "1996_CR74", "doi-asserted-by": "crossref", "first-page": "254", "DOI": "10.1016/S0006-8993(00)02080-1", "volume": "863", "author": "Q Yan", "year": "2000", "unstructured": "Yan Q, Reith ME, Yan S (2000) Enhanced accumbal dopamine release following 5-HT(2A) receptor stimulation in rats pretreated with intermittent cocaine. Brain Res 863:254\u2013258", "journal-title": "Brain Res"}], "container-title": ["Psychopharmacology"], "language": "en", "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1007/s00213-010-1996-3", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 6, 3]], "date-time": "2019-06-03T05:28:39Z", "timestamp": 1559539719000}, "score": 22.478346, "issued": {"date-parts": [[2010, 9, 3]]}, "references-count": 74, "journal-issue": {"published-print": {"date-parts": [[2011, 2]]}, "issue": "2-3"}, "alternative-id": ["1996"], "URL": "http://dx.doi.org/10.1007/s00213-010-1996-3", "relation": {"cites": []}, "ISSN": ["0033-3158", "1432-2072"], "issn-type": [{"value": "0033-3158", "type": "print"}, {"value": "1432-2072", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T10:43:33Z", "timestamp": 1574505813263}, "reference-count": 20, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "4", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Behavioural Pharmacology"], "published-print": {"date-parts": [[2002, 7]]}, "DOI": "10.1097/00008877-200207000-00008", "type": "journal-article", "created": {"date-parts": [[2011, 4, 11]], "date-time": "2011-04-11T10:07:40Z", "timestamp": 1302516460000}, "page": "313-318", "source": "Crossref", "is-referenced-by-count": 22, "title": ["Role of 5-HT2 receptors in the tryptamine-induced 5-HT syndrome in rats"], "prefix": "10.1097", "volume": "13", "author": [{"given": "D.", "family": "Van Oekelen", "sequence": "first", "affiliation": []}, {"given": "A.", "family": "Megens", "sequence": "additional", "affiliation": []}, {"given": "T.", "family": "Meert", "sequence": "additional", "affiliation": []}, {"given": "W.H.M.L.", "family": "Luyten", "sequence": "additional", "affiliation": []}, {"given": "J.E.", "family": "Leysen", "sequence": "additional", "affiliation": []}], "member": "276", "container-title": ["Behavioural Pharmacology"], "language": "en", "link": [{"URL": "http://journals.lww.com/behaviouralpharm/Fulltext/10.1097/00008877-200207000-00008", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 11, 29]], "date-time": "2018-11-29T13:22:47Z", "timestamp": 1543497767000}, "score": 22.346972, "subtitle": [""], "issued": {"date-parts": [[2002, 7]]}, "references-count": 20, "journal-issue": {"issue": "4"}, "URL": "http://dx.doi.org/10.1097/00008877-200207000-00008", "ISSN": ["0955-8810"], "issn-type": [{"value": "0955-8810", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T06:24:41Z", "timestamp": 1574490281349}, "reference-count": 30, "publisher": "Wiley", "issue": "4", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 7397, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[1995, 6]]}, "DOI": "10.1111/j.1476-5381.1995.tb14977.x", "type": "journal-article", "created": {"date-parts": [[2012, 7, 20]], "date-time": "2012-07-20T08:08:03Z", "timestamp": 1342771683000}, "page": "622-628", "source": "Crossref", "is-referenced-by-count": 200, "title": ["The pharmacology and distribution of human 5-hydroxytryptamine2B (5-HT2b) receptor gene products: comparison with 5-HT2a and 5-HT2c receptors"], "prefix": "10.1111", "volume": "115", "author": [{"given": "Douglas W.", "family": "Bonhaus", "sequence": "first", "affiliation": []}, {"given": "Chinh", "family": "Bach", "sequence": "additional", "affiliation": []}, {"given": "Andrea", "family": "DeSouza", "sequence": "additional", "affiliation": []}, {"given": "F.H. Rick", "family": "Salazar", "sequence": "additional", "affiliation": []}, {"given": "Barbara D.", "family": "Matsuoka", "sequence": "additional", "affiliation": []}, {"given": "Patricia", "family": "Zuppan", "sequence": "additional", "affiliation": []}, {"given": "Hardy W.", "family": "Chan", "sequence": "additional", "affiliation": []}, {"given": "Richard M.", "family": "Eglen", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2012, 7, 19]]}, "reference": [{"key": "10.1111/j.1476-5381.1995.tb14977.x-BIB1|cit1", "doi-asserted-by": "crossref", "first-page": "323", "DOI": "10.1111/j.1476-5381.1994.tb13072.x", "article-title": "Further characterization of 5-hydroxytryptamine receptors (the putative 5-HT2b) in rat stomach fundus longitudinal muscle", "volume": "112", "author": "Baxter", "year": "1994a", "journal-title": "Bri. J. Pharmacol."}, {"key": "10.1111/j.1476-5381.1995.tb14977.x-BIB2|cit2", "unstructured": "Baxter , G.S. Murphy , O.E. Ellis , E. Tilford , N. Jones , G.J. Forbes , I. 1994b Identification of a potent and selective antagonist at rat 5-HT 2B receptors 75"}, {"key": "10.1111/j.1476-5381.1995.tb14977.x-BIB3|cit3", "doi-asserted-by": "crossref", "first-page": "248", "DOI": "10.1016/0003-2697(76)90527-3", "article-title": "A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding", "volume": "72", "author": "Bradford", "year": "1979", "journal-title": "Anal. Biochem."}, {"key": "10.1111/j.1476-5381.1995.tb14977.x-BIB4|cit4", "first-page": "881", "article-title": "Relationship between inhibition constant (Ki) and the concentration of inhibitor which causes 50 percent inhibition (IC50) of an enzymatic reaction", "volume": "92", "author": "Cheng", "year": "1973", "journal-title": "Biochem. Pharmacol."}, {"key": "10.1111/j.1476-5381.1995.tb14977.x-BIB5|cit5", "doi-asserted-by": "crossref", "first-page": "393", "DOI": "10.1016/0014-5793(94)00968-6", "article-title": "The human serotonin 5-HT2B receptor: Pharmacological link between 5-HT2 and 5-HT1D receptors", "volume": "352", "author": "Choi", "year": "1994", "journal-title": "FEBS Lett."}, {"key": "10.1111/j.1476-5381.1995.tb14977.x-BIB6|cit6", "first-page": "696", "article-title": "Characterization of 5-Hydroyxytryptamine receptors in rat stomach fundus", "volume": "235", "author": "Clineschmidt", "year": "1985", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "10.1111/j.1476-5381.1995.tb14977.x-BIB7|cit7", "author": "Cohen", "first-page": "201", "year": "1989", "volume-title": "The Peripheral Actions of 5-Hydroxytryptamine."}, {"key": "10.1111/j.1476-5381.1995.tb14977.x-BIB8|cit8", "doi-asserted-by": "crossref", "first-page": "176", "DOI": "10.1097/00005344-198708000-00007", "article-title": "Serotonin receptor activation of phosphoinositide turnover in uterie, fundal, vascular and tracheal smooth muscle", "volume": "10", "author": "Cohen", "year": "1987", "journal-title": "J. Cardiovasc. Pharmacol."}, {"key": "10.1111/j.1476-5381.1995.tb14977.x-BIB9|cit9", "doi-asserted-by": "crossref", "first-page": "7413", "DOI": "10.1073/pnas.84.21.7413", "article-title": "Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure", "volume": "84", "author": "Flegner", "year": "1987", "journal-title": "Proc. Natl. Acad. Sci. U.S.A."}, {"key": "10.1111/j.1476-5381.1995.tb14977.x-BIB10|cit10", "doi-asserted-by": "crossref", "first-page": "3481", "DOI": "10.1002/j.1460-2075.1992.tb05427.x", "article-title": "Cloning and functional characterization of the rat stomach fundus serotonin receptor", "volume": "11", "author": "Foguet", "year": "1992a", "journal-title": "EMBO J."}, {"key": "10.1111/j.1476-5381.1995.tb14977.x-BIB11|cit11", "doi-asserted-by": "crossref", "first-page": "345", "DOI": "10.1097/00001756-199204000-00014", "article-title": "Structure of the mouse 5-HT1C,5-HT2 and stomach fundus serotonin receptor genes", "volume": "3", "author": "Foguet", "year": "1992b", "journal-title": "Neuroreport"}, {"key": "10.1111/j.1476-5381.1995.tb14977.x-BIB12|cit12", "doi-asserted-by": "crossref", "first-page": "1104", "DOI": "10.1021/jm00060a019", "article-title": "N-(1-Methyl-5-indolyl)-N\u2032-(3-pyridyl)urea hydrochloride: the first selective 5-HT1c receptor antagonist", "volume": "36", "author": "Forbes", "year": "1993", "journal-title": "J. Med. Chem."}, {"key": "10.1111/j.1476-5381.1995.tb14977.x-BIB13|cit13", "doi-asserted-by": "crossref", "first-page": "471", "DOI": "10.1007/BF00166737", "article-title": "Endothelium-dependent relaxation of porcine pulmonary arteries via 5-HT1C-like receptors", "volume": "347", "author": "Glusa", "year": "1993", "journal-title": "Naunyn-Schmied Arch. Pharmacol."}, {"key": "10.1111/j.1476-5381.1995.tb14977.x-BIB14|cit14", "first-page": "157", "article-title": "International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin)", "volume": "46", "author": "Hoyer", "year": "1994", "journal-title": "Pharmacol. Rev."}, {"key": "10.1111/j.1476-5381.1995.tb14977.x-BIB15|cit15", "doi-asserted-by": "crossref", "first-page": "324", "DOI": "10.1016/0014-5793(92)80705-L", "article-title": "Site-directed mutagenesis of a single residue changes the binding properties of the serotonin 5-HT2 receptor from a human to a rat pharmacology", "volume": "307", "author": "Kao", "year": "1992", "journal-title": "FEBS Lett."}, {"key": "10.1111/j.1476-5381.1995.tb14977.x-BIB16|cit16", "first-page": "227", "article-title": "Molecular cloning, functional expression, and mRNA tissue distribution of the human 5-hydroxytryptamine2B receptor", "volume": "46", "author": "Kursar", "year": "1994", "journal-title": "Mol. Pharmacol."}, {"key": "10.1111/j.1476-5381.1995.tb14977.x-BIB17|cit17", "first-page": "549", "article-title": "Molecular cloning, functional expression, and pharmacological characterization of a novel serotonin receptor (5-hydroxytryptamine2B) from rat stomach fundus", "volume": "42", "author": "Kursar", "year": "1992", "journal-title": "Mol. Pharmacol."}, {"key": "10.1111/j.1476-5381.1995.tb14977.x-BIB18|cit18", "doi-asserted-by": "crossref", "first-page": "203", "DOI": "10.1016/0014-5793(92)80936-B", "article-title": "New mouse 5-HT2-like receptor. Expression in brain, heart and intestine", "volume": "312", "author": "Loric", "year": "1992", "journal-title": "FEBS Lett."}, {"key": "10.1111/j.1476-5381.1995.tb14977.x-BIB19|cit19", "doi-asserted-by": "crossref", "first-page": "261", "DOI": "10.1016/0028-3908(94)90058-2", "article-title": "Receptors for 5-hydroxytryptamine: current perspectives on classification and nomenclature", "volume": "33", "author": "Martin", "year": "1994", "journal-title": "Neuropharmacol."}, {"key": "10.1111/j.1476-5381.1995.tb14977.x-BIB20|cit20", "doi-asserted-by": "crossref", "first-page": "275", "DOI": "10.1016/0028-3908(94)90059-0", "article-title": "Molecular biology of 5-HT receptors", "volume": "33", "author": "Martin", "year": "1994", "journal-title": "Neuropharmacol."}, {"key": "10.1111/j.1476-5381.1995.tb14977.x-BIB21|cit21", "doi-asserted-by": "crossref", "first-page": "220", "DOI": "10.1016/0003-2697(80)90515-1", "article-title": "LIGAND: a versatile computerized approach for characterization of ligand systems", "volume": "107", "author": "Munson", "year": "1980", "journal-title": "Anal. Biochem."}, {"key": "10.1111/j.1476-5381.1995.tb14977.x-BIB22|cit22", "first-page": "1272", "article-title": "Species differences in the pharmacology of the 5-hydroxytryptamine2 receptor: structurally specific differentiation by ergolines and tryptamines", "volume": "265", "author": "Nelson", "year": "1993", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "10.1111/j.1476-5381.1995.tb14977.x-BIB23|cit23", "doi-asserted-by": "crossref", "first-page": "539", "DOI": "10.1016/0014-2999(84)90057-8", "article-title": "The binding of serotonergic ligands to the porcine choroid plexus: characterization of a new type of serotonin recognition site", "volume": "106", "author": "Pazos", "year": "1984", "journal-title": "Eur. J. Pharmacol."}, {"key": "10.1111/j.1476-5381.1995.tb14977.x-BIB24|cit24", "doi-asserted-by": "crossref", "first-page": "531", "DOI": "10.1016/0014-2999(84)90056-6", "article-title": "Mesulergine, a selective serotonin-2 ligand in the rat cortex, does not label these receptors in porcine and human cortex: evidence for species differences in brain serotonin-2 receptors", "volume": "106", "author": "Pazos", "year": "1985", "journal-title": "Eur. J. Pharmacol."}, {"key": "10.1111/j.1476-5381.1995.tb14977.x-BIB25|cit25", "doi-asserted-by": "crossref", "first-page": "1469", "DOI": "10.1016/0006-291X(91)92105-S", "article-title": "Cloning of the human serotonin 5-HT2 and 5-HT1C receptors", "volume": "181", "author": "Saltzman", "year": "1991", "journal-title": "Biochem. Biophys. Res. Commun."}, {"key": "10.1111/j.1476-5381.1995.tb14977.x-BIB26|cit26", "doi-asserted-by": "crossref", "first-page": "85", "DOI": "10.1016/0014-5793(94)80590-3", "article-title": "Cloning and functional characterization of the human 5-HT2B serotonin receptor", "volume": "342", "author": "Schmuck", "year": "1994", "journal-title": "FEBS Lett."}, {"key": "10.1111/j.1476-5381.1995.tb14977.x-BIB27|cit27", "doi-asserted-by": "crossref", "first-page": "466", "DOI": "10.1128/MCB.8.1.466", "article-title": "Sra promoter: an efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-US segment of human T-cell leukemia virus type 1 long terminal repeat", "volume": "8", "author": "Takebe", "year": "1988", "journal-title": "Mol. Cell. Biol."}, {"key": "10.1111/j.1476-5381.1995.tb14977.x-BIB28|cit28", "doi-asserted-by": "crossref", "first-page": "78", "DOI": "10.1111/j.1476-5381.1959.tb00933.x", "article-title": "The relative activities of some tryptamine analogues on the isolated rat stomach strip preparation", "volume": "14", "author": "Vane", "year": "1959", "journal-title": "Br. J. Pharmacol. Chemother."}, {"key": "10.1111/j.1476-5381.1995.tb14977.x-BIB29|cit29", "first-page": "419", "article-title": "Pharmacological characteristics of the newly cloned rat 5-hydroxytryptamine2F receptor", "volume": "43", "author": "Wainscott", "year": "1993", "journal-title": "Mol. Pharmacol."}, {"key": "10.1111/j.1476-5381.1995.tb14977.x-BIB30|cit30", "doi-asserted-by": "crossref", "first-page": "196", "DOI": "10.1002/jnr.490330203", "article-title": "Gene structure and expression of the mouse 5-HT2receptor", "volume": "33", "author": "Yang", "year": "1992", "journal-title": "J. Neurosci. Res."}], "container-title": ["British Journal of Pharmacology"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1476-5381.1995.tb14977.x", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 7, 1]], "date-time": "2019-07-01T09:37:47Z", "timestamp": 1561973867000}, "score": 22.158142, "issued": {"date-parts": [[1995, 6]]}, "references-count": 30, "journal-issue": {"published-print": {"date-parts": [[1995, 6]]}, "issue": "4"}, "URL": "http://dx.doi.org/10.1111/j.1476-5381.1995.tb14977.x", "relation": {"cites": []}, "ISSN": ["0007-1188"], "issn-type": [{"value": "0007-1188", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T00:24:55Z", "timestamp": 1575246295511}, "publisher-location": "Cham", "reference-count": 54, "publisher": "Springer International Publishing", "isbn-type": [{"value": "9783319704722", "type": "print"}, {"value": "9783319704746", "type": "electronic"}], "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2018, 1, 1]], "date-time": "2018-01-01T00:00:00Z", "timestamp": 1514764800000}, "delay-in-days": 0, "content-version": "unspecified"}], "content-domain": {"domain": ["link.springer.com"], "crossmark-restriction": false}, "published-print": {"date-parts": [[2018]]}, "DOI": "10.1007/978-3-319-70474-6_6", "type": "book-chapter", "created": {"date-parts": [[2018, 2, 14]], "date-time": "2018-02-14T08:33:45Z", "timestamp": 1518597225000}, "page": "137-145", "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Serotonergic Receptor 5-HT2A in the Cardiosympathovagal System"], "prefix": "10.1007", "author": [{"given": "M.", "family": "Kermorgant", "sequence": "first", "affiliation": []}, {"given": "A.", "family": "Pavy-Le Traon", "sequence": "additional", "affiliation": []}, {"given": "J. M.", "family": "Senard", "sequence": "additional", "affiliation": []}, {"given": "D. N.", "family": "Arvanitis", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2018, 2, 15]]}, "reference": [{"issue": "15", "key": "6_CR1", "doi-asserted-by": "crossref", "first-page": "1728", "DOI": "10.1016/j.febslet.2015.05.054", "volume": "589", "author": "R El-Merahbi", "year": "2015", "unstructured": "El-Merahbi R, L\u00f6ffler M, Mayer A, Sumara G (2015) The roles of peripheral serotonin in metabolic homeostasis. FEBS Lett 589(15):1728\u20131734", "journal-title": "FEBS Lett"}, {"issue": "17", "key": "6_CR2", "doi-asserted-by": "crossref", "first-page": "2807", "DOI": "10.1016/0006-2952(84)90699-3", "volume": "33", "author": "F Clerck De", "year": "1984", "unstructured": "De Clerck F, Xhonneux B, Leysen J, Janssen PA (1984) Evidence for functional 5-HT2 receptor sites on human blood platelets. Biochem Pharmacol 33(17):2807\u20132811", "journal-title": "Biochem Pharmacol"}, {"issue": "12", "key": "6_CR3", "first-page": "7603", "volume": "260", "author": "D Chaffoy de Courcelles De", "year": "1985", "unstructured": "De Chaffoy de Courcelles D, Leysen JE, De Clerck F, Van Belle H, Janssen PA (1985) Evidence that phospholipid turnover is the signal transducing system coupled to serotonin-S2 receptor sites. J Biol Chem 260(12):7603\u20137608", "journal-title": "J Biol Chem"}, {"issue": "4", "key": "6_CR4", "doi-asserted-by": "crossref", "first-page": "356", "DOI": "10.1055/s-0037-1617140", "volume": "29", "author": "D Duerschmied", "year": "2009", "unstructured": "Duerschmied D, Bode C (2009) The role of serotonin in haemostasis. Hamostaseologie 29(4):356\u2013359", "journal-title": "Hamostaseologie"}, {"issue": "4", "key": "6_CR5", "first-page": "1825", "volume": "158", "author": "DD Henninger", "year": "1997", "unstructured": "Henninger DD, Pan\u00e9s J, Eppihimer M, Russell J, Gerritsen M, Anderson DC, Granger DN (1997) Cytokine-induced VCAM-1 and ICAM-1 expression in different organs of the mouse. J Immunol 158(4):1825\u20131832", "journal-title": "J Immunol"}, {"issue": "1\u20132", "key": "6_CR6", "first-page": "57", "volume": "199", "author": "S Kato", "year": "1998", "unstructured": "Kato S, Kumamoto H, Hirano M, Akiyama H, Kaneko N (1998) Expression of 5-HT2A and 5-HT1B receptor mRNA in blood vessels. Mol Cell Biochem 199(1\u20132):57\u201361", "journal-title": "Mol Cell Biochem"}, {"issue": "5", "key": "6_CR7", "doi-asserted-by": "crossref", "first-page": "599", "DOI": "10.1093/intimm/dxh242", "volume": "17", "author": "T D\u00fcrk", "year": "2005", "unstructured": "D\u00fcrk T, Panther E, M\u00fcller T, Sorichter S, Ferrari D, Pizzirani C, Di Virgilio F, Myrtek D, Norgauer J, Idzko M (2005) 5-Hydroxytryptamine modulates cytokine and chemokine production in LPS-primed human monocytes via stimulation of different 5-HTR subtypes. Int Immunol 17(5):599\u2013606", "journal-title": "Int Immunol"}, {"issue": "3", "key": "6_CR8", "doi-asserted-by": "crossref", "first-page": "674", "DOI": "10.1016/j.pharmthera.2005.12.004", "volume": "111", "author": "AJ Kaumann", "year": "2006", "unstructured": "Kaumann AJ, Levy FO (2006) 5-hydroxytryptamine receptors in the human cardiovascular system. Pharmacol Ther 111(3):674\u2013706", "journal-title": "Pharmacol Ther"}, {"issue": "2", "key": "6_CR9", "doi-asserted-by": "crossref", "first-page": "270", "DOI": "10.1002/cne.10497", "volume": "455", "author": "J Huang", "year": "2003", "unstructured": "Huang J, Pickel VM (2003) Ultrastructural localization of serotonin 2A and N-methyl-D-aspartate receptors in somata and dendrites of single neurons within rat dorsal motor nucleus of the vagus. J Comp Neurol 455(2):270\u2013280", "journal-title": "J Comp Neurol"}, {"key": "6_CR10", "first-page": "225", "volume": "6", "author": "G Zhang", "year": "2015", "unstructured": "Zhang G, Stackman RW Jr (2015) The role of serotonin 5-HT2A receptors in memory and cognition. Front Pharmacol 6:225", "journal-title": "Front Pharmacol"}, {"issue": "6", "key": "6_CR11", "doi-asserted-by": "crossref", "first-page": "1307", "DOI": "10.1038/sj.bjp.0702908", "volume": "128", "author": "KN Browning", "year": "1999", "unstructured": "Browning KN, Travagli RA (1999) Characterization of the in vitro effects of 5-hydroxytryptamine (5-HT) on identified neurones of the rat dorsal motor nucleus of the vagus (DMV). Br J Pharmacol 128(6):1307\u20131315", "journal-title": "Br J Pharmacol"}, {"issue": "46", "key": "6_CR12", "doi-asserted-by": "crossref", "first-page": "16530", "DOI": "10.1523/JNEUROSCI.1372-12.2012", "volume": "32", "author": "RJ Cui", "year": "2012", "unstructured": "Cui RJ, Roberts BL, Zhao H, Zhu M, Appleyard SM (2012) Serotonin activates catecholamine neurons in the solitary tract nucleus by increasing spontaneous glutamate inputs. J Neurosci 32(46):16530\u201316538", "journal-title": "J Neurosci"}, {"issue": "5", "key": "6_CR13", "doi-asserted-by": "crossref", "first-page": "447", "DOI": "10.1007/BF00169132", "volume": "349", "author": "PD Feldman", "year": "1994", "unstructured": "Feldman PD (1994) Electrophysiological effects of serotonin in the solitary tract nucleus of the rat. Naunyn Schmiedeberg\u2019s Arch Pharmacol 349(5):447\u2013454", "journal-title": "Naunyn Schmiedeberg\u2019s Arch Pharmacol"}, {"issue": "1\u20132", "key": "6_CR14", "doi-asserted-by": "crossref", "first-page": "119", "DOI": "10.1016/0165-1838(95)00054-3", "volume": "56", "author": "PD Feldman", "year": "1995", "unstructured": "Feldman PD (1995) Effects of serotonin-1 and serotonin-2 receptor agonists on neuronal activity in the nucleus tractus solitarius. J Auton Nerv Syst 56(1\u20132):119\u2013124", "journal-title": "J Auton Nerv Syst"}, {"issue": "10", "key": "6_CR15", "doi-asserted-by": "crossref", "first-page": "2469", "DOI": "10.1016/0306-4522(82)90208-1", "volume": "7", "author": "B Maley", "year": "1982", "unstructured": "Maley B, Elde R (1982) Immunohistochemical localization of putative neurotransmitters within the feline nucleus tractus solitarii. Neuroscience 7(10):2469\u20132490", "journal-title": "Neuroscience"}, {"issue": "2", "key": "6_CR16", "doi-asserted-by": "crossref", "first-page": "291", "DOI": "10.1002/cne.902250212", "volume": "225", "author": "VM Pickel", "year": "1984", "unstructured": "Pickel VM, Joh TH, Chan J, Beaudet A (1984) Serotoninergic terminals: ultrastructure and synaptic interaction with catecholamine-containing neurons in the medial nuclei of the solitary tracts. J Comp Neurol 225(2):291\u2013301", "journal-title": "J Comp Neurol"}, {"issue": "4", "key": "6_CR17", "doi-asserted-by": "crossref", "first-page": "557", "DOI": "10.1016/0306-4522(81)90146-9", "volume": "6", "author": "HW Steinbusch", "year": "1981", "unstructured": "Steinbusch HW (1981) Distribution of serotonin immunoreactivity in the central nervous system of the rat-cell bodies and terminals. Neuroscience 6(4):557\u2013618", "journal-title": "Neuroscience"}, {"issue": "1", "key": "6_CR18", "doi-asserted-by": "crossref", "first-page": "135", "DOI": "10.1016/0006-8993(85)90900-X", "volume": "347", "author": "L Calz\u00e0", "year": "1985", "unstructured": "Calz\u00e0 L, Giardino L, Grimaldi R, Rigoli M, Steinbusch HW, Tiengo M (1985) Presence of 5-HT-positive neurons in the medial nuclei of the solitary tract. Brain Res 347(1):135\u2013139", "journal-title": "Brain Res"}, {"issue": "1", "key": "6_CR19", "doi-asserted-by": "crossref", "first-page": "39", "DOI": "10.1007/s12576-012-0229-4", "volume": "63", "author": "JT Curtis", "year": "2013", "unstructured": "Curtis JT, Anderson MB, Curtis KS (2013) Regional differences in serotonin content in the nucleus of the solitary tract of male rats after hypovolemia produced by polyethylene glycol. J Physiol Sci 63(1):39\u201346", "journal-title": "J Physiol Sci"}, {"issue": "2", "key": "6_CR20", "doi-asserted-by": "crossref", "first-page": "275", "DOI": "10.1002/cne.902650210", "volume": "265", "author": "KB Thor", "year": "1987", "unstructured": "Thor KB, Helke CJ (1987) Serotonin- and substance P-containing to the nucleus tractus solitarii of the rat. J Comp Neurol 265(2):275\u2013293", "journal-title": "J Comp Neurol"}, {"issue": "3", "key": "6_CR21", "doi-asserted-by": "crossref", "first-page": "951", "DOI": "10.1016/0306-4522(88)90111-X", "volume": "26", "author": "N Schaffar", "year": "1988", "unstructured": "Schaffar N, Kessler JP, Bosler O, Jean A (1988) Central serotonergic projections to the nucleus tractus solitarii: evidence from a double labeling study in the rat. Neuroscience 26(3):951\u2013958", "journal-title": "Neuroscience"}, {"issue": "1", "key": "6_CR22", "doi-asserted-by": "crossref", "first-page": "22", "DOI": "10.1016/0304-3940(90)90422-6", "volume": "114", "author": "A Nosjean", "year": "1990", "unstructured": "Nosjean A, Compoint C, Buisseret-Delmas C, Orer HS, Merahi N, Puizillout JJ, Laguzzi R (1990) Serotonergic projections from the nodose ganglia to the nucleus tractus solitarius: an immunohistochemical and double labeling study in the rat. Neurosci Lett 114(1):22\u201326", "journal-title": "Neurosci Lett"}, {"key": "6_CR23", "doi-asserted-by": "crossref", "first-page": "195", "DOI": "10.1016/0306-4522(94)90110-4", "volume": "59", "author": "RM Sykes", "year": "1994", "unstructured": "Sykes RM, Spyer KM, Izzo PN (1994) Central distribution of substance P, calcitonin gene-related peptide and 5-hydroxytryptamine in vagal sensory afferents in the rat dorsal medulla. Neuroscience 59:195\u2013210", "journal-title": "Neuroscience"}, {"issue": "3", "key": "6_CR24", "doi-asserted-by": "crossref", "first-page": "344", "DOI": "10.1002/cne.902340306", "volume": "234", "author": "RE Shapiro", "year": "1985", "unstructured": "Shapiro RE, Miselis RR (1985) The central neural connections of the area postrema of the rat. J Comp Neurol 234(3):344\u2013364", "journal-title": "J Comp Neurol"}, {"issue": "2", "key": "6_CR25", "doi-asserted-by": "crossref", "first-page": "175", "DOI": "10.1113/expphysiol.2004.029058", "volume": "90", "author": "D Jordan", "year": "2005", "unstructured": "Jordan D (2005) Vagal control of the heart: central serotonergic (5-HT) mechanisms. Exp Physiol 90(2):175\u2013181", "journal-title": "Exp Physiol"}, {"key": "6_CR26", "doi-asserted-by": "crossref", "first-page": "27", "DOI": "10.1016/j.brainres.2013.09.006", "volume": "1537", "author": "JR Austgen", "year": "2013", "unstructured": "Austgen JR, Kline DD (2013) Endocannabinoids blunt the augmentation of synaptic transmission by serotonin 2A receptors in the nucleus tractus solitarii (nTS). Brain Res 1537:27\u201336", "journal-title": "Brain Res"}, {"issue": "1\u20132", "key": "6_CR27", "doi-asserted-by": "crossref", "first-page": "82", "DOI": "10.1016/j.autneu.2009.05.243", "volume": "150", "author": "DT Brozoski", "year": "2009", "unstructured": "Brozoski DT, Dean C, Hopp FA, Hillard CJ, Seagard JL (2009) Differential endocannabinoid regulation of baroreflex-evoked sympathoinhibition in normotensive versus hypertensive rats. Auton Neurosci 150(1\u20132):82\u201393", "journal-title": "Auton Neurosci"}, {"issue": "1", "key": "6_CR28", "doi-asserted-by": "crossref", "first-page": "309", "DOI": "10.1152/physrev.00019.2008", "volume": "89", "author": "M Kano", "year": "2009", "unstructured": "Kano M, Ohno-Shosaku T, Hashimotodani Y, Uchigashima M, Watanabe M (2009) Endocannabinoid-mediated control of synaptic transmission. Physiol Rev 89(1):309\u2013380", "journal-title": "Physiol Rev"}, {"issue": "8", "key": "6_CR29", "doi-asserted-by": "crossref", "first-page": "451", "DOI": "10.1038/nrcardio.2015.96", "volume": "12", "author": "RG Victor", "year": "2015", "unstructured": "Victor RG (2015) Carotid baroreflex activation therapy for resistant hypertension. Nat Rev Cardiol 12(8):451\u2013463", "journal-title": "Nat Rev Cardiol"}, {"key": "6_CR30", "author": "HN Sapru", "first-page": "195", "year": "1991", "unstructured": "Sapru HN (1991) Baroreceptor reflex components and their alteration in hypertension. In: Zucker IH, Gilmore JP (eds) Reflex control of circulation. CRC, Boca Raton, pp 195\u2013214", "volume-title": "Reflex control of circulation"}, {"issue": "2", "key": "6_CR31", "doi-asserted-by": "crossref", "first-page": "107", "DOI": "10.1016/S0361-9230(99)00233-6", "volume": "51", "author": "SA Aicher", "year": "2000", "unstructured": "Aicher SA, Milner TA, Pickel VM, Reis DJ (2000) Anatomical substrates for baroreflex sympathoinhibition in the rat. Brain Res Bull 51(2):107\u2013110", "journal-title": "Brain Res Bull"}, {"issue": "2", "key": "6_CR32", "doi-asserted-by": "crossref", "first-page": "323", "DOI": "10.1152/physrev.1994.74.2.323", "volume": "74", "author": "RAL Dampney", "year": "1994", "unstructured": "Dampney RAL (1994) Functional organization of central pathways regulating the cardiovascular system. Physiol Rev 74(2):323\u2013364", "journal-title": "Physiol Rev"}, {"issue": "4", "key": "6_CR33", "doi-asserted-by": "crossref", "first-page": "261", "DOI": "10.1046/j.1440-1681.2002.03640.x", "volume": "29", "author": "RAL Dampney", "year": "2002", "unstructured": "Dampney RAL, Coleman MJ, Fontes MAP, Hirooka Y, Horiuchi J, Li YW, Polson JW, Potts PD, Tagawa T (2002) Central mechanisms underlying short- and long-term regulation of the cardiovascular system. Clin Exp Pharmacol Physiol 29(4):261\u2013268", "journal-title": "Clin Exp Pharmacol Physiol"}, {"issue": "10", "key": "6_CR34", "doi-asserted-by": "crossref", "first-page": "356", "DOI": "10.1016/S0165-6147(96)80009-5", "volume": "17", "author": "N Singewald", "year": "1996", "unstructured": "Singewald N, Philippu A (1996) Involvement of biogenic amines and amino acids in the central regulation of cardiovascular homeostasis. Trends Pharmacol Sci 17(10):356\u2013363", "journal-title": "Trends Pharmacol Sci"}, {"issue": "2", "key": "6_CR35", "doi-asserted-by": "crossref", "first-page": "R284", "DOI": "10.1152/ajpregu.00219.2002", "volume": "283", "author": "HM Stauss", "year": "2002", "unstructured": "Stauss HM (2002) Baroreceptor reflex function. Am J Physiol Regul Integr Comp Physiol 283(2):R284\u2013R286", "journal-title": "Am J Physiol Regul Integr Comp Physiol"}, {"issue": "3", "key": "6_CR36", "doi-asserted-by": "crossref", "first-page": "530", "DOI": "10.1038/sj.bjp.0702822", "volume": "128", "author": "ID Knowles", "year": "1999", "unstructured": "Knowles ID, Ramage AG (1999) Evidence for a role for central 5-HT2B as well as 5-HT2A receptors in cardiovascular regulation in anaesthetized rats. Br J Pharmacol 128(3):530\u2013542", "journal-title": "Br J Pharmacol"}, {"issue": "2\u20133", "key": "6_CR37", "doi-asserted-by": "crossref", "first-page": "283", "DOI": "10.1016/0014-2999(86)90617-5", "volume": "132", "author": "A Shvaloff", "year": "1986", "unstructured": "Shvaloff A, Laguzzi R (1986) Serotonin receptors in the rat nucleus tractus solitarii and cardiovascular regulation. Eur J Pharmacol 132(2\u20133):283\u2013288", "journal-title": "Eur J Pharmacol"}, {"key": "6_CR38", "unstructured": "Sevoz-Couche C (2006) Cardiac baroreflex facilitation evoked by hypothalamus and prefrontal cortex stimulation: role of the nucleus tractus solitarius 5-HT2A receptors. AJP: Regul Integr Comp Physiol 291(4):R1007-R1015", "DOI": "10.1152/ajpregu.00052.2006", "doi-asserted-by": "crossref"}, {"issue": "2", "key": "6_CR39", "doi-asserted-by": "crossref", "first-page": "345", "DOI": "10.1111/j.1460-9568.2007.05673.x", "volume": "26", "author": "MA Comet", "year": "2007", "unstructured": "Comet MA, Vernard JF, Hamon M, Laguzzi R, S\u00e9voz-Couche C (2007) Activation of nucleus tractus solitarius 5-HT2A but not other 5-HT2 receptor subtypes inhibits the sympathetic activity in rats. Eur J Neurosci 26(2):345\u2013354", "journal-title": "Eur J Neurosci"}, {"issue": "8", "key": "6_CR40", "doi-asserted-by": "crossref", "first-page": "702", "DOI": "10.1111/j.1440-1681.2007.04626.x", "volume": "34", "author": "FM Shen", "year": "2007", "unstructured": "Shen FM, Wang J, Ni CR, JG Y, Wang WZ, DF S (2007) Ketanserin-induced baroreflex enhancement in spontaneously hypertensive rats depends on central 5-HT(2A) receptors. Clin Exp Pharmacol Physiol 34(8):702\u2013707", "journal-title": "Clin Exp Pharmacol Physiol"}, {"issue": "3", "key": "6_CR41", "first-page": "231", "volume": "46", "author": "RB Mc Call", "year": "1994", "unstructured": "Mc Call RB, Clement ME (1994) Role of serotonin1A and serotonin2 receptors in the central regulation of the cardiovascular system. Pharmacol Rev 46(3):231\u2013243", "journal-title": "Pharmacol Rev"}, {"issue": "5", "key": "6_CR42", "doi-asserted-by": "crossref", "first-page": "425", "DOI": "10.1016/S0361-9230(01)00612-8", "volume": "56", "author": "AG Ramage", "year": "2001", "unstructured": "Ramage AG (2001) Central cardiovascular regulation and 5-hydroxytryptamine receptors. Brain Res Bull 56(5):425\u2013439", "journal-title": "Brain Res Bull"}, {"issue": "17", "key": "6_CR43", "doi-asserted-by": "crossref", "first-page": "2365", "DOI": "10.1097/00001756-200212030-00039", "volume": "13", "author": "A Nosjean", "year": "2002", "unstructured": "Nosjean A, Hamon M, Darmon M (2002) 5-HT2A receptors are expressed by catecholaminergic neurons in the rat nucleus tractus solitarii. Neuroreport 13(17):2365\u20132369", "journal-title": "Neuroreport"}, {"issue": "11", "key": "6_CR44", "doi-asserted-by": "crossref", "first-page": "1069", "DOI": "10.2174/138945009789735156", "volume": "10", "author": "BP Guiard", "year": "2009", "unstructured": "Guiard BP, El Mansari M, Blier P (2009) Prospect of a dopamine contribution in the next generation of antidepressant drugs: the triple reuptake inhibitors. Curr Drug Targets 10(11):1069\u20131084", "journal-title": "Curr Drug Targets"}, {"issue": "1\u20133", "key": "6_CR45", "doi-asserted-by": "crossref", "first-page": "142", "DOI": "10.1016/j.ejphar.2012.02.010", "volume": "682", "author": "Y Mbaki", "year": "2012", "unstructured": "Mbaki Y, Gardiner J, Mc Murray G, Ramage AG (2012) 5-HT 2A receptor activation of the external urethral sphincter and 5-HT 2C receptor inhibition of micturition: a study based on pharmacokinetics in the anaesthetized female rat. Eur J Pharmacol 682(1\u20133):142\u2013152", "journal-title": "Eur J Pharmacol"}, {"issue": "4\u20135", "key": "6_CR46", "doi-asserted-by": "crossref", "first-page": "489", "DOI": "10.1016/S0028-3908(97)00063-4", "volume": "36", "author": "Y Wang", "year": "1997", "unstructured": "Wang Y, Ramage AG, Jordan D (1997) In vivo effects of 5-hydroxytryptamine receptor activation on rat nucleus tractus solitarius neurones excited by vagal C-fibre afferents. Neuropharmacology 36(4\u20135):489\u2013498", "journal-title": "Neuropharmacology"}, {"issue": "7", "key": "6_CR47", "doi-asserted-by": "crossref", "first-page": "1445", "DOI": "10.1038/sj.bjp.0703722", "volume": "131", "author": "C S\u00e9voz-Couche", "year": "2000", "unstructured": "S\u00e9voz-Couche C, Spyer KM, Jordan D (2000) In vivo modulation of vagal-identified dorsal medullary neurones by activation of different 5-Hydroxytryptamine(2) receptors in rats. Br J Pharmacol 131(7):1445\u20131453", "journal-title": "Br J Pharmacol"}, {"issue": "2", "key": "6_CR48", "doi-asserted-by": "crossref", "first-page": "H335", "DOI": "10.1152/ajpheart.00117.2015", "volume": "309", "author": "JE Vantrease", "year": "2015", "unstructured": "Vantrease JE, Dudek N, Don Carlos LL, Scrogin KE (2015) 5-HT1A receptors of the nucleus tractus solitarii facilitate sympathetic recovery following hypotensive hemorrhage in rats. Am J Physiol Heart Circ Physiol 309(2):H335\u2013H344", "journal-title": "Am J Physiol Heart Circ Physiol"}, {"issue": "3", "key": "6_CR49", "doi-asserted-by": "crossref", "first-page": "215", "DOI": "10.1016/0014-5793(95)00828-W", "volume": "370", "author": "C Ullmer", "year": "1995", "unstructured": "Ullmer C, Schmuck K, Kalkman HO, L\u00fcbbert H (1995) Expression of serotonin receptor mRNAs in blood vessels. FEBS Lett 370(3):215\u2013221", "journal-title": "FEBS Lett"}, {"issue": "9", "key": "6_CR50", "doi-asserted-by": "crossref", "first-page": "2870", "DOI": "10.1073/pnas.0308723101", "volume": "101", "author": "E Bush", "year": "2004", "unstructured": "Bush E, Fielitz J, Melvin L, Martinez-Arnold M, Mc Kinsey TA, Plichta R, Olson EN (2004) A small molecular activator of cardiac hypertrophy uncovered in a chemical screen for modifiers of the calcineurin signaling pathway. Proc Natl Acad Sci U S A 101(9):2870\u20132875", "journal-title": "Proc Natl Acad Sci U S A"}, {"issue": "12", "key": "6_CR51", "doi-asserted-by": "crossref", "first-page": "2094", "DOI": "10.1093/cvr/27.12.2094", "volume": "27", "author": "AJ Kaumann", "year": "1993", "unstructured": "Kaumann AJ, Parsons AA, Brown AM (1993) Human arterial constrictor serotonin receptors. Cardiovasc Res 27(12):2094\u20132103", "journal-title": "Cardiovasc Res"}, {"issue": "6", "key": "6_CR52", "doi-asserted-by": "crossref", "first-page": "2209", "DOI": "10.1016/S0002-9440(10)64497-5", "volume": "161", "author": "J Xu", "year": "2002", "unstructured": "Xu J, Jian B, Chu R, Lu Z, Li Q, Dunlop J, Rosenzweig-Lipson S, Mc Gonigle P, Levy RJ, Liang B (2002) Serotonin mechanisms in heart valve disease II\u2014the 5-HT2 receptor and its signaling pathway in aortic valve interstitial cells. Am J Pathol 161(6):2209\u20132218", "journal-title": "Am J Pathol"}, {"issue": "2", "key": "6_CR53", "doi-asserted-by": "crossref", "first-page": "146", "DOI": "10.1016/j.pharmthera.2011.03.008", "volume": "132", "author": "JD Hutcheson", "year": "2011", "unstructured": "Hutcheson JD, Setola V, Roth BL, Merryman WD (2011) Serotonin receptors and heart valve disease\u2014it was meant 2B. Pharmacol Ther 132(2):146\u2013157", "journal-title": "Pharmacol Ther"}, {"issue": "6", "key": "6_CR54", "doi-asserted-by": "crossref", "first-page": "927", "DOI": "10.1007/s00702-013-1011-3", "volume": "120", "author": "O Lairez", "year": "2013", "unstructured": "Lairez O, Cognet T, Schaak S, Calise D, Guilbeau-Frugier C, Parini A, Mialet-Perez J (2013) Role of serotonin 5-HT2A receptors in the development of cardiac hypertrophy in response to aortic constriction in mice. J Neural Transm (Vienna) 120(6):927\u2013935", "journal-title": "J Neural Transm (Vienna)"}], "container-title": ["5-HT2A Receptors in the Central Nervous System"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/978-3-319-70474-6_6", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 10, 10]], "date-time": "2019-10-10T23:20:13Z", "timestamp": 1570749613000}, "score": 21.919415, "issued": {"date-parts": [[2018]]}, "ISBN": ["9783319704722", "9783319704746"], "references-count": 54, "URL": "http://dx.doi.org/10.1007/978-3-319-70474-6_6", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T11:37:52Z", "timestamp": 1574509072168}, "publisher-location": "Berlin, Heidelberg", "reference-count": 166, "publisher": "Springer Berlin Heidelberg", "isbn-type": [{"value": "9783540667155", "type": "print"}, {"value": "9783642609213", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2000]]}, "DOI": "10.1007/978-3-642-60921-3_20", "type": "book-chapter", "created": {"date-parts": [[2012, 10, 6]], "date-time": "2012-10-06T01:46:05Z", "timestamp": 1349487965000}, "page": "537-562", "source": "Crossref", "is-referenced-by-count": 1, "title": ["5-HT Receptors Involved in the Regulation of Hormone Secretion"], "prefix": "10.1007", "author": [{"given": "L. D.", "family": "Van De Kar", "sequence": "first", "affiliation": []}], "member": "297", "reference": [{"key": "20_CR1", "doi-asserted-by": "publisher", "first-page": "157", "DOI": "10.1016/0014-2999(94)90396-4", "volume": "251", "author": "A Albinsson", "year": "1994", "unstructured": "Albinsson A, Palazidou E, Stephenson J, Andersson G (1994) Involvement of the 5-HT2 receptor in the 5-HT receptor-mediated stimulation of prolactin release. Eur J Pharmacol 251:157\u2013161", "journal-title": "Eur J Pharmacol"}, {"key": "20_CR2", "doi-asserted-by": "publisher", "first-page": "323", "DOI": "10.1016/0014-2999(90)90571-M", "volume": "175", "author": "RH Alper", "year": "1990", "unstructured": "Alper RH (1990) Hemodynamic and renin response to (+)-DOI, a selective 5-HT2 receptor agonist, in conscious rats. Eur J Pharmacol 175:323\u2013332", "journal-title": "Eur J Pharmacol"}, {"key": "20_CR3", "first-page": "829", "volume": "243", "author": "RH Alper", "year": "1987", "unstructured": "Alper RH, Snider JM (1987) Activation of serotonin2 (5-HT2) receptors by quipazine increases arterial pressure and renin secretion in conscious rats. J Pharmacol Exp Ther 243:829\u2013833", "journal-title": "J Pharmacol Exp Ther"}, {"key": "20_CR4", "doi-asserted-by": "crossref", "first-page": "R879", "DOI": "10.1152/ajpregu.1994.266.3.R879", "volume": "266", "author": "JL Andersen", "year": "1994", "unstructured": "Andersen JL, Andersen LJ, Thrasher TN, Keil LC, Ramsay DJ (1994) Left heart and arterial baroreceptors interact in control of plasma vasopressin, renin, and Cortisol in awake dogs. Am J Physiol Regul Integr Comp Physiol 266:R879-R888", "journal-title": "Am J Physiol Regul Integr Comp Physiol"}, {"key": "20_CR5", "doi-asserted-by": "publisher", "first-page": "428", "DOI": "10.1007/BF02245430", "volume": "106", "author": "IM Anderson", "year": "1992", "unstructured": "Anderson IM, Cowen PJ (1992) Effect of pindolol on endocrine and temperature responses to buspirone in healthy volunteers. Psychopharmacology 106:428\u2013432", "journal-title": "Psychopharmacology"}, {"key": "20_CR6", "doi-asserted-by": "publisher", "first-page": "126", "DOI": "10.1210/en.130.1.126", "volume": "130", "author": "BJ Arey", "year": "1992", "unstructured": "Arey BJ, Freeman ME (1992) Activity of oxytocinergic neurons in the paraventricular nucleus mirrors the periodicity of the endogenous stimulatory rhythm regulating prolactin secretion. Endocrinology 130:126\u2013132", "journal-title": "Endocrinology"}, {"key": "20_CR7", "first-page": "588", "volume": "263", "author": "CS Aulakh", "year": "1992", "unstructured": "Aulakh CS, Hill JL, Murphy DL (1992) Effects of various serotonin receptor subtype-selective antagonists alone and on m-chlorophenylpiperazine-induced neuroendocrine changes in rats. J Pharmacol Exp Ther 263:588\u2013595", "journal-title": "J Pharmacol Exp Ther"}, {"key": "20_CR8", "first-page": "143", "volume": "271", "author": "CS Aulakh", "year": "1994", "unstructured": "Aulakh CS, Mazzola-Pomietto P, Hill JL, Murphy DL (1994) Role of various 5-HT receptor subtypes in mediating neuroendocrine effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane (DOM) in rats. J Pharmacol Exp Ther 271:143\u2013148", "journal-title": "J Pharmacol Exp Ther"}, {"key": "20_CR9", "doi-asserted-by": "publisher", "first-page": "641", "DOI": "10.1002/cne.901790311", "volume": "179", "author": "EC Azmitia", "year": "1978", "unstructured": "Azmitia EC, Segal M (1978) An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat. J Comp Neurol 179:641\u2013668", "journal-title": "J Comp Neurol"}, {"key": "20_CR10", "first-page": "72", "volume": "250", "author": "G Bagdy", "year": "1989", "unstructured": "Bagdy G, Szemeredi K, Kanyicska B, Murphy DL (1989) Different serotonin receptors mediate blood pressure, heart rate, plasma catecholamine and prolactin responses to m-chlorophenylpiperazine in conscious rats. J Pharmacol Exp Ther 250:72\u201378", "journal-title": "J Pharmacol Exp Ther"}, {"key": "20_CR11", "doi-asserted-by": "publisher", "first-page": "227", "DOI": "10.1016/0006-8993(90)90362-F", "volume": "537", "author": "G Bagdy", "year": "1990", "unstructured": "Bagdy G, Calogero AE, Szemeredi K, Gomez MT, Murphy DL, Chrousos GP, Gold PW (1990) \u03b2-Endorphin responses to different serotonin agonists: involvement of corticotropin-releasing hormone, vasopressin and direct pituitary action. Brain Res 537:227\u2013232", "journal-title": "Brain Res"}, {"key": "20_CR12", "doi-asserted-by": "publisher", "first-page": "9", "DOI": "10.1016/0014-2999(92)90279-D", "volume": "229", "author": "G Bagdy", "year": "1992", "unstructured": "Bagdy G, Kalogeras KT, Szemeredi K (1992a) Effect of 5-HT1C and 5-HT2 receptor stimulation on excessive grooming, penile erection and plasma oxytocin concentrations. Eur J Pharmacol 229:9\u201314", "journal-title": "Eur J Pharmacol"}, {"key": "20_CR13", "doi-asserted-by": "publisher", "first-page": "285", "DOI": "10.1016/0014-2999(92)90417-3", "volume": "210", "author": "G Bagdy", "year": "1992", "unstructured": "Bagdy G, Sved AF, Murphy DL, Szemeredi K (1992b) Pharmacological characterization of serotonin receptor subtypes involved in vasopressin and plasma renin activity responses to serotonin agonists. Eur J Pharmacol 210:285\u2013289", "journal-title": "Eur J Pharmacol"}, {"key": "20_CR14", "doi-asserted-by": "publisher", "first-page": "1573", "DOI": "10.1016/0024-3205(93)90180-B", "volume": "53", "author": "G Bagdy", "year": "1993", "unstructured": "Bagdy G, Szemeredi K, Listwak SJ, Keiser HR, Goldstein DS (1993) Plasma catecholamine, renin activity, and ACTH responses to the serotonin receptor agonist DOI in juvenile spontaneously hypertensive rats. Life Sci 53:1573\u20131582", "journal-title": "Life Sci"}, {"key": "20_CR15", "doi-asserted-by": "publisher", "first-page": "330", "DOI": "10.1016/0006-8993(93)90521-N", "volume": "611", "author": "G Bagdy", "year": "1993", "unstructured": "Bagdy G, Kalogeras KT (1993) Stimulation of 5-HT1A and 5-HT2/5-HT1C receptors induce oxytocin release in the male rat. Brain Res 611:330\u2013332", "journal-title": "Brain Res"}, {"key": "20_CR16", "doi-asserted-by": "publisher", "first-page": "1127", "DOI": "10.1210/en.134.3.1127", "volume": "134", "author": "G Bagdy", "year": "1994", "unstructured": "Bagdy G, Makara GB (1994) Hypothalamic paraventricular nucleus lesions differentially affect serotonin-1A (5-HT 1A) and 5-HT2 receptor agonist-induced oxytocin, prolactin, and corticosterone responses. Endocrinology 134:1127\u20131131", "journal-title": "Endocrinology"}, {"key": "20_CR17", "doi-asserted-by": "publisher", "first-page": "301", "DOI": "10.1016/0014-2999(95)00051-L", "volume": "275", "author": "G Bagdy", "year": "1995", "unstructured": "Bagdy G, Makara GB (1995) Paraventricular nucleus controls 5-HT2C receptor-mediated corticosterone and prolactin but not oxytocin and penile erection responses. Eur J Pharmacol 275:301\u2013305", "journal-title": "Eur J Pharmacol"}, {"key": "20_CR18", "doi-asserted-by": "publisher", "first-page": "1894", "DOI": "10.1210/endo-113-5-1894", "volume": "113", "author": "AL Barofsky", "year": "1983", "unstructured": "Barofsky AL, Taylor J, Massari VJ (1983) Dorsal raphe-hypothalamic projections provide the stimulatory serotoninergic input to suckling-induced prolactin release. Endocrinology 113:1894\u20131903", "journal-title": "Endocrinology"}, {"key": "20_CR19", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.1007/BF02247357", "volume": "112", "author": "JE Barrett", "year": "1993", "unstructured": "Barrett JE, Vanover KE (1993) 5-HT receptors as targets for the development of novel anxiolytic drugs: models, mechanisms and future directions. Psychopharmacology (Berl) 112:1\u201312", "journal-title": "Psychopharmacology"}, {"key": "20_CR20", "doi-asserted-by": "publisher", "first-page": "833", "DOI": "10.1001/archpsyc.1990.01810210041006", "volume": "47", "author": "B Bastani", "year": "1990", "unstructured": "Bastani B, Nash JF, Meltzer HY (1990) Prolactin and Cortisol responses to MK-212, a serotonin agonist, in obsessive-compulsive disorder. Arch Gen Psychiatry 47:833\u2013839", "journal-title": "Arch Gen Psychiatry"}, {"key": "20_CR21", "doi-asserted-by": "crossref", "first-page": "772", "DOI": "10.1152/ajplegacy.1976.231.3.772", "volume": "231", "author": "ML Blair", "year": "1976", "unstructured": "Blair ML, Feigl EO, Smith OA (1976) Elevation of plasma renin activity during avoidance performance in baboons. Am J Physiol 231:772\u2013776", "journal-title": "Am J Physiol"}, {"key": "20_CR22", "doi-asserted-by": "publisher", "first-page": "159", "DOI": "10.1159/000126836", "volume": "61", "author": "MT Bluet Pajot", "year": "1995", "unstructured": "Bluet Pajot MT, Mounier F, Di Sciullo A, Schmidt B, Kordon C (1995) Differential sites of action of 8-OH-DPAT, a 5-HT1A agonist, on ACTH and PRL secretion in the rat. Neuroendocrinology 61:159\u2013166", "journal-title": "Neuroendocrinology"}, {"key": "20_CR23", "doi-asserted-by": "publisher", "first-page": "275", "DOI": "10.1016/0028-3908(94)90059-0", "volume": "33", "author": "FG Boess", "year": "1994", "unstructured": "Boess FG, Martin IL (1994) Molecular biology of 5-HT receptors. Neuropharmacology 33:275\u2013317", "journal-title": "Neuropharmacology"}, {"key": "20_CR24", "doi-asserted-by": "publisher", "first-page": "387", "DOI": "10.1097/00002826-199310000-00002", "volume": "16", "author": "M Briley", "year": "1993", "unstructured": "Briley M, Moret C (1993) Neurobiological mechanisms involved in antidepressant therapies. Clin Neuropharmacol 16:387\u2013400", "journal-title": "Clin Neuropharmacol"}, {"key": "20_CR25", "doi-asserted-by": "publisher", "first-page": "277", "DOI": "10.1159/000124925", "volume": "47", "author": "MS Brownfield", "year": "1988", "unstructured": "Brownfield MS, Greathouse J, Lorens SA, Armstrong J, Urban JH, Van de Kar LD (1988) Neuropharmacological characterization of serotoninergic stimulation of vasopressin secretion in conscious rats. Neuroendocrinology 47:277\u2013283", "journal-title": "Neuroendocrinology"}, {"key": "20_CR26", "first-page": "823", "volume": "18", "author": "MS Brownfield", "year": "1992", "unstructured": "Brownfield MS, Armstrong J, Rittenhouse PA, Li Q, Levy AD, Van de Kar LD (1992) Pharmacological differentiation of serotonergic (5-HT) stimulation of oxytocin and vasopressin secretion in the conscious rat. Neurosci Abstr 18:823 (#346.7)", "journal-title": "Neurosci Abstr"}, {"key": "20_CR27", "doi-asserted-by": "publisher", "first-page": "8", "DOI": "10.1016/0006-8993(92)91499-5", "volume": "597", "author": "MF Callahan", "year": "1992", "unstructured": "Callahan MF, Thore CR, Sundberg DK, Gruber KA, O\u2019Steen K, Morris M (1992) Excitotoxin paraventricular nucleus lesions: stress and endocrine reactivity and oxytocin mRNA levels. Brain Res 597:8\u201315", "journal-title": "Brain Res"}, {"key": "20_CR28", "doi-asserted-by": "publisher", "first-page": "189", "DOI": "10.1016/0196-9781(89)90096-X", "volume": "10", "author": "AE Calogero", "year": "1989", "unstructured": "Calogero AE, Bernardini R, Margioris AN, Bagdy G, Gallucci WT, Tamarkin L, Tomai TP (1989) Effect of serotonergic agonists and antagonists on corticotropin-releasing hormone secretion by explanted rat hypothalami. Peptides 10:189\u2013200", "journal-title": "Peptides"}, {"key": "20_CR29", "doi-asserted-by": "publisher", "first-page": "251", "DOI": "10.1530/eje.0.1330251", "volume": "133", "author": "AE Calogero", "year": "1995", "unstructured": "Calogero AE, Bagdy G, Burrello N, Polosa P, D\u2019Agata R (1995) Role for serotonin3 receptors in the control of adrenocorticotropic hormone release from rat pituitary cell cultures. Eur J Endocrinol 133:251\u2013254", "journal-title": "Eur J Endocrinol"}, {"key": "20_CR30", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.1016/0165-0173(93)90005-K", "volume": "18", "author": "F Chaouloff", "year": "1993", "unstructured": "Chaouloff F (1993) Physiopharmacological interactions between stress hormones and central serotonergic systems. Brain Res Rev 18:1\u201332", "journal-title": "Brain Res Rev"}, {"key": "20_CR31", "doi-asserted-by": "publisher", "first-page": "21S", "DOI": "10.1097/00004714-199006001-00005", "volume": "10", "author": "PJ Cowen", "year": "1990", "unstructured": "Cowen PJ, Anderson IM, Grahame-Smith DG (1990) Neuroendocrine effects of azapirones. J Clin Psychopharmacol 10 [Suppl]:21S-25S", "journal-title": "J Clin Psychopharmacol"}, {"key": "20_CR32", "doi-asserted-by": "publisher", "first-page": "372", "DOI": "10.1192/bjp.164.3.372", "volume": "164", "author": "PJ Cowen", "year": "1994", "unstructured": "Cowen PJ, Power AC, Ware CJ, Anderson IM (1994) 5-HT1A receptor sensitivity in major depression. A neuroendocrine study with buspirone. Br J Psychiatry 164:372\u2013379", "journal-title": "Br J Psychiatry"}, {"key": "20_CR33", "doi-asserted-by": "publisher", "first-page": "95", "DOI": "10.1016/0014-2999(94)90642-4", "volume": "264", "author": "DJP Critchley", "year": "1994", "unstructured": "Critchley DJP, Childs KJ, Middlefell VC, Dourish CT (1994) Inhibition of 8-OH-DPAT-induced elevation of plasma corticotrophin by the 5-HT1A receptor antagonist WAY100635. Eur J Pharmacol 264:95\u201397", "journal-title": "Eur J Pharmacol"}, {"key": "20_CR34", "first-page": "33", "volume": "13", "author": "WR Crowley", "year": "1992", "unstructured": "Crowley WR, Armstrong WE (1992) Neurochemical regulation of oxytocin secretion in lactation. Endocr Rev 13:33\u201365", "journal-title": "Endocr Rev"}, {"key": "20_CR35", "doi-asserted-by": "publisher", "first-page": "567", "DOI": "10.1210/endo-127-2-567", "volume": "127", "author": "A Sciullo Di", "year": "1990", "unstructured": "Di Sciullo A, Bluet Pajot MT, Mounier F, Oliver C, Schmidt B, Kordon C (1990) Changes in anterior pituitary hormone levels after serotonin 1A receptor stimulation. Endocrinology 127:567\u2013572", "journal-title": "Endocrinology"}, {"key": "20_CR36", "doi-asserted-by": "publisher", "first-page": "212", "DOI": "10.1016/0165-6147(86)90318-4", "volume": "7", "author": "CT Dourish", "year": "1986", "unstructured": "Dourish CT, Hutson PH, Curzon G (1986) Putative anxiolytics 8-OH-DPAT, buspirone and TVX Q 7821 are agonists at 5-HT1A autoreceptors in the raphe nuclei. Trends Pharmacol Sci 7:212\u2013214", "journal-title": "Trends Pharmacol Sci"}, {"issue": "Suppl 1", "key": "20_CR37", "doi-asserted-by": "publisher", "first-page": "13", "DOI": "10.1159/000284622", "volume": "22", "author": "MS Eison", "year": "1989", "unstructured": "Eison MS (1989) The new generation of serotonergic anxiolytics: possible clinical roles. Psychopathology 22 [Suppl 1]:13\u201320", "journal-title": "Psychopathology"}, {"key": "20_CR38", "doi-asserted-by": "publisher", "first-page": "389", "DOI": "10.1111/j.1365-2125.1995.tb04467.x", "volume": "39", "author": "SJ Entwisle", "year": "1995", "unstructured": "Entwisle SJ, Fowler PA, Thomas M, Eckland DJA, Lettis S, York M, Freedman PS (1995) The effects of oral sumatriptan, a 5-HT1 receptor agonist, on circulating ACTH and Cortisol concentrations in man. Br J Clin Pharmacol 39:389\u2013395", "journal-title": "Br J Clin Pharmacol"}, {"key": "20_CR39", "doi-asserted-by": "publisher", "first-page": "113", "DOI": "10.1016/0306-4530(81)90003-2", "volume": "6", "author": "MIK Fekete", "year": "1981", "unstructured": "Fekete MIK, Szentendrei T, Kanyicska B, Palkovits M (1981) Effects of anxiolytic drugs on the catecholamine and dopac (3, 4-dihydroxyphenylacetic acid) levels in brain cortical areas and on corticosterone and prolactin secretion in rats subjected to stress. Psychoneuroendocrinology 6:113\u2013120", "journal-title": "Psychoneuroendocrinology"}, {"key": "20_CR40", "doi-asserted-by": "publisher", "first-page": "143", "DOI": "10.1016/0304-3940(95)11957-X", "volume": "198", "author": "S Feldman", "year": "1995", "unstructured": "Feldman S, Weidenfeld J (1995) Posterior hypothalamic deafferentiation or 5,7-dihydroxytryptamine inhibit corticotropin-releasing hormone, ACTH and corticosterone responses following photic stimulation. Neurosci Lett 198:143\u2013145", "journal-title": "Neurosci Lett"}, {"key": "20_CR41", "doi-asserted-by": "publisher", "first-page": "661", "DOI": "10.1016/0014-4886(84)90038-4", "volume": "85", "author": "S Feldman", "year": "1984", "unstructured": "Feldman S, Melamed E, Conforti N, Weidenfeld J (1984) Effect of central serotonin depletion on adrenocortical responses to neural stimuli. Exp Neurol 85:661\u2013666", "journal-title": "Exp Neurol"}, {"key": "20_CR42", "doi-asserted-by": "publisher", "first-page": "165", "DOI": "10.1016/0361-9230(87)90186-9", "volume": "18", "author": "S Feldman", "year": "1987", "unstructured": "Feldman S, Conforti N, Melamed E (1987) Paraventricular nucleus serotonin mediates neurally stimulated adrenocortical secretion. Brain Res Bull 18:165\u2013168", "journal-title": "Brain Res Bull"}, {"key": "20_CR43", "doi-asserted-by": "publisher", "first-page": "144", "DOI": "10.1007/BF00229995", "volume": "85", "author": "S Feldman", "year": "1991", "unstructured": "Feldman S, Weidenfeld J, Conforti N, Saphier D (1991) Differential recovery of adrenocortical responses to neural stimuli following administration of 5,7-dihydroxytryptamine into the hypothalamus. Exp Brain Res 85:144\u2013148", "journal-title": "Exp Brain Res"}, {"key": "20_CR44", "doi-asserted-by": "publisher", "first-page": "235", "DOI": "10.1016/0149-7634(94)00062-6", "volume": "19", "author": "S Feldman", "year": "1995", "unstructured": "Feldman S, Conforti N, Weidenfeld J (1995) Limbic pathways and hypothalamic neurotransmitters mediating adrenocortical responses to neural stimuli. Neurosci Biobehav Rev 19:235\u2013240", "journal-title": "Neurosci Biobehav Rev"}, {"key": "20_CR45", "doi-asserted-by": "publisher", "first-page": "235", "DOI": "10.1016/0028-3908(94)90014-0", "volume": "33", "author": "R Franceschini", "year": "1994", "unstructured": "Franceschini R, Cataldi A, Garibaldi A, Cianciosi P, Scordamaglia A, Barreca T, Rolandi E (1994) The effects of sumatriptan on pituitary secretion in man. Neuropharmacology 33:235\u2013239", "journal-title": "Neuropharmacology"}, {"key": "20_CR46", "doi-asserted-by": "publisher", "first-page": "206", "DOI": "10.1159/000125586", "volume": "52", "author": "RW Fuller", "year": "1990", "unstructured": "Fuller RW, Snoddy HD (1990) Serotonin receptor subtypes involved in the elevation of serum corticosterone concentration in rats by direct- and indirect-acting serotonin agonists. Neuroendocrinology 52:206\u2013211", "journal-title": "Neuroendocrinology"}, {"key": "20_CR47", "doi-asserted-by": "publisher", "first-page": "740", "DOI": "10.1016/0006-3223(94)00208-K", "volume": "37", "author": "D Garcia-Borreguero", "year": "1995", "unstructured": "Garcia-Borreguero D, Jacobsen FM, Murphy DL, Joseph-Vanderpool JR, Chiara A, Rosenthal NE (1995) Hormonal responses to the administration of m-chlorophenylpiperazine in patients with seasonal affective disorder and controls. Biol Psychiatry 37:740\u2013749", "journal-title": "Biol Psychiatry"}, {"key": "20_CR48", "doi-asserted-by": "publisher", "first-page": "27", "DOI": "10.1016/0014-2999(92)90768-Y", "volume": "221", "author": "SE Gartside", "year": "1992", "unstructured": "Gartside SE, Ellis PM, Sharp T, Cowen PJ (1992) Selective 5-HT1A and 5-HT2 receptor-mediated adrenocorticotropin release in the rat: effect of repeated antidepressant treatments. Eur J Pharmacol 221:27\u201333", "journal-title": "Eur J Pharmacol"}, {"key": "20_CR49", "doi-asserted-by": "publisher", "first-page": "356", "DOI": "10.1007/BF02311184", "volume": "120", "author": "Y Gelfin", "year": "1995", "unstructured": "Gelfin Y, Lerer B, Lesch KP, Gorf\u00ecne M, Allolio B (1995) Complex effects of age and gender on hypothermic, adrenocorticotrophic hormone and Cortisol responses to ipsapirone challenge in normal subjects. Psychopharmacology (Berl) 120:356\u2013364", "journal-title": "Psychopharmacology"}, {"key": "20_CR50", "doi-asserted-by": "publisher", "first-page": "19", "DOI": "10.1055/s-2007-1017143", "volume": "19", "author": "LF Gram", "year": "1986", "unstructured": "Gram LF, Christensen P (1986) Benzodiazepine suppression of Cortisol secretion: a measure of anxiolytic activity. Pharmacopsychiatry 19:19\u201322", "journal-title": "Pharmacopsychiatry"}, {"key": "20_CR51", "doi-asserted-by": "publisher", "first-page": "185", "DOI": "10.1016/0014-2999(95)00209-4", "volume": "280", "author": "L Groenink", "year": "1995", "unstructured": "Groenink L, Van der Gugten J, Verdouw PM, Maes RAA, Olivier B (1995) The anxiolytic effects of flesinoxan, a 5-HT1A receptor agonist, are not related to its neuroendocrine effects. Eur J Pharmacol 280:185\u2013193", "journal-title": "Eur J Pharmacol"}, {"key": "20_CR52", "doi-asserted-by": "publisher", "first-page": "434", "DOI": "10.1016/0006-3223(94)00181-2", "volume": "37", "author": "U Halbreich", "year": "1995", "unstructured": "Halbreich U, Rojansky N, Palter S, Tworek H, Hissin P, Wang K (1995) Estrogen augments serotonergic activity in postmenopausal women. Biol Psychiatry 37:434\u2013441", "journal-title": "Biol Psychiatry"}, {"key": "20_CR53", "doi-asserted-by": "publisher", "first-page": "21", "DOI": "10.1001/archpsyc.1992.01820010021003", "volume": "49", "author": "E Hollander", "year": "1992", "unstructured": "Hollander E, DeCaria CM, Nitescu A, Gully R, Suckow RF, Cooper TB, Gorman JM, Klein DF, Liebowitz MR (1992) Serotonergic function in obsessive-compulsive disorder: behavioral and neuroendocrine responses to oral m-chlorophenylpiperazine and fenfluramine in patients and healthy volunteers. Arch Gen Psychiatry 49:21\u201328", "journal-title": "Arch Gen Psychiatry"}, {"key": "20_CR54", "doi-asserted-by": "crossref", "first-page": "277", "DOI": "10.1176/ajp.151.2.277", "volume": "151", "author": "E Hollander", "year": "1994", "unstructured": "Hollander E, Stein DJ, DeCaria CM, Cohen L, Saoud JB, Skodol AE, Kellman D, Rosnick L, Oldham JM (1994) Serotonergic sensitivity in borderline personality disorder: preliminary findings. Am J Psychiatry 151:277\u2013280", "journal-title": "Am J Psychiatry"}, {"key": "20_CR55", "doi-asserted-by": "crossref", "first-page": "59", "DOI": "10.3109/10799898809048978", "volume": "8", "author": "D Hoyer", "year": "1988", "unstructured": "Hoyer D (1988) Functional correlates of serotonin 5-HT1 recognition sites. J Recept Res 8:59\u201381", "journal-title": "J Recept Res"}, {"key": "20_CR56", "doi-asserted-by": "publisher", "first-page": "251", "DOI": "10.1016/0169-328X(91)90068-9", "volume": "10", "author": "S Idres", "year": "1991", "unstructured": "Idres S, Delarue C, Lefebvre H, Vaudry H (1991) Benzamide derivatives provide evidence for the involvement of a 5-HT4 receptor type in the mechanism of action of serotonin in frog adrenocortical cells. Mol Brain Res 10:251\u2013258", "journal-title": "Mol Brain Res"}, {"key": "20_CR57", "doi-asserted-by": "publisher", "first-page": "336", "DOI": "10.1159/000126134", "volume": "55", "author": "H Jorgensen", "year": "1992", "unstructured": "Jorgensen H, Knigge U, Warberg J (1992) Involvement of 5-HT1, 5-HT2, and 5-HT3 receptors in the mediation of the prolactin responses to serotonin and 5-hydroxytryptophan. Neuroendocrinology 55:336\u2013343", "journal-title": "Neuroendocrinology"}, {"key": "20_CR58", "doi-asserted-by": "publisher", "first-page": "225", "DOI": "10.1007/BF02245312", "volume": "108", "author": "RS Kahn", "year": "1992", "unstructured": "Kahn RS, Kling MA, Wetzler S, Asnis GM, Van Praag H (1992) Effect of m-chlorophenylpiperazine on plasma arginine-vasopressin concentrations in healthy subjects. Psychopharmacology (Berl) 108:225\u2013228", "journal-title": "Psychopharmacology"}, {"key": "20_CR59", "doi-asserted-by": "publisher", "first-page": "909", "DOI": "10.1016/0006-3223(94)91236-X", "volume": "35", "author": "RS Kahn", "year": "1994", "unstructured": "Kahn RS, Davidson M, Siever LJ, Sevy S, Davis KL (1994) Clozapine treatment and its effect on neuroendocrine responses induced by the serotonin agonist, m-chlorophenylpiperazine. Biol Psychiatry 35:909\u2013912", "journal-title": "Biol Psychiatry"}, {"key": "20_CR60", "doi-asserted-by": "publisher", "first-page": "573", "DOI": "10.1016/0361-9230(92)90105-7", "volume": "28", "author": "S Kawano", "year": "1992", "unstructured": "Kawano S, Osaka T, Kannan H, Yamashita H (1992) Excitation of hypothalamic paraventricular neurons by stimulation of the raphe nuclei. Brain Res Bull 28:573\u2013579", "journal-title": "Brain Res Bull"}, {"key": "20_CR61", "doi-asserted-by": "publisher", "first-page": "121", "DOI": "10.1007/BF00165292", "volume": "346", "author": "D Kelder", "year": "1992", "unstructured": "Kelder D, Ross SB (1992) Long lasting attenuation of 8-OH-DPAT-induced corticosterone secretion after a single injection of a 5-HT1A receptor agonist. Naunyn Schmiedebergs Arch Pharmacol 346:121\u2013126", "journal-title": "Naunyn Schmiedebergs Arch Pharmacol"}, {"key": "20_CR62", "doi-asserted-by": "publisher", "first-page": "643", "DOI": "10.1016/0028-3908(92)90142-C", "volume": "31", "author": "KJ Kellar", "year": "1992", "unstructured": "Kellar KJ, Hulihan-Giblin BA, Mulroney SE, Lumpkin MD, Flores CM (1992) Stimulation of serotonin1A receptors increases release of prolactin in the rat. Neuropharmacology 31:643\u2013647", "journal-title": "Neuropharmacology"}, {"key": "20_CR63", "doi-asserted-by": "publisher", "first-page": "174", "DOI": "10.1016/0304-3940(89)90032-3", "volume": "105", "author": "BH King", "year": "1989", "unstructured": "King BH, Brazell C, Dourish CT, Middlemiss DN (1989) MK-212 increases rat plasma ACTH concentration by activation of the 5-HT1C receptor subtype. Neurosci Lett 105:174\u2013176", "journal-title": "Neurosci Lett"}, {"key": "20_CR64", "doi-asserted-by": "publisher", "first-page": "870", "DOI": "10.1210/endo-119-2-870", "volume": "119", "author": "JZ Kiss", "year": "1986", "unstructured": "Kiss JZ, Kanycska B, Nagy GY (1986) Hypothalamic paraventricular nucleus has a pivotal role in regulation of prolactin release in lactating rats. Endocrinology 119:870\u2013873", "journal-title": "Endocrinology"}, {"key": "20_CR65", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.1016/0014-2999(87)90175-0", "volume": "137", "author": "JI Koenig", "year": "1987", "unstructured": "Koenig JI, Gudelsky GA, Meltzer HY (1987) Stimulation of corticosterone and beta-endorphin secretion in the rat by selective 5-HT receptor subtype activation. Eur J Pharmacol 137:1\u20138", "journal-title": "Eur J Pharmacol"}, {"key": "20_CR66", "doi-asserted-by": "publisher", "first-page": "711", "DOI": "10.1016/0091-3057(88)90192-X", "volume": "29", "author": "JI Koenig", "year": "1988", "unstructured": "Koenig JI, Meltzer HY, Gudelsky GA (1988) 5-Hydroxytryptamine1A receptor-mediated effects of buspirone, gepirone and ipsapirone. Pharmacol Biochem Behav 29:711\u2013715", "journal-title": "Pharmacol Biochem Behav"}, {"key": "20_CR67", "doi-asserted-by": "publisher", "first-page": "624", "DOI": "10.1001/archpsyc.1993.01820200034004", "volume": "50", "author": "JH Krystal", "year": "1993", "unstructured": "Krystal JH, Seibyl JP, Price LH, Woods SW, Heninger GR, Aghajanian GK, Charney DS (1993) m-Chlorophenylpiperazine effects in neuroleptic-free schizophrenic patients: evidence implicating serotonergic systems in the positive symptoms of schizophrenia. Arch Gen Psychiatry 50:624\u2013635", "journal-title": "Arch Gen Psychiatry"}, {"key": "20_CR68", "doi-asserted-by": "publisher", "first-page": "314", "DOI": "10.1159/000123566", "volume": "37", "author": "RE Lang", "year": "1983", "unstructured": "Lang RE, Heil JWE, Ganten D, Hermann K, Unger T, Rascher W (1983) Oxytocin unlike vasopressin is a stress hormone in the rat. Neuroendocrinology 37:314\u2013316", "journal-title": "Neuroendocrinology"}, {"key": "20_CR69", "doi-asserted-by": "publisher", "first-page": "1662", "DOI": "10.1210/jc.77.6.1662", "volume": "77", "author": "H Lefebvre", "year": "1993", "unstructured": "Lefebvre H, Contesse V, Delarue C, Soubrane C, Legrand A, Kuhn J-M, Wolf L-M, Vaudry H (1993) Effect of the serotonin-4 receptor agonist zacopride on aldosterone secretion from the human adrenal cortex: in vivo and in vitro studies. J Clin Endocrinol Metab 77:1662\u20131666", "journal-title": "J Clin Endocrinol Metab"}, {"key": "20_CR70", "first-page": "305", "volume": "211", "author": "G Fur Le", "year": "1979", "unstructured": "Le Fur G, Guilloux F, Mitrani N, Miazoule J, Uzan A (1979) Relationship between plasma corticosteroids and benzodiazepines in stress. J Pharmacol Exp Ther 211:305\u2013308", "journal-title": "J Pharmacol Exp Ther"}, {"key": "20_CR71", "doi-asserted-by": "publisher", "first-page": "307", "DOI": "10.1016/0014-2999(93)90915-5", "volume": "240", "author": "F Lejeune", "year": "1993", "unstructured": "Lejeune F, Rivet J-M, Gobert A, Canton H, Millan MJ (1993) WAY 100,135 and (-)- tertatolol act as antagonists at both 5-HT1A autoreceptors and postsynaptic 5-HT1A receptors in vivo. Eur J Pharmacol 240:307\u2013310", "journal-title": "Eur J Pharmacol"}, {"key": "20_CR72", "doi-asserted-by": "publisher", "first-page": "723", "DOI": "10.1016/0278-5846(91)90001-H", "volume": "15", "author": "KP Lesch", "year": "1991", "unstructured": "Lesch KP (1991) 5-HT1A receptor responsivity in anxiety disorders and depression. Prog Neuropsychopharmacol Biol Psychiatry 15:723\u2013733", "journal-title": "Prog Neuropsychopharmacol Biol Psychiatry"}, {"key": "20_CR73", "doi-asserted-by": "publisher", "first-page": "203", "DOI": "10.1016/0006-3223(89)90024-3", "volume": "26", "author": "KP Lesch", "year": "1989", "unstructured": "Lesch KP, Rupprecht R, Poten B, Muller U, Sohnle K, Fritze J (1989) Endocrine responses to 5-hydroxytryptamine-1A receptor activation by ipsapirone in humans. Biol Psychiatry 26:203\u2013205", "journal-title": "Biol Psychiatry"}, {"key": "20_CR74", "doi-asserted-by": "publisher", "first-page": "620", "DOI": "10.1016/0006-3223(90)90400-V", "volume": "28", "author": "KP Lesch", "year": "1990", "unstructured": "Lesch KP, Mayer M, Disselkamp-Tietze J, Hoh A, Wiesmann M, Osterheider M, Schulte HM (1990a) 5-HT1A receptor responsivity in unipolar depression. Evaluation of ipsapirone-induced ACTH and Cortisol secretion in patients and controls. Biol Psychiatry 28:620\u2013628", "journal-title": "Biol Psychiatry"}, {"key": "20_CR75", "doi-asserted-by": "publisher", "first-page": "670", "DOI": "10.1210/jcem-70-3-670", "volume": "70", "author": "KP Lesch", "year": "1990", "unstructured": "Lesch KP, Sohnle K, Poten B, Schoellnhammer G, Rupprecht R, Schulte HM (1990b) Corticotropin and Cortisol secretion after central 5-hydroxytryptamine-1A (5-HT1A) receptor activation: effects of 5-HT receptor and \u03b2-adrenoceptor antagonists. J Clin Endocrinol Metab 70:670\u2013674", "journal-title": "J Clin Endocrinol Metab"}, {"key": "20_CR76", "doi-asserted-by": "publisher", "first-page": "415", "DOI": "10.1007/BF02244438", "volume": "105", "author": "KP Lesch", "year": "1991", "unstructured": "Lesch KP, Schulte HM, Osterheider M, Muller T (1991) Long-term fluoxetine treatment decreases 5-HT1A receptor responsivity in obsessive-compulsive disorder. Psychopharmacology 105:415\u2013420", "journal-title": "Psychopharmacology"}, {"key": "20_CR77", "doi-asserted-by": "publisher", "first-page": "83", "DOI": "10.1016/0024-3205(92)90001-6", "volume": "51", "author": "AD Levy", "year": "1992", "unstructured": "Levy AD, Van de Kar LD (1992) Endocrine and receptor pharmacology of serotonergic anxiolytics, antipsychotics and antidepressants. Life Sci 51:83\u201394", "journal-title": "Life Sci"}, {"key": "20_CR78", "doi-asserted-by": "publisher", "first-page": "121", "DOI": "10.1016/0014-2999(92)90780-8", "volume": "221", "author": "AD Levy", "year": "1992", "unstructured": "Levy AD, Li Q, Alvarez Sanz MC, Rittenhouse PA, Brownf\u00eceld MS, Van de Kar LD (1992) Repeated cocaine modifies the neuroendocrine responses to the 5-HT1C/5-HT2 receptor agonist DOI. Eur J Pharmacol 221:121\u2013127", "journal-title": "Eur J Pharmacol"}, {"key": "20_CR79", "doi-asserted-by": "publisher", "first-page": "65", "DOI": "10.1159/000126513", "volume": "58", "author": "AD Levy", "year": "1993", "unstructured": "Levy AD, Li Q, Rittenhouse PA, Van de Kar LD (1993) Investigation of the role of 5-HT, receptors in the secretion of prolactin, ACTH and renin. Neuroendocrinology 58:65\u201370", "journal-title": "Neuroendocrinology"}, {"key": "20_CR80", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.1006/frne.1994.1006", "volume": "15", "author": "AD Levy", "year": "1994", "unstructured": "Levy AD, Baumann MH, Van de Kar LD (1994) Monoaminergic regulation of neuroendocrine function and its modification by cocaine. Front Neuroendocrinol 15:1\u201372", "journal-title": "Front Neuroendocrinol"}, {"key": "20_CR81", "doi-asserted-by": "publisher", "first-page": "141", "DOI": "10.1016/0014-2999(94)00719-N", "volume": "274", "author": "AD Levy", "year": "1995", "unstructured": "Levy AD, Li Q, Gustafson M, Van de Kar LD (1995) Neuroendocrine profile of the potential anxiolytic drug S-20499. Eur J Pharmacol 274:141\u2013149", "journal-title": "Eur J Pharmacol"}, {"key": "20_CR82", "doi-asserted-by": "publisher", "first-page": "983", "DOI": "10.1016/0028-3908(92)90098-A", "volume": "31", "author": "Q Li", "year": "1992", "unstructured": "Li Q, Rittenhouse PA. Levy AD, Alvarez Sanz MC, Van de Kar LD (1992) Neuroendocrine responses to the serotonin2 agonist DOI are differentially modified by three 5-HT1A agonists. Neuropharmacology 31:983\u2013989", "journal-title": "Neuropharmacology"}, {"key": "20_CR83", "first-page": "836", "volume": "266", "author": "Q Li", "year": "1993", "unstructured": "Li Q, Brownf\u00eceld MS, Battaglia G, Cabrera TM, Levy AD, Rittenhouse PA, Van de Kar LD (1993a) Long-term treatment with the antidepressants fluoxetine and desipramine potentiates endocrine responses to the serotonin agonists 6-chloro-2-(1-piperazinyl)-pyrazine (MK-212) and (\u00b1)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane HCI (DOI). J Pharmacol Exp Ther 266:836\u2013844", "journal-title": "J Pharmacol Exp Ther"}, {"key": "20_CR84", "doi-asserted-by": "publisher", "first-page": "148", "DOI": "10.1016/0006-8993(93)90652-4", "volume": "630", "author": "Q Li", "year": "1993", "unstructured": "Li Q, Levy AD, Cabrera TM, Brownf\u00eceld MS, Battaglia G, Van de Kar LD (1993b) Long-term fluoxetine, but not desipramine, inhibits the ACTH and oxytocin responses to the 5-HT1A agonist 8-OH-DPAT in male rats. Brain Res 630:148\u2013156", "journal-title": "Brain Res"}, {"key": "20_CR85", "doi-asserted-by": "publisher", "first-page": "300", "DOI": "10.1016/0006-3223(94)90627-0", "volume": "36", "author": "Q Li", "year": "1994", "unstructured": "Li Q, Brownf\u00eceld MS, Levy AD, Battaglia G, Cabrera TM, Van de Kar LD (1994) Attenuation of hormone responses to the 5-HT1A agonist ipsapirone by long-term treatment with fluoxetine, but not desipramine, in male rats. Biol Psychiatry 36:300\u2013308", "journal-title": "Biol Psychiatry"}, {"key": "20_CR86", "first-page": "343.13", "volume": "21", "author": "Q Li", "year": "1995", "unstructured": "Li Q, Battaglia G, Pinto W, Vicentic A, Chambers CB, Van de Kar LD (1995) Repeated injections of fluoxetine produce a delayed and gradual reduction in the ACTH and oxytocin responses to the 5-HT1A agonist 8-OH-DPAT. Soc Neurosci Abstr 21:343.13", "journal-title": "Soc Neurosci Abstr"}, {"key": "20_CR87", "doi-asserted-by": "publisher", "first-page": "541", "DOI": "10.1007/BF00489545", "volume": "86", "author": "Z Liposits", "year": "1987", "unstructured": "Liposits Z, Phelix C, Paull WK (1987) Synaptic interaction of serotonergic axons and corticotropin releasing factor (CRF) synthesizing neurons in the hypothalamic paraventricular nucleus of the rat. A light and electron microscopic immunocytochemical study. Histochemistry 86:541\u2013549", "journal-title": "Histochemistry"}, {"key": "20_CR88", "doi-asserted-by": "publisher", "first-page": "305", "DOI": "10.1159/000124754", "volume": "45", "author": "SA Lorens", "year": "1987", "unstructured": "Lorens SA, Van de Kar LD (1987) Differential effects of serotonin (5-HT1A and 5-HT2) agonists and antagonists on renin and corticosterone secretion. Neuroendocrinology 45:305\u2013310", "journal-title": "Neuroendocrinology"}, {"key": "20_CR89", "doi-asserted-by": "publisher", "first-page": "818", "DOI": "10.1016/0006-3223(88)90070-4", "volume": "23", "author": "MT Lowy", "year": "1988", "unstructured": "Lowy MT, Meltzer HY (1988) Stimulation of serum Cortisol and prolactin secretion in humans by MK-212, a centrally active serotonin agonist. Biol Psychiatry 23:818\u2013828", "journal-title": "Biol Psychiatry"}, {"key": "20_CR90", "doi-asserted-by": "publisher", "first-page": "235", "DOI": "10.1016/0006-3223(94)00264-4", "volume": "38", "author": "DD Maskall", "year": "1995", "unstructured": "Maskall DD, Zis AP, Lam RW, Clark CM, Kuan AJ (1995) Prolactin response to buspirone challenge in the presence of dopaminergic blockade. Biol Psychiatry 38:235\u2013239", "journal-title": "Biol Psychiatry"}, {"key": "20_CR91", "doi-asserted-by": "publisher", "first-page": "329", "DOI": "10.1016/0028-3908(89)90026-9", "volume": "28", "author": "GK Matheson", "year": "1989", "unstructured": "Matheson GK, Gage-White D, White G, Guthrie D, Rhoades J, Dixon V (1989) The effects of gepirone and 1-(2-pyrimidinyl)-piperazine on levels of corticosterone in rat plasma. Neuropharmacology 28:329\u2013334", "journal-title": "Neuropharmacology"}, {"key": "20_CR92", "doi-asserted-by": "publisher", "first-page": "675", "DOI": "10.1016/0306-3623(94)90245-3", "volume": "25", "author": "GK Matheson", "year": "1994", "unstructured": "Matheson GK, Pfeifer DM, Weiberg MB, Michel C (1994) The effects of azapirones on serotonin1A neurons of the dorsal raphe. Gen Pharmacol 25:675\u2013683", "journal-title": "Gen Pharmacol"}, {"key": "20_CR93", "first-page": "1246", "volume": "271", "author": "E Meller", "year": "1994", "unstructured": "Meller E, Bohmaker K (1994) Differential receptor reserve for 5-HT1A receptor-mediated regulation of plasma neuroendocrine hormones. J Pharmacol Exp Ther 271:1246\u20131252", "journal-title": "J Pharmacol Exp Ther"}, {"key": "20_CR94", "doi-asserted-by": "publisher", "first-page": "316", "DOI": "10.1016/0006-3223(94)90035-3", "volume": "35", "author": "HY Meltzer", "year": "1994", "unstructured": "Meltzer HY, Maes M (1994) Effects of buspirone on plasma prolactin and Cortisol levels in major depressed and normal subjects. Biol Psychiatry 35:316\u2013323", "journal-title": "Biol Psychiatry"}, {"key": "20_CR95", "doi-asserted-by": "publisher", "first-page": "310", "DOI": "10.1016/0006-3223(95)00301-V", "volume": "38", "author": "HY Meltzer", "year": "1995", "unstructured": "Meltzer HY, Maes M (1995) Effect of pindolol pretreatment on MK-212-induced plasma Cortisol and prolactin responses in normal men. Biol Psychiatry 38:310\u2013318", "journal-title": "Biol Psychiatry"}, {"key": "20_CR96", "doi-asserted-by": "publisher", "first-page": "1073", "DOI": "10.1016/0024-3205(76)90300-3", "volume": "19", "author": "HY Meltzer", "year": "1976", "unstructured": "Meltzer HY, Fang VS, Paul SM, Kaluskar R (1976) Effect of quipazine on rat plasma prolactin levels. Life Sci 19:1073\u20131078", "journal-title": "Life Sci"}, {"key": "20_CR97", "doi-asserted-by": "publisher", "first-page": "860", "DOI": "10.1210/endo-120-3-860", "volume": "120", "author": "N Minamitani", "year": "1987", "unstructured": "Minamitani N, Minamitani T, Lechan RM, Bollinger-Gruber J (1987) Paraventricular nucleus mediates prolactin secretory responses to restraint stress, ether stress, and 5-hydroxy-1-tryptophan injection in the rat. Endocrinology 120:860\u2013867", "journal-title": "Endocrinology"}, {"key": "20_CR98", "doi-asserted-by": "publisher", "first-page": "1179", "DOI": "10.1210/jcem-61-6-1179", "volume": "61", "author": "EA Mueller", "year": "1985", "unstructured": "Mueller EA, Murphy DL, Sunderland T (1985) Neuroendocrine effects of m-chlorophenylpiperazine, a serotonin agonist, in humans. J Clin Endocrinol Metab 61:1179\u20131184", "journal-title": "J Clin Endocrinol Metab"}, {"key": "20_CR99", "doi-asserted-by": "publisher", "first-page": "388", "DOI": "10.1007/BF00174380", "volume": "89", "author": "EA Mueller", "year": "1986", "unstructured": "Mueller EA, Murphy DL, Sunderland T (1986) Further studies of the putative serotonin agonist, m-chlorophenylpiperazine: evidence for a serotonin receptor mediated mechanism of action in humans. Psychopharmacology 89:388\u2013391", "journal-title": "Psychopharmacology"}, {"key": "20_CR100", "first-page": "527", "volume": "43", "author": "DL Murphy", "year": "1991", "unstructured": "Murphy DL, Lesch KP, Aulakh CS, Pigott TA (1991) Serotonin-selective arylpiperazines with neuroendocrine, behavioral, temperature, and cardiovascular effects in humans. Pharmacol Rev 43:527\u2013552", "journal-title": "Pharmacol Rev"}, {"key": "20_CR101", "first-page": "236", "volume": "249", "author": "JF Nash", "year": "1989", "unstructured": "Nash JF, Meltzer HY (1989) Effect of gepirone and ipsapirone on the stimulated and unstimulated secretion of prolactin in the rat. J Pharmacol Exp Ther 249:236\u2013241", "journal-title": "J Pharmacol Exp Ther"}, {"key": "20_CR102", "doi-asserted-by": "publisher", "first-page": "123", "DOI": "10.1016/0006-8993(86)90817-6", "volume": "271", "author": "T Nishikawa", "year": "1986", "unstructured": "Nishikawa T, Scatton B (1986) Neuroanatomical site of the inhibitory influence of anxiolytic drugs on central serotonergic transmission. Brain Res 271:123\u2013132", "journal-title": "Brain Res"}, {"key": "20_CR103", "first-page": "795", "volume": "256", "author": "MJ Owens", "year": "1991", "unstructured": "Owens MJ, Knight DL, Ritchie JC, Nemeroff CB (1991) The 5-hydroxytryptamine2 agonist, (\u00b1)-1-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane stimulates the hypothalamic-pituitary-adrenal (HPA) axis. II. Biochemical and physiological evidence for the development of tolerance after chronic administration. J Pharmacol Exp Ther 256:795\u2013800", "journal-title": "J Pharmacol Exp Ther"}, {"key": "20_CR104", "doi-asserted-by": "publisher", "first-page": "839", "DOI": "10.1016/0024-3205(92)90611-R", "volume": "51", "author": "J-T Pan", "year": "1992", "unstructured": "Pan J-T, Tai M-H (1992) Effects of ketanserin on DOI-, MCPP- and TRH-induced prolactin secretion in estrogen-treated rats. Life Sci 51:839\u2013845", "journal-title": "Life Sci"}, {"key": "20_CR105", "doi-asserted-by": "publisher", "first-page": "797", "DOI": "10.1159/000126332", "volume": "56", "author": "L Pan", "year": "1992", "unstructured": "Pan L, Gilbert F (1992) Activation of 5-HT1A receptor subtype in the paraventricular nuclei of the hypothalamus induces CRH ACTH release in the rat. Neuroendocrinology 56:797\u2013802", "journal-title": "Neuroendocrinology"}, {"key": "20_CR106", "doi-asserted-by": "publisher", "first-page": "33", "DOI": "10.1016/0031-9384(87)90341-6", "volume": "39", "author": "JM Paris", "year": "1987", "unstructured": "Paris JM, Lorens SA, Van de Kar LD, Urban JH, Richardson-Morton KD, Bethea CL (1987) A comparison of acute stress paradigms: hormonal responses and hypothalamic serotonin. Physiol Behav 39:33\u201343", "journal-title": "Physiol Behav"}, {"key": "20_CR107", "doi-asserted-by": "publisher", "first-page": "550", "DOI": "10.1159/000126404", "volume": "57", "author": "PE Pergola", "year": "1993", "unstructured": "Pergola PE, Sved AF, Voogt JL, Alper RH (1993) Effect of serotonin on vasopressin release: a comparison to corticosterone, prolactin and renin. Neuroendocrinology 57:550\u2013558", "journal-title": "Neuroendocrinology"}, {"key": "20_CR108", "doi-asserted-by": "publisher", "first-page": "289", "DOI": "10.1007/BF00327776", "volume": "277", "author": "T Petrov", "year": "1994", "unstructured": "Petrov T, Krukoff TL, Jhamandas JH (1994) Chemically defined collateral projections from the pons to the central nucleus of the amygdala and hypothalamic paraventricular nucleus in the rat. Cell Tissue Res 277:289\u2013295", "journal-title": "Cell Tissue Res"}, {"key": "20_CR109", "first-page": "1539", "volume": "19", "author": "W Pinto", "year": "1994", "unstructured": "Pinto W, Cabrera TM, Li Q, Van de Kar LD, Battaglia G (1994) Receptor reserve for 5-HT1A receptors in rat brain as assessed by neuroendocrine responses to 8-OH-DPAT stimulation. Soc Neurosci Abstr 19:1539 (no 632.4)", "journal-title": "Soc Neurosci Abstr"}, {"key": "20_CR110", "doi-asserted-by": "publisher", "first-page": "521", "DOI": "10.1016/0028-3908(90)90063-W", "volume": "29", "author": "E Przegalinski", "year": "1990", "unstructured": "Przegalinski E, Ismaiel AM, Chojnacka-Wojcik E, Budziszewska B, Tatarczynska E, Blaszczynska E (1990) The behavioural, but not the hypothermic or corticosterone, response to 8-hydroxy-2-(di-n-propylamino)-tetralin, is antagonized by NAN-190 in the rat. Neuropharmacology 29:521\u2013526", "journal-title": "Neuropharmacology"}, {"key": "20_CR111", "doi-asserted-by": "publisher", "first-page": "71", "DOI": "10.1016/0006-8993(79)90804-7", "volume": "174", "author": "A Quattrone", "year": "1979", "unstructured": "Quattrone A, Schettini G, Di Renzo G, Tedeschi G, Preziosi P (1979) Effect of midbrain raphe lesion or 5,7-dihydroxytryptamine treatment on the prolactin-releasing action of quipazine and D-fenfluramine in rats. Brain Res 174:71\u201379", "journal-title": "Brain Res"}, {"key": "20_CR112", "doi-asserted-by": "publisher", "first-page": "9", "DOI": "10.1016/0014-2999(81)90003-0", "volume": "76", "author": "A Quattrone", "year": "1981", "unstructured": "Quattrone A, Schettini G, Annunziato L, Di Renzo G (1981) Pharmacological evidence of supersensitivity of central serotonergic receptors involved in the control of prolactin secretion. Eur J Pharmacol 76:9\u201313", "journal-title": "Eur J Pharmacol"}, {"key": "20_CR113", "first-page": "290.15", "volume": "12", "author": "KD Richardson Morton", "year": "1986", "unstructured": "Richardson Morton KD, Van de Kar LD, Lorens SA, Paris JM, Urban JH, Kunimoto K (1986) The effect of stress on renin and corticosterone secretion is blocked by electrolytic lesions in the mesencephalic dorsal raphe and hypothalamic paraventricular nuclei. Soc Neurosci Abstr 12:290.15", "journal-title": "Soc Neurosci Abstr"}, {"key": "20_CR114", "doi-asserted-by": "publisher", "first-page": "73", "DOI": "10.1159/000125204", "volume": "50", "author": "KD Richardson Morton", "year": "1989", "unstructured": "Richardson Morton KD, Van de Kar LD, Brownfield MS, Bethea CL (1989) Neuronal cell bodies in the hypothalamic paraventricular nucleus mediate stress-induced renin and corticosterone secretion. Neuroendocrinology 50:73\u201380", "journal-title": "Neuroendocrinology"}, {"issue": "6", "key": "20_CR115", "first-page": "4", "volume": "52", "author": "E Richelson", "year": "1991", "unstructured": "Richelson E (1991) Biological basis of depression and therapeutic relevance. J Clin Psychiatry 52 [6, Suppl]:4\u201310", "journal-title": "J Clin Psychiatry"}, {"key": "20_CR116", "first-page": "58", "volume": "259", "author": "PA Rittenhouse", "year": "1991", "unstructured": "Rittenhouse PA, Bakkum EA, Van de Kar LD (1991) Evidence that the serotonin agonist, DOI, increases renin secretion and blood pressure through both central and peripheral 5-HT2 receptors. J Pharmacol Exp Ther 259:58\u201365", "journal-title": "J Pharmacol Exp Ther"}, {"key": "20_CR117", "doi-asserted-by": "publisher", "first-page": "205", "DOI": "10.1016/0006-8993(92)90946-7", "volume": "580", "author": "PA Rittenhouse", "year": "1992", "unstructured": "Rittenhouse PA, Bakkum EA, O\u2019Connor PA, Carnes M, Bethea CL, Van de Kar LD (1992a) Comparison of neuroendocrine and behavioral effects of ipsapirone, a 5-HT1A agonist, in three stress paradigms: immobilization, forced swim and conditioned fear. Brain Res 580:205\u2013214", "journal-title": "Brain Res"}, {"key": "20_CR118", "doi-asserted-by": "publisher", "first-page": "105", "DOI": "10.1016/0006-8993(92)91270-O", "volume": "593", "author": "PA Rittenhouse", "year": "1992", "unstructured": "Rittenhouse PA, Li Q, Levy AD, Van de Kar LD (1992b) Neurons in the hypothalamic paraventricular nucleus mediate the serotonergic stimulation of renin secretion. Brain Res 593:105\u2013113", "journal-title": "Brain Res"}, {"key": "20_CR119", "doi-asserted-by": "publisher", "first-page": "661", "DOI": "10.1210/en.133.2.661", "volume": "133", "author": "PA Rittenhouse", "year": "1993", "unstructured": "Rittenhouse PA, Levy AD, Li Q, Bethea CL, Van de Kar LD (1993) Neurons in the hypothalamic paraventricular nucleus mediate the serotonergic stimulation of prolactin secretion via 5-HT1C/2 receptors. Endocrinology 133:661\u2013667", "journal-title": "Endocrinology"}, {"key": "20_CR120", "first-page": "1647", "volume": "271", "author": "PA Rittenhouse", "year": "1994", "unstructured": "Rittenhouse PA, Bakkum EA, Levy AD, Li Q, Carnes M, Van de Kar LD (1994a) Evidence that ACTH secretion is regulated by serotonin2A/2C (5-HT2A/2C) receptors. J Pharmacol Exp Ther 271:1647\u20131655", "journal-title": "J Pharmacol Exp Ther"}, {"key": "20_CR121", "doi-asserted-by": "publisher", "first-page": "205", "DOI": "10.1159/000126754", "volume": "60", "author": "PA Rittenhouse", "year": "1994", "unstructured": "Rittenhouse PA, Bakkum EA, Levy AD, Li Q, Yracheta JM, Kunimoto K, Van de Kar LD (1994b) Central stimulation of renin secretion through serotonergic, noncardiovascular mechanisms. Neuroendocrinology 60:205\u2013214", "journal-title": "Neuroendocrinology"}, {"key": "20_CR122", "doi-asserted-by": "publisher", "first-page": "377", "DOI": "10.1007/BF00191172", "volume": "47", "author": "CA Rizzi", "year": "1994", "unstructured": "Rizzi CA (1994) A serotonergic mechanism for the metoclopramide-induced increase in aldosterone level. Eur J Clin Pharmacol 47:377\u2013378", "journal-title": "Eur J Clin Pharmacol"}, {"key": "20_CR123", "first-page": "1361", "volume": "260", "author": "BL Roth", "year": "1992", "unstructured": "Roth BL, Ciaranello RD, Meltzer HY (1992) Binding of typical and atypical antipsychotic agents to transiently expressed 5-HT1C receptors. J Pharmacol Exp Ther 260:1361\u20131365", "journal-title": "J Pharmacol Exp Ther"}, {"key": "20_CR124", "doi-asserted-by": "publisher", "first-page": "359", "DOI": "10.1007/BF00229413", "volume": "85", "author": "D Saphier", "year": "1991", "unstructured": "Saphier D (1991) Paraventricular nucleus magnocellular neuronal responses following electrical stimulation of the midbrain dorsal raphe. Exp Brain Res 85:359\u2013363", "journal-title": "Exp Brain Res"}, {"key": "20_CR125", "first-page": "167", "volume": "14", "author": "D Saphier", "year": "1994", "unstructured": "Saphier D, Welch JE (1994) 5-HT3 receptor activation in the rat increases adrenocortical secretion at the level of the central nervous system. Neurosci Res Commun 14:167\u2013173", "journal-title": "Neurosci Res Commun"}, {"key": "20_CR126", "doi-asserted-by": "publisher", "first-page": "239", "DOI": "10.1016/0306-4530(94)00056-G", "volume": "20", "author": "D Saphier", "year": "1995", "unstructured": "Saphier D, Farrar GE, Welch JE (1995) Differential inhibition of stress-induced adrenocortical responses by 5-HT1A agonists and by 5-HT2 and 5-HT3 antagonists. Psychoneuroendocrinology 20:239\u2013257", "journal-title": "Psychoneuroendocrinology"}, {"key": "20_CR127", "first-page": "221", "volume": "44", "author": "PE Sawchenko", "year": "1985", "unstructured": "Sawchenko PE, Swanson LW (1985) Localization, colocalization and plasticity of corticotropin-releasing factor immunoreactivity in rat brain. Fed Proc 44:221\u2013227", "journal-title": "Fed Proc"}, {"key": "20_CR128", "doi-asserted-by": "publisher", "first-page": "355", "DOI": "10.1016/0006-8993(83)90945-9", "volume": "277", "author": "PE Sawchenko", "year": "1983", "unstructured": "Sawchenko PE, Swanson LW, Steinbusch HWM, Verhofstad AAJ (1983) The distribution and cells of origin of serotonergic inputs to the paraventricular and supraoptic nuclei of the rat. Brain Res 277:355\u2013360", "journal-title": "Brain Res"}, {"key": "20_CR129", "first-page": "95", "volume": "257", "author": "JA Saydoff", "year": "1991", "unstructured": "Saydoff JA, Rittenhouse PA, Van de Kar LD, Brownf\u00eceld MS (1991) Enhanced serotonergic transmission stimulates oxytocin secretion in conscious male rats. J Pharmacol Exp Ther 257:95\u201399", "journal-title": "J Pharmacol Exp Ther"}, {"key": "20_CR130", "first-page": "823", "volume": "18", "author": "JA Saydoff", "year": "1992", "unstructured": "Saydoff JA, Leanza F, Carnes M, Brownf\u00eceld MS (1992) Central serotonin induces vasopressin and oxytocin secretion and a specific pattern of c-Fos expression in rat brain. Soc Neurosci Abstr 18:823 (no 346.5)", "journal-title": "Soc Neurosci Abstr"}, {"key": "20_CR131", "doi-asserted-by": "publisher", "first-page": "567", "DOI": "10.1016/0361-9230(93)90156-6", "volume": "32", "author": "JA Saydoff", "year": "1993", "unstructured": "Saydoff JA, Carnes M, Brownf\u00eceld MS (1993) The role of serotonergic neurons in intravenous hypertonic saline-induced secretion of vasopressin, oxytocin, and ACTH. Brain Res Bull 32:567\u2013572", "journal-title": "Brain Res Bull"}, {"key": "20_CR132", "first-page": "E513", "volume": "33", "author": "JA Saydoff", "year": "1996", "unstructured": "Saydoff JA, Rittenhouse PA, Carnes M, Armstrong J, Van de Kar LD, Brownf\u00eceld MS (1996) Neuroendocrine and cardiovascular activation by serotonin: selective role of brain angiotensin in vasopressin secretion. Am J Physiol Regul Integr Comp Physiol 33:E513-E521", "journal-title": "Am J Physiol Regul Integr Comp Physiol"}, {"key": "20_CR133", "doi-asserted-by": "crossref", "first-page": "511", "DOI": "10.1113/jphysiol.1993.sp019826", "volume": "469", "author": "H Scholz", "year": "1993", "unstructured": "Scholz H, Vogel U, Kurtz A (1993) Interrelation between baroreceptor and macula densa mechanisms in the control of renin secretion. J Physiol (Lond) 469:511\u2013524", "journal-title": "J Physiol"}, {"key": "20_CR134", "doi-asserted-by": "publisher", "first-page": "227", "DOI": "10.1016/0165-1781(91)90013-F", "volume": "38", "author": "JP Seibyl", "year": "1991", "unstructured": "Seibyl JP, Krystal JH, Price LH, Woods SW, D\u2019Amico C, Heninger GR, Charney DS (1991) Effects of ritanserin on the behavioral, neuroendocrine, and cardiovascular responses to meta-chlorophenylpiperazine in healthy human subjects. Psychiatry Res 38:227\u2013236", "journal-title": "Psychiatry Res"}, {"key": "20_CR135", "doi-asserted-by": "publisher", "first-page": "93", "DOI": "10.1016/0893-133X(95)00025-9", "volume": "13", "author": "B Seletti", "year": "1995", "unstructured": "Seletti B, Benkelfat C, Blier P, Annable L, Gilbert F, de Montigny C (1995) Serotonin1A receptor activation by flesinoxan in humans. Body temperature and neuroendocrine responses. Neuropsychopharmacology 13:93\u2013104", "journal-title": "Neuropsychopharmacology"}, {"key": "20_CR136", "doi-asserted-by": "publisher", "first-page": "143", "DOI": "10.1007/BF01255412", "volume": "59", "author": "M Simonovic", "year": "1984", "unstructured": "Simonovic M, Gudelsky GA, Meltzer HY (1984) Effect of 8-hydroxy-2-(di-n-propylamino)tetralin on rat prolactin secretion. J Neural Transm 59:143\u2013149", "journal-title": "J Neural Transm"}, {"key": "20_CR137", "doi-asserted-by": "publisher", "first-page": "145", "DOI": "10.1016/0006-8993(86)90122-8", "volume": "382", "author": "L Steardo", "year": "1986", "unstructured": "Steardo L, Iovino M (1986) Vasopressin release after enhanced serotonergic transmission is not due to activation of the peripheral renin-angiotensin system. Brain Res 382:145\u2013148", "journal-title": "Brain Res"}, {"key": "20_CR138", "doi-asserted-by": "publisher", "first-page": "269", "DOI": "10.1146/annurev.ne.06.030183.001413", "volume": "6", "author": "LW Swanson", "year": "1983", "unstructured": "Swanson LW, Sawchenko PE (1983) Hypothalamic integration: organization of the paraventricular and supraoptic nuclei. Annu Rev Neurosci 6:269\u2013324", "journal-title": "Annu Rev Neurosci"}, {"key": "20_CR139", "doi-asserted-by": "publisher", "first-page": "364", "DOI": "10.1016/0006-3223(94)00137-R", "volume": "37", "author": "JH Thakore", "year": "1995", "unstructured": "Thakore JH, Dinan TG (1995) Cortisol synthesis inhibition: a new treatment strategy for the clinical and endocrine manifestations of depression. Biol Psychiatry 37:364\u2013368", "journal-title": "Biol Psychiatry"}, {"key": "20_CR140", "doi-asserted-by": "publisher", "first-page": "2287", "DOI": "10.1016/0306-4522(82)90139-7", "volume": "7", "author": "MH Thiebot", "year": "1982", "unstructured": "Thiebot MH, Hamon M, Soubrie P (1982) Attenuation of induced-anxiety in rats by chlordiazepoxide: role of raphe dorsalis benzodiazepine binding sites and serotoninergic neurons. Neuroscience 7:2287\u20132294", "journal-title": "Neuroscience"}, {"key": "20_CR141", "doi-asserted-by": "publisher", "first-page": "3265", "DOI": "10.1016/0006-2952(87)90643-5", "volume": "36", "author": "M Titeler", "year": "1987", "unstructured": "Titeler M, Lyon RA, Davis KH, Glennon RA (1987) Selectivity of serotonergic drugs for multiple brain serotonin receptors. Biochem Pharmacol 36:3265\u20133271", "journal-title": "Biochem Pharmacol"}, {"key": "20_CR142", "doi-asserted-by": "publisher", "first-page": "457", "DOI": "10.1016/0091-3057(86)90023-7", "volume": "25", "author": "JH Urban", "year": "1986", "unstructured": "Urban JH, Van de Kar LD, Lorens SA, Bethea CL (1986) Effect of the anxiolytic drug buspirone on prolactin and corticosterone secretion in stressed and unstressed rats. Pharmacol Biochem Behav 25:457\u2013462", "journal-title": "Pharmacol Biochem Behav"}, {"key": "20_CR143", "doi-asserted-by": "publisher", "first-page": "188", "DOI": "10.1016/0006-8993(93)90077-Z", "volume": "624", "author": "EJ Bockstaele Van", "year": "1993", "unstructured": "Van Bockstaele EJ, Biswas A, Pickel VM (1993) Topography of serotonin neurons in the dorsal raphe nucleus that send axon collaterals to the rat prefrontal cortex and nucleus accumbens. Brain Res 624:188\u2013198", "journal-title": "Brain Res"}, {"key": "20_CR144", "doi-asserted-by": "publisher", "first-page": "289", "DOI": "10.1146/annurev.pa.31.040191.001445", "volume": "31", "author": "LD Kar Van de", "year": "1991", "unstructured": "Van de Kar LD (1991) Neuroendocrine pharmacology of serotonergic (5-HT) neurons. Annu Rev Pharmacol Toxicol 31:289\u2013320", "journal-title": "Annu Rev Pharmacol Toxicol"}, {"key": "20_CR145", "doi-asserted-by": "publisher", "first-page": "166", "DOI": "10.1111/j.1440-1681.1996.tb02591.x", "volume": "23", "author": "LD Kar Van de", "year": "1996", "unstructured": "Van de Kar LD (1996) Forebrain pathways mediating stress-induced renin secretion. Clin Exp Pharmacol Physiol 23: 166\u2013170", "journal-title": "Clin Exp Pharmacol Physiol"}, {"key": "20_CR146", "doi-asserted-by": "publisher", "first-page": "225", "DOI": "10.1159/000123386", "volume": "35", "author": "LD Kar Van de", "year": "1982", "unstructured": "Van de Kar LD, Bethea CL (1982) Pharmacological evidence that serotonergic stimulation of prolactin secretion is mediated via the dorsal raphe nucleus. Neuroendocrinology 35:225\u2013230", "journal-title": "Neuroendocrinology"}, {"key": "20_CR147", "first-page": "202", "volume": "8", "author": "LD Kar Van de", "year": "1993", "unstructured": "Van de Kar LD, Brownf\u00eceld MS (1993) Serotonergic neurons and neuroendocrine function. NIPS 8:202\u2013207", "journal-title": "NIPS"}, {"key": "20_CR148", "doi-asserted-by": "publisher", "first-page": "45", "DOI": "10.1016/0006-8993(79)90754-6", "volume": "162", "author": "LD Kar Van de", "year": "1979", "unstructured": "Van de Kar LD, Lorens SA (1979) Differential serotonergic innervation of individual hypothalamic nuclei and other forebrain regions by the dorsal and median raphe nuclei. Brain Res 162:45\u201354", "journal-title": "Brain Res"}, {"key": "20_CR149", "first-page": "85", "volume": "219", "author": "LD Kar Van de", "year": "1981", "unstructured": "Van de Kar LD, Wilkinson CW, Ganong WF (1981) Pharmacological evidence for a role of brain serotonin in the maintenance of plasma renin activity in unanesthetized rats. J Pharmacol Exp Ther 219:85\u201390", "journal-title": "J Pharmacol Exp Ther"}, {"key": "20_CR150", "doi-asserted-by": "publisher", "first-page": "233", "DOI": "10.1016/0006-8993(82)91003-4", "volume": "235", "author": "LD Kar Van de", "year": "1982", "unstructured": "Van de Kar LD, Wilkinson CW, Skrobik Y, Brownf\u00eceld MS, Ganong WF (1982) Evidence that serotonergic neurons in the dorsal raphe nucleus exert a stimulatory effect on the secretion of renin but not of corticosterone. Brain Res 235:233\u2013243", "journal-title": "Brain Res"}, {"key": "20_CR151", "doi-asserted-by": "publisher", "first-page": "333", "DOI": "10.1016/0006-8993(84)90096-9", "volume": "311", "author": "LD Kar Van de", "year": "1984", "unstructured": "Van de Kar LD, Lorens SA, McWilliams CR, Kunimoto K, Urban JH, Bethea CL (1984) Role of midbrain raphe in stress-induced renin and prolactin secretion. Brain Res 311:333\u2013341", "journal-title": "Brain Res"}, {"key": "20_CR152", "doi-asserted-by": "publisher", "first-page": "257", "DOI": "10.1016/0006-8993(85)91001-7", "volume": "345", "author": "LD Kar Van de", "year": "1985", "unstructured": "Van de Kar LD, Lorens SA, Urban JH, Richardson KD, Paris J (1985a) Pharmacological studies on stress-induced renin and prolactin secretion: effects of benzodiazepines, naloxone, propranolol and diisopropylfluorophosphate (DFP). Brain Res 345:257\u2013263", "journal-title": "Brain Res"}, {"key": "20_CR153", "doi-asserted-by": "publisher", "first-page": "1149", "DOI": "10.1016/0024-3205(85)90231-0", "volume": "36", "author": "LD Kar Van de", "year": "1985", "unstructured": "Van de Kar LD, Urban JH, Lorens SA, Richardson KD (1985b) The non-benzodiazepine anxiolytic buspirone inhibits stress-induced renin secretion and lowers heart rate. Life Sci 36:1149\u20131155", "journal-title": "Life Sci"}, {"key": "20_CR154", "first-page": "428", "volume": "251", "author": "LD Kar Van de", "year": "1989", "unstructured": "Van de Kar LD, Carnes M, Maslowski RJ, Bonadonna AM, Rittenhouse PA, Kunimoto K, Piechowski RA, Bethea CL (1989a) Neuroendocrine evidence for denervation supersensitivity of serotonin receptors: effects of the 5-HT agonist RU 24969 on corticotropin, corticosterone, prolactin and renin secretion. J Pharmacol Exp Ther 251:428\u2013434", "journal-title": "J Pharmacol Exp Ther"}, {"key": "20_CR155", "doi-asserted-by": "publisher", "first-page": "299", "DOI": "10.1016/0028-3908(89)90107-X", "volume": "28", "author": "LD Kar Van de", "year": "1989", "unstructured": "Van de Kar LD, Lorens SA, Urban JH, Bethea CL (1989b) Effect of selective serotonin (5-HT) agonists and 5-HT2 antagonist on prolactin secretion. Neuropharmacology 28:299\u2013305", "journal-title": "Neuropharmacology"}, {"key": "20_CR156", "author": "LD Kar Van de", "first-page": "123", "year": "1990", "unstructured": "Van de Kar LD, Urban JH, Brownf\u00eceld MS (1990) Serotonergic regulation of renin and vasopressin secretion. In: Paoletti R, Vanhoutte PM, Brunello N, Maggi FM (eds) Serotonin. From cell biology to pharmacology and therapeutics. Kluwer Academic, Dordrecht, Netherlands, pp 123\u2013129", "volume-title": "Serotonin. From cell biology to pharmacology and therapeutics"}, {"key": "20_CR157", "author": "LD Kar Van de", "first-page": "133", "year": "1991", "unstructured": "Van de Kar LD, Richardson Morton KD, Rittenhouse PA (1991) Stress: neuroendocrine and pharmacological mechanisms. In: Jasmin G, Cantin M (eds) Stress revisited. 1. Neuroendocrinology of stress. Methods and achievements in experimental pathology. Karger, Basel, pp 133\u2013173", "volume-title": "Stress revisited. 1. Neuroendocrinology of stress. Methods and achievements in experimental pathology"}, {"key": "20_CR158", "doi-asserted-by": "publisher", "first-page": "258", "DOI": "10.1016/0006-3223(92)90107-B", "volume": "32", "author": "LD Kar Van de", "year": "1992", "unstructured": "Van de Kar LD, Rittenhouse PA, O\u2019Connor P, Palionis T, Brownf\u00eceld MS, Lent SJ, Carnes M, Bethea CL (1992) Repeated cocaine injections reduce the magnitude of the effect of the serotonin agonist MK-212 on prolactin, vasopressin, oxytocin and renin but not ACTH or corticosterone secretion. Biol Psychiatry 32:258\u2013269", "journal-title": "Biol Psychiatry"}, {"key": "20_CR159", "doi-asserted-by": "publisher", "first-page": "429", "DOI": "10.1016/0091-3057(94)90548-7", "volume": "48", "author": "LD Kar Van de", "year": "1994", "unstructured": "Van de Kar LD, Alvarez Sanz MC, Yracheta JM, Kunimoto K, Li Q, Levy AD, Rittenhouse PA (1994) ICV injection of the serotonin 5-HT1B agonist CP-93,129 increases the secretion of ACTH, prolactin, and renin and increases blood pressure by nonserotonergic mechanisms. Pharmacol Biochem Behav 48:429\u2013436", "journal-title": "Pharmacol Biochem Behav"}, {"key": "20_CR160", "first-page": "343.14", "volume": "21", "author": "LD Kar Van de", "year": "1995", "unstructured": "Van de Kar LD, Li Q, Vicentini A, Battaglia G (1995a) Evidence that the prolactin response to the 5-HT1A agonist 8-OH-DPAT is mediated by Gi proteins. Soc Neurosci Abstr 21:343.14", "journal-title": "Soc Neurosci Abstr"}, {"key": "20_CR161", "doi-asserted-by": "publisher", "first-page": "45", "DOI": "10.1016/0361-9230(94)00161-S", "volume": "36", "author": "LD Kar Van de", "year": "1995", "unstructured": "Van de Kar LD, Rittenhouse PA, Li Q, Levy AD, Brownfield MS (1995b) Hypothalamic paraventricular, but not supraoptic neurons, mediate the serotonergic stimulation of oxytocin secretion. Brain Res Bull 36:45\u201350", "journal-title": "Brain Res Bull"}, {"key": "20_CR162", "doi-asserted-by": "publisher", "first-page": "301", "DOI": "10.1016/0922-4106(90)90190-9", "volume": "188", "author": "I Wijngaarden Van", "year": "1990", "unstructured": "Van Wijngaarden I, Tulp MTM, Soudijn W (1990) The concept of selectivity in 5-HT receptor research. Eur J Pharmacol 188:301\u2013312", "journal-title": "Eur J Pharmacol"}, {"key": "20_CR163", "doi-asserted-by": "publisher", "first-page": "123", "DOI": "10.1016/0014-2999(86)90343-2", "volume": "129", "author": "CP VanderMaelen", "year": "1986", "unstructured": "VanderMaelen CP, Matheson GK, Wilderman RC, Patterson LA (1986) Inhibition of serotonergic dorsal raphe neurons by systemic and iontophoretic administration of buspirone, a non-benzodiazepine anxiolytic drug. Eur J Pharmacol 129:123\u2013130", "journal-title": "Eur J Pharmacol"}, {"key": "20_CR164", "doi-asserted-by": "publisher", "first-page": "447", "DOI": "10.1016/0024-3205(93)90696-Z", "volume": "53", "author": "LN Yatham", "year": "1993", "unstructured": "Yatham LN, Steiner M (1993) Neuroendocrine probes of serotonergic function: a critical review. Life Sci 53:447\u2013463", "journal-title": "Life Sci"}, {"key": "20_CR165", "first-page": "401", "volume": "44", "author": "E Zifa", "year": "1992", "unstructured": "Zifa E, Fillion G (1992) 5-Hydroxytryptamine receptors. Pharmacol Rev 44:401\u2013458", "journal-title": "Pharmacol Rev"}, {"key": "20_CR166", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.1097/00005344-199001000-00001", "volume": "15", "author": "MH Zink III", "year": "1990", "unstructured": "Zink MH, III, Pergola PE, Doane JF, Sved AF, Alper RH (1990) Quipazine increases renin release by a peripheral hemodynamic mechanism. J Cardiovasc Pharmacol 15:1\u20139", "journal-title": "J Cardiovasc Pharmacol"}], "container-title": ["Serotoninergic Neurons and 5-HT Receptors in the CNS", "Handbook of Experimental Pharmacology"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/978-3-642-60921-3_20", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 8]], "date-time": "2019-05-08T04:20:05Z", "timestamp": 1557289205000}, "score": 21.837341, "issued": {"date-parts": [[2000]]}, "ISBN": ["9783540667155", "9783642609213"], "references-count": 166, "URL": "http://dx.doi.org/10.1007/978-3-642-60921-3_20", "relation": {"cites": []}, "ISSN": ["0171-2004"], "issn-type": [{"value": "0171-2004", "type": "print"}]}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}